id	sid	tid	token	lemma	pos
dpc-1242	1	1	dermatology	dermatology	NOUN
dpc-1242	1	2	:	:	PUNCT
dpc-1242	1	3	practical	practical	ADJ
dpc-1242	1	4	and	and	CCONJ
dpc-1242	1	5	conceptual	conceptual	ADJ
dpc-1242	1	6	research	research	NOUN
dpc-1242	1	7	|	|	ADV
dpc-1242	1	8	dermatol	dermatol	ADJ
dpc-1242	1	9	pract	pract	NOUN
dpc-1242	1	10	concept	concept	NOUN
dpc-1242	1	11	2020;10(4):e2020094	2020;10(4):e2020094	NUM
dpc-1242	1	12	1	1	NUM
dpc-1242	1	13	dermatology	dermatology	NOUN
dpc-1242	1	14	practical	practical	ADJ
dpc-1242	1	15	&	&	CCONJ
dpc-1242	1	16	conceptual	conceptual	ADJ
dpc-1242	1	17	an	an	DET
dpc-1242	1	18	open	open	ADJ
dpc-1242	1	19	-	-	PUNCT
dpc-1242	1	20	label	label	NOUN
dpc-1242	1	21	prospective	prospective	ADJ
dpc-1242	1	22	study	study	NOUN
dpc-1242	1	23	to	to	PART
dpc-1242	1	24	compare	compare	VERB
dpc-1242	1	25	the	the	DET
dpc-1242	1	26	efficacy	efficacy	NOUN
dpc-1242	1	27	and	and	CCONJ
dpc-1242	1	28	safety	safety	NOUN
dpc-1242	1	29	of	of	ADP
dpc-1242	1	30	topical	topical	ADJ
dpc-1242	1	31	fluticasone	fluticasone	NOUN
dpc-1242	1	32	versus	versus	ADP
dpc-1242	1	33	tacrolimus	tacrolimus	NOUN
dpc-1242	1	34	in	in	ADP
dpc-1242	1	35	the	the	DET
dpc-1242	1	36	proactive	proactive	ADJ
dpc-1242	1	37	treatment	treatment	NOUN
dpc-1242	1	38	of	of	ADP
dpc-1242	1	39	atopic	atopic	NOUN
dpc-1242	1	40	dermatitis	dermatitis	NOUN
dpc-1242	1	41	vinodhini	vinodhini	PROPN
dpc-1242	1	42	r.	r.	PROPN
dpc-1242	1	43	mudaliyar1	mudaliyar1	PROPN
dpc-1242	1	44	,	,	PUNCT
dpc-1242	1	45	asha	asha	PROPN
dpc-1242	1	46	pathak1	pathak1	PROPN
dpc-1242	1	47	,	,	PUNCT
dpc-1242	1	48	alok	alok	PROPN
dpc-1242	1	49	dixit1	dixit1	PROPN
dpc-1242	1	50	,	,	PUNCT
dpc-1242	1	51	sweta	sweta	PROPN
dpc-1242	1	52	s.	s.	PROPN
dpc-1242	1	53	kumar2	kumar2	PROPN
dpc-1242	2	1	1	1	NUM
dpc-1242	2	2	department	department	NOUN
dpc-1242	2	3	of	of	ADP
dpc-1242	2	4	pharmacology	pharmacology	PROPN
dpc-1242	2	5	,	,	PUNCT
dpc-1242	2	6	uttar	uttar	PROPN
dpc-1242	2	7	pradesh	pradesh	PROPN
dpc-1242	2	8	university	university	PROPN
dpc-1242	2	9	of	of	ADP
dpc-1242	2	10	medical	medical	ADJ
dpc-1242	2	11	sciences	sciences	PROPN
dpc-1242	2	12	,	,	PUNCT
dpc-1242	2	13	saifai	saifai	PROPN
dpc-1242	2	14	,	,	PUNCT
dpc-1242	2	15	etawah	etawah	PROPN
dpc-1242	2	16	,	,	PUNCT
dpc-1242	2	17	india	india	PROPN
dpc-1242	2	18	2	2	NUM
dpc-1242	2	19	department	department	NOUN
dpc-1242	2	20	of	of	ADP
dpc-1242	2	21	dermatology	dermatology	NOUN
dpc-1242	2	22	,	,	PUNCT
dpc-1242	2	23	uttar	uttar	PROPN
dpc-1242	2	24	pradesh	pradesh	PROPN
dpc-1242	2	25	university	university	PROPN
dpc-1242	2	26	of	of	ADP
dpc-1242	2	27	medical	medical	ADJ
dpc-1242	2	28	sciences	sciences	PROPN
dpc-1242	2	29	,	,	PUNCT
dpc-1242	2	30	saifai	saifai	PROPN
dpc-1242	2	31	,	,	PUNCT
dpc-1242	2	32	etawah	etawah	NOUN
dpc-1242	2	33	,	,	PUNCT
dpc-1242	2	34	india	india	PROPN
dpc-1242	2	35	key	key	ADJ
dpc-1242	2	36	words	word	NOUN
dpc-1242	2	37	:	:	PUNCT
dpc-1242	2	38	topical	topical	ADJ
dpc-1242	2	39	corticosteroids	corticosteroid	NOUN
dpc-1242	2	40	,	,	PUNCT
dpc-1242	2	41	topical	topical	ADJ
dpc-1242	2	42	calcineurin	calcineurin	NOUN
dpc-1242	2	43	inhibitors	inhibitor	NOUN
dpc-1242	2	44	,	,	PUNCT
dpc-1242	2	45	fluticasone	fluticasone	NOUN
dpc-1242	2	46	propionate	propionate	NOUN
dpc-1242	2	47	,	,	PUNCT
dpc-1242	2	48	tacrolimus	tacrolimus	NOUN
dpc-1242	2	49	,	,	PUNCT
dpc-1242	2	50	atopic	atopic	NOUN
dpc-1242	2	51	dermatitis	dermatitis	NOUN
dpc-1242	2	52	citation	citation	NOUN
dpc-1242	2	53	:	:	PUNCT
dpc-1242	2	54	mudaliyar	mudaliyar	PROPN
dpc-1242	2	55	vr	vr	PROPN
dpc-1242	2	56	,	,	PUNCT
dpc-1242	2	57	pathak	pathak	PROPN
dpc-1242	2	58	a	a	PROPN
dpc-1242	2	59	,	,	PUNCT
dpc-1242	2	60	dixit	dixit	PROPN
dpc-1242	2	61	a	a	PROPN
dpc-1242	2	62	,	,	PUNCT
dpc-1242	2	63	kumar	kumar	PROPN
dpc-1242	2	64	ss	ss	PROPN
dpc-1242	2	65	.	.	PUNCT
dpc-1242	3	1	an	an	DET
dpc-1242	3	2	open	open	ADJ
dpc-1242	3	3	-	-	PUNCT
dpc-1242	3	4	label	label	NOUN
dpc-1242	3	5	prospective	prospective	ADJ
dpc-1242	3	6	study	study	NOUN
dpc-1242	3	7	to	to	PART
dpc-1242	3	8	compare	compare	VERB
dpc-1242	3	9	the	the	DET
dpc-1242	3	10	efficacy	efficacy	NOUN
dpc-1242	3	11	and	and	CCONJ
dpc-1242	3	12	safety	safety	NOUN
dpc-1242	3	13	of	of	ADP
dpc-1242	3	14	topical	topical	ADJ
dpc-1242	3	15	fluticasone	fluticasone	NOUN
dpc-1242	3	16	versus	versus	ADP
dpc-1242	3	17	tacrolimus	tacrolimus	NOUN
dpc-1242	3	18	in	in	ADP
dpc-1242	3	19	the	the	DET
dpc-1242	3	20	proactive	proactive	ADJ
dpc-1242	3	21	treatment	treatment	NOUN
dpc-1242	3	22	of	of	ADP
dpc-1242	3	23	atopic	atopic	NOUN
dpc-1242	3	24	dermatitis	dermatitis	NOUN
dpc-1242	3	25	.	.	PUNCT
dpc-1242	4	1	dermatol	dermatol	NOUN
dpc-1242	4	2	pract	pract	PROPN
dpc-1242	4	3	concept	concept	NOUN
dpc-1242	4	4	.	.	PUNCT
dpc-1242	5	1	2020;10(4):e2020094	2020;10(4):e2020094	X
dpc-1242	5	2	.	.	PUNCT
dpc-1242	5	3	doi	doi	NOUN
dpc-1242	5	4	:	:	PUNCT
dpc-1242	5	5	https://	https://	PROPN
dpc-1242	5	6	doi.org/10.5826/dpc.1004a94	doi.org/10.5826/dpc.1004a94	PROPN
dpc-1242	5	7	accepted	accept	VERB
dpc-1242	5	8	:	:	PUNCT
dpc-1242	5	9	may	may	AUX
dpc-1242	5	10	14	14	NUM
dpc-1242	5	11	,	,	PUNCT
dpc-1242	5	12	2020	2020	NUM
dpc-1242	5	13	;	;	PUNCT
dpc-1242	5	14	published	publish	VERB
dpc-1242	5	15	:	:	PUNCT
dpc-1242	5	16	october	october	PROPN
dpc-1242	5	17	26	26	NUM
dpc-1242	5	18	,	,	PUNCT
dpc-1242	5	19	2020	2020	NUM
dpc-1242	5	20	copyright	copyright	NOUN
dpc-1242	5	21	:	:	PUNCT
dpc-1242	6	1	©	©	PROPN
dpc-1242	6	2	2020	2020	NUM
dpc-1242	6	3	mudaliyar	mudaliyar	NOUN
dpc-1242	6	4	et	et	PROPN
dpc-1242	6	5	al	al	PROPN
dpc-1242	6	6	.	.	PUNCT
dpc-1242	7	1	this	this	PRON
dpc-1242	7	2	is	be	AUX
dpc-1242	7	3	an	an	DET
dpc-1242	7	4	open	open	ADJ
dpc-1242	7	5	-	-	PUNCT
dpc-1242	7	6	access	access	NOUN
dpc-1242	7	7	article	article	NOUN
dpc-1242	7	8	distributed	distribute	VERB
dpc-1242	7	9	under	under	ADP
dpc-1242	7	10	the	the	DET
dpc-1242	7	11	terms	term	NOUN
dpc-1242	7	12	of	of	ADP
dpc-1242	7	13	the	the	DET
dpc-1242	7	14	creative	creative	ADJ
dpc-1242	7	15	commons	common	NOUN
dpc-1242	7	16	attribution	attribution	NOUN
dpc-1242	7	17	license	license	NOUN
dpc-1242	7	18	by	by	ADP
dpc-1242	7	19	-	-	PUNCT
dpc-1242	7	20	nc-4.0	nc-4.0	NOUN
dpc-1242	7	21	,	,	PUNCT
dpc-1242	7	22	which	which	PRON
dpc-1242	7	23	permits	permit	VERB
dpc-1242	7	24	unrestricted	unrestricted	ADJ
dpc-1242	7	25	noncommercial	noncommercial	ADJ
dpc-1242	7	26	use	use	NOUN
dpc-1242	7	27	,	,	PUNCT
dpc-1242	7	28	distribution	distribution	NOUN
dpc-1242	7	29	,	,	PUNCT
dpc-1242	7	30	and	and	CCONJ
dpc-1242	7	31	reproduction	reproduction	NOUN
dpc-1242	7	32	in	in	ADP
dpc-1242	7	33	any	any	DET
dpc-1242	7	34	medium	medium	NOUN
dpc-1242	7	35	,	,	PUNCT
dpc-1242	7	36	provided	provide	VERB
dpc-1242	7	37	the	the	DET
dpc-1242	7	38	original	original	ADJ
dpc-1242	7	39	author	author	NOUN
dpc-1242	7	40	and	and	CCONJ
dpc-1242	7	41	source	source	NOUN
dpc-1242	7	42	are	be	AUX
dpc-1242	7	43	credited	credit	VERB
dpc-1242	7	44	.	.	PUNCT
dpc-1242	8	1	funding	funding	NOUN
dpc-1242	8	2	:	:	PUNCT
dpc-1242	8	3	none	none	NOUN
dpc-1242	8	4	.	.	PUNCT
dpc-1242	9	1	competing	compete	VERB
dpc-1242	9	2	interests	interest	NOUN
dpc-1242	9	3	:	:	PUNCT
dpc-1242	9	4	the	the	DET
dpc-1242	9	5	authors	author	NOUN
dpc-1242	9	6	have	have	VERB
dpc-1242	9	7	no	no	DET
dpc-1242	9	8	conflicts	conflict	NOUN
dpc-1242	9	9	of	of	ADP
dpc-1242	9	10	interest	interest	NOUN
dpc-1242	9	11	to	to	PART
dpc-1242	9	12	disclose	disclose	VERB
dpc-1242	9	13	.	.	PUNCT
dpc-1242	10	1	authorship	authorship	NOUN
dpc-1242	10	2	:	:	PUNCT
dpc-1242	10	3	all	all	DET
dpc-1242	10	4	authors	author	NOUN
dpc-1242	10	5	have	have	AUX
dpc-1242	10	6	contributed	contribute	VERB
dpc-1242	10	7	significantly	significantly	ADV
dpc-1242	10	8	to	to	ADP
dpc-1242	10	9	this	this	DET
dpc-1242	10	10	publication	publication	NOUN
dpc-1242	10	11	.	.	PUNCT
dpc-1242	11	1	corresponding	correspond	VERB
dpc-1242	11	2	author	author	NOUN
dpc-1242	11	3	:	:	PUNCT
dpc-1242	11	4	dr	dr	PROPN
dpc-1242	11	5	.	.	PROPN
dpc-1242	11	6	vinodhini	vinodhini	PROPN
dpc-1242	11	7	r.	r.	PROPN
dpc-1242	11	8	mudaliyar	mudaliyar	PROPN
dpc-1242	11	9	,	,	PUNCT
dpc-1242	11	10	department	department	NOUN
dpc-1242	11	11	of	of	ADP
dpc-1242	11	12	pharmacology	pharmacology	PROPN
dpc-1242	11	13	,	,	PUNCT
dpc-1242	11	14	uttar	uttar	PROPN
dpc-1242	11	15	pradesh	pradesh	PROPN
dpc-1242	11	16	university	university	PROPN
dpc-1242	11	17	of	of	ADP
dpc-1242	11	18	medical	medical	ADJ
dpc-1242	11	19	sciences	sciences	PROPN
dpc-1242	11	20	,	,	PUNCT
dpc-1242	11	21	saifai	saifai	PROPN
dpc-1242	11	22	,	,	PUNCT
dpc-1242	11	23	etawah	etawah	NOUN
dpc-1242	11	24	,	,	PUNCT
dpc-1242	11	25	206130	206130	NUM
dpc-1242	11	26	india	india	PROPN
dpc-1242	11	27	.	.	PUNCT
dpc-1242	12	1	email	email	NOUN
dpc-1242	12	2	:	:	PUNCT
dpc-1242	12	3	drvinodhini14@gmail.com	drvinodhini14@gmail.com	X
dpc-1242	12	4	background	background	NOUN
dpc-1242	12	5	:	:	PUNCT
dpc-1242	12	6	atopic	atopic	NOUN
dpc-1242	12	7	dermatitis	dermatitis	NOUN
dpc-1242	12	8	(	(	PUNCT
dpc-1242	12	9	ad	ad	NOUN
dpc-1242	12	10	)	)	PUNCT
dpc-1242	12	11	,	,	PUNCT
dpc-1242	12	12	a	a	DET
dpc-1242	12	13	chronic	chronic	NOUN
dpc-1242	12	14	,	,	PUNCT
dpc-1242	12	15	recurrent	recurrent	ADJ
dpc-1242	12	16	inflammatory	inflammatory	ADJ
dpc-1242	12	17	skin	skin	NOUN
dpc-1242	12	18	condition	condition	NOUN
dpc-1242	12	19	primarily	primarily	ADV
dpc-1242	12	20	affects	affect	VERB
dpc-1242	12	21	children	child	NOUN
dpc-1242	12	22	.	.	PUNCT
dpc-1242	13	1	topical	topical	ADJ
dpc-1242	13	2	treatment	treatment	NOUN
dpc-1242	13	3	,	,	PUNCT
dpc-1242	13	4	systemic	systemic	ADJ
dpc-1242	13	5	treatment	treatment	NOUN
dpc-1242	13	6	,	,	PUNCT
dpc-1242	13	7	and	and	CCONJ
dpc-1242	13	8	phototherapy	phototherapy	NOUN
dpc-1242	13	9	are	be	AUX
dpc-1242	13	10	mainstays	mainstay	NOUN
dpc-1242	13	11	of	of	ADP
dpc-1242	13	12	treatment	treatment	NOUN
dpc-1242	13	13	.	.	PUNCT
dpc-1242	14	1	topical	topical	ADJ
dpc-1242	14	2	corticosteroids	corticosteroid	NOUN
dpc-1242	14	3	(	(	PUNCT
dpc-1242	14	4	tcs	tcs	NOUN
dpc-1242	14	5	)	)	PUNCT
dpc-1242	14	6	are	be	AUX
dpc-1242	14	7	first	first	ADJ
dpc-1242	14	8	-	-	PUNCT
dpc-1242	14	9	line	line	NOUN
dpc-1242	14	10	therapy	therapy	NOUN
dpc-1242	14	11	for	for	ADP
dpc-1242	14	12	ad	ad	NOUN
dpc-1242	14	13	but	but	CCONJ
dpc-1242	14	14	are	be	AUX
dpc-1242	14	15	associated	associate	VERB
dpc-1242	14	16	with	with	ADP
dpc-1242	14	17	various	various	ADJ
dpc-1242	14	18	adverse	adverse	ADJ
dpc-1242	14	19	effects	effect	NOUN
dpc-1242	14	20	.	.	PUNCT
dpc-1242	15	1	topical	topical	ADJ
dpc-1242	15	2	calcineurin	calcineurin	ADJ
dpc-1242	15	3	inhibitors	inhibitor	NOUN
dpc-1242	15	4	(	(	PUNCT
dpc-1242	15	5	tci	tci	NOUN
dpc-1242	15	6	)	)	PUNCT
dpc-1242	15	7	can	can	AUX
dpc-1242	15	8	be	be	AUX
dpc-1242	15	9	used	use	VERB
dpc-1242	15	10	as	as	ADP
dpc-1242	15	11	an	an	DET
dpc-1242	15	12	alternative	alternative	NOUN
dpc-1242	15	13	to	to	ADP
dpc-1242	15	14	tcs	tcs	NOUN
dpc-1242	15	15	.	.	PUNCT
dpc-1242	16	1	objective	objective	NOUN
dpc-1242	16	2	:	:	PUNCT
dpc-1242	16	3	the	the	DET
dpc-1242	16	4	aim	aim	NOUN
dpc-1242	16	5	of	of	ADP
dpc-1242	16	6	the	the	DET
dpc-1242	16	7	study	study	NOUN
dpc-1242	16	8	is	be	AUX
dpc-1242	16	9	to	to	PART
dpc-1242	16	10	compare	compare	VERB
dpc-1242	16	11	the	the	DET
dpc-1242	16	12	efficacy	efficacy	NOUN
dpc-1242	16	13	of	of	ADP
dpc-1242	16	14	topical	topical	ADJ
dpc-1242	16	15	preparations	preparation	NOUN
dpc-1242	16	16	of	of	ADP
dpc-1242	16	17	fluticasone	fluticasone	NOUN
dpc-1242	16	18	and	and	CCONJ
dpc-1242	16	19	tacrolimus	tacrolimus	NOUN
dpc-1242	16	20	in	in	ADP
dpc-1242	16	21	reducing	reduce	VERB
dpc-1242	16	22	the	the	DET
dpc-1242	16	23	severity	severity	NOUN
dpc-1242	16	24	of	of	ADP
dpc-1242	16	25	disease	disease	NOUN
dpc-1242	16	26	and	and	CCONJ
dpc-1242	16	27	,	,	PUNCT
dpc-1242	16	28	to	to	PART
dpc-1242	16	29	assess	assess	VERB
dpc-1242	16	30	the	the	DET
dpc-1242	16	31	quality	quality	NOUN
dpc-1242	16	32	of	of	ADP
dpc-1242	16	33	life	life	NOUN
dpc-1242	16	34	(	(	PUNCT
dpc-1242	16	35	qol	qol	NOUN
dpc-1242	16	36	)	)	PUNCT
dpc-1242	16	37	,	,	PUNCT
dpc-1242	16	38	and	and	CCONJ
dpc-1242	16	39	to	to	PART
dpc-1242	16	40	estimate	estimate	VERB
dpc-1242	16	41	if	if	SCONJ
dpc-1242	16	42	any	any	DET
dpc-1242	16	43	association	association	NOUN
dpc-1242	16	44	exists	exist	VERB
dpc-1242	16	45	between	between	ADP
dpc-1242	16	46	severity	severity	NOUN
dpc-1242	16	47	of	of	ADP
dpc-1242	16	48	disease	disease	NOUN
dpc-1242	16	49	and	and	CCONJ
dpc-1242	17	1	qol	qol	PROPN
dpc-1242	17	2	.	.	PUNCT
dpc-1242	17	3	methods	method	NOUN
dpc-1242	17	4	:	:	PUNCT
dpc-1242	17	5	thirty	thirty	NUM
dpc-1242	17	6	-	-	PUNCT
dpc-1242	17	7	seven	seven	NUM
dpc-1242	17	8	children	child	NOUN
dpc-1242	17	9	with	with	ADP
dpc-1242	17	10	ad	ad	NOUN
dpc-1242	17	11	randomly	randomly	ADV
dpc-1242	17	12	received	receive	VERB
dpc-1242	17	13	one	one	NUM
dpc-1242	17	14	of	of	ADP
dpc-1242	17	15	the	the	DET
dpc-1242	17	16	2	2	NUM
dpc-1242	17	17	topical	topical	ADJ
dpc-1242	17	18	treatments	treatment	NOUN
dpc-1242	17	19	,	,	PUNCT
dpc-1242	17	20	with	with	ADP
dpc-1242	17	21	daily	daily	ADJ
dpc-1242	17	22	application	application	NOUN
dpc-1242	17	23	for	for	ADP
dpc-1242	17	24	the	the	DET
dpc-1242	17	25	first	first	ADJ
dpc-1242	17	26	4	4	NUM
dpc-1242	17	27	weeks	week	NOUN
dpc-1242	17	28	in	in	ADP
dpc-1242	17	29	the	the	DET
dpc-1242	17	30	acute	acute	ADJ
dpc-1242	17	31	phase	phase	NOUN
dpc-1242	17	32	and	and	CCONJ
dpc-1242	17	33	twice	twice	ADJ
dpc-1242	17	34	weekly	weekly	ADJ
dpc-1242	17	35	for	for	ADP
dpc-1242	17	36	next	next	ADJ
dpc-1242	17	37	4	4	NUM
dpc-1242	17	38	weeks	week	NOUN
dpc-1242	17	39	in	in	ADP
dpc-1242	17	40	the	the	DET
dpc-1242	17	41	maintenance	maintenance	NOUN
dpc-1242	17	42	phase	phase	NOUN
dpc-1242	17	43	.	.	PUNCT
dpc-1242	18	1	the	the	DET
dpc-1242	18	2	severity	severity	NOUN
dpc-1242	18	3	of	of	ADP
dpc-1242	18	4	disease	disease	NOUN
dpc-1242	18	5	was	be	AUX
dpc-1242	18	6	assessed	assess	VERB
dpc-1242	18	7	using	use	VERB
dpc-1242	18	8	scoring	score	VERB
dpc-1242	18	9	atopic	atopic	NOUN
dpc-1242	18	10	dermatitis	dermatitis	NOUN
dpc-1242	18	11	(	(	PUNCT
dpc-1242	18	12	scorad	scorad	NOUN
dpc-1242	18	13	)	)	PUNCT
dpc-1242	18	14	,	,	PUNCT
dpc-1242	18	15	and	and	CCONJ
dpc-1242	18	16	qol	qol	PROPN
dpc-1242	18	17	was	be	AUX
dpc-1242	18	18	assessed	assess	VERB
dpc-1242	18	19	using	use	VERB
dpc-1242	18	20	the	the	DET
dpc-1242	18	21	children	child	NOUN
dpc-1242	18	22	’s	’s	PART
dpc-1242	18	23	dermatology	dermatology	NOUN
dpc-1242	18	24	life	life	NOUN
dpc-1242	18	25	quality	quality	NOUN
dpc-1242	18	26	index	index	NOUN
dpc-1242	18	27	(	(	PUNCT
dpc-1242	18	28	cdlqi	cdlqi	PROPN
dpc-1242	18	29	)	)	PUNCT
dpc-1242	18	30	.	.	PUNCT
dpc-1242	19	1	results	result	NOUN
dpc-1242	19	2	:	:	PUNCT
dpc-1242	19	3	at	at	ADP
dpc-1242	19	4	the	the	DET
dpc-1242	19	5	end	end	NOUN
dpc-1242	19	6	of	of	ADP
dpc-1242	19	7	the	the	DET
dpc-1242	19	8	acute	acute	ADJ
dpc-1242	19	9	phase	phase	NOUN
dpc-1242	19	10	,	,	PUNCT
dpc-1242	19	11	there	there	PRON
dpc-1242	19	12	was	be	VERB
dpc-1242	19	13	a	a	DET
dpc-1242	19	14	reduction	reduction	NOUN
dpc-1242	19	15	in	in	ADP
dpc-1242	19	16	scorad	scorad	ADJ
dpc-1242	19	17	score	score	NOUN
dpc-1242	19	18	of	of	ADP
dpc-1242	19	19	69.29	69.29	NUM
dpc-1242	19	20	%	%	NOUN
dpc-1242	19	21	in	in	ADP
dpc-1242	19	22	the	the	DET
dpc-1242	19	23	fluticasone	fluticasone	NOUN
dpc-1242	19	24	group	group	NOUN
dpc-1242	19	25	and	and	CCONJ
dpc-1242	19	26	64.2	64.2	NUM
dpc-1242	19	27	%	%	NOUN
dpc-1242	19	28	in	in	ADP
dpc-1242	19	29	the	the	DET
dpc-1242	19	30	tacrolimus	tacrolimus	NOUN
dpc-1242	19	31	group	group	NOUN
dpc-1242	19	32	(	(	PUNCT
dpc-1242	19	33	p	p	X
dpc-1242	19	34	<	<	X
dpc-1242	19	35	0.001	0.001	NUM
dpc-1242	19	36	)	)	PUNCT
dpc-1242	19	37	.	.	PUNCT
dpc-1242	20	1	in	in	ADP
dpc-1242	20	2	the	the	DET
dpc-1242	20	3	maintenance	maintenance	NOUN
dpc-1242	20	4	phase	phase	NOUN
dpc-1242	20	5	,	,	PUNCT
dpc-1242	20	6	the	the	DET
dpc-1242	20	7	score	score	NOUN
dpc-1242	20	8	had	have	AUX
dpc-1242	20	9	risen	rise	VERB
dpc-1242	20	10	in	in	ADP
dpc-1242	20	11	the	the	DET
dpc-1242	20	12	fluticasone	fluticasone	NOUN
dpc-1242	20	13	group	group	NOUN
dpc-1242	20	14	by	by	ADP
dpc-1242	20	15	a	a	DET
dpc-1242	20	16	mean	mean	ADJ
dpc-1242	20	17	difference	difference	NOUN
dpc-1242	20	18	of	of	ADP
dpc-1242	20	19	0.81	0.81	NUM
dpc-1242	20	20	,	,	PUNCT
dpc-1242	20	21	while	while	SCONJ
dpc-1242	20	22	in	in	ADP
dpc-1242	20	23	the	the	DET
dpc-1242	20	24	tacrolimus	tacrolimus	NOUN
dpc-1242	20	25	group	group	NOUN
dpc-1242	20	26	it	it	PRON
dpc-1242	20	27	decreased	decrease	VERB
dpc-1242	20	28	by	by	ADP
dpc-1242	20	29	0.99	0.99	NUM
dpc-1242	20	30	.	.	PUNCT
dpc-1242	21	1	both	both	PRON
dpc-1242	21	2	fluticasone	fluticasone	PROPN
dpc-1242	21	3	and	and	CCONJ
dpc-1242	21	4	tacrolimus	tacrolimus	NOUN
dpc-1242	21	5	groups	group	NOUN
dpc-1242	21	6	improved	improve	VERB
dpc-1242	21	7	in	in	ADP
dpc-1242	21	8	children	child	NOUN
dpc-1242	21	9	’s	’s	PART
dpc-1242	21	10	qol	qol	NOUN
dpc-1242	21	11	(	(	PUNCT
dpc-1242	21	12	p	p	X
dpc-1242	21	13	<	<	X
dpc-1242	21	14	0.001	0.001	NUM
dpc-1242	21	15	)	)	PUNCT
dpc-1242	21	16	.	.	PUNCT
dpc-1242	22	1	positive	positive	ADJ
dpc-1242	22	2	correlation	correlation	NOUN
dpc-1242	22	3	(	(	PUNCT
dpc-1242	22	4	r	r	NOUN
dpc-1242	22	5	=	=	SYM
dpc-1242	22	6	0.4668	0.4668	NUM
dpc-1242	22	7	)	)	PUNCT
dpc-1242	22	8	exists	exist	VERB
dpc-1242	22	9	between	between	ADP
dpc-1242	22	10	scorad	scorad	NOUN
dpc-1242	22	11	and	and	CCONJ
dpc-1242	22	12	qol	qol	NOUN
dpc-1242	22	13	.	.	PUNCT
dpc-1242	23	1	the	the	DET
dpc-1242	23	2	most	most	ADV
dpc-1242	23	3	common	common	ADJ
dpc-1242	23	4	adverse	adverse	ADJ
dpc-1242	23	5	skin	skin	NOUN
dpc-1242	23	6	reaction	reaction	NOUN
dpc-1242	23	7	noted	note	VERB
dpc-1242	23	8	was	be	AUX
dpc-1242	23	9	skin	skin	NOUN
dpc-1242	23	10	burning	burn	VERB
dpc-1242	23	11	with	with	ADP
dpc-1242	23	12	tacrolimus	tacrolimus	NOUN
dpc-1242	23	13	.	.	PUNCT
dpc-1242	24	1	conclusions	conclusion	NOUN
dpc-1242	24	2	:	:	PUNCT
dpc-1242	24	3	fluticasone	fluticasone	NOUN
dpc-1242	24	4	and	and	CCONJ
dpc-1242	24	5	tacrolimus	tacrolimus	NOUN
dpc-1242	24	6	are	be	AUX
dpc-1242	24	7	equally	equally	ADV
dpc-1242	24	8	efficacious	efficacious	ADJ
dpc-1242	24	9	in	in	ADP
dpc-1242	24	10	the	the	DET
dpc-1242	24	11	treatment	treatment	NOUN
dpc-1242	24	12	of	of	ADP
dpc-1242	24	13	ad	ad	NOUN
dpc-1242	24	14	and	and	CCONJ
dpc-1242	24	15	have	have	VERB
dpc-1242	24	16	similar	similar	ADJ
dpc-1242	24	17	benefits	benefit	NOUN
dpc-1242	24	18	with	with	ADP
dpc-1242	24	19	children	child	NOUN
dpc-1242	24	20	’s	’s	PART
dpc-1242	24	21	qol	qol	PROPN
dpc-1242	24	22	.	.	PUNCT
dpc-1242	25	1	tacrolimus	tacrolimus	PROPN
dpc-1242	25	2	is	be	AUX
dpc-1242	25	3	better	well	ADJ
dpc-1242	25	4	than	than	ADP
dpc-1242	25	5	fluticasone	fluticasone	NOUN
dpc-1242	25	6	at	at	ADP
dpc-1242	25	7	reducing	reduce	VERB
dpc-1242	25	8	the	the	DET
dpc-1242	25	9	extent	extent	NOUN
dpc-1242	25	10	of	of	ADP
dpc-1242	25	11	lesions	lesion	NOUN
dpc-1242	25	12	.	.	PUNCT
dpc-1242	26	1	abstract	abstract	ADJ
dpc-1242	26	2	2	2	NUM
dpc-1242	26	3	research	research	NOUN
dpc-1242	26	4	|	|	ADV
dpc-1242	26	5	dermatol	dermatol	NOUN
dpc-1242	26	6	pract	pract	NOUN
dpc-1242	26	7	concept	concept	NOUN
dpc-1242	26	8	2020;10(4):e2020094	2020;10(4):e2020094	NUM
dpc-1242	26	9	ad	ad	NOUN
dpc-1242	26	10	.	.	PUNCT
dpc-1242	27	1	the	the	DET
dpc-1242	27	2	secondary	secondary	ADJ
dpc-1242	27	3	objective	objective	NOUN
dpc-1242	27	4	was	be	AUX
dpc-1242	27	5	to	to	PART
dpc-1242	27	6	assess	assess	VERB
dpc-1242	27	7	the	the	DET
dpc-1242	27	8	qol	qol	NOUN
dpc-1242	27	9	,	,	PUNCT
dpc-1242	27	10	to	to	PART
dpc-1242	27	11	find	find	VERB
dpc-1242	27	12	the	the	DET
dpc-1242	27	13	association	association	NOUN
dpc-1242	27	14	between	between	ADP
dpc-1242	27	15	severity	severity	NOUN
dpc-1242	27	16	of	of	ADP
dpc-1242	27	17	disease	disease	NOUN
dpc-1242	27	18	and	and	CCONJ
dpc-1242	27	19	qol	qol	NOUN
dpc-1242	27	20	,	,	PUNCT
dpc-1242	27	21	and	and	CCONJ
dpc-1242	27	22	to	to	PART
dpc-1242	27	23	assess	assess	VERB
dpc-1242	27	24	the	the	DET
dpc-1242	27	25	safety	safety	NOUN
dpc-1242	27	26	and	and	CCONJ
dpc-1242	27	27	tolerability	tolerability	NOUN
dpc-1242	27	28	of	of	ADP
dpc-1242	27	29	the	the	DET
dpc-1242	27	30	medications	medication	NOUN
dpc-1242	27	31	.	.	PUNCT
dpc-1242	28	1	methods	method	NOUN
dpc-1242	28	2	study	study	PROPN
dpc-1242	28	3	design	design	VERB
dpc-1242	28	4	the	the	DET
dpc-1242	28	5	present	present	ADJ
dpc-1242	28	6	study	study	NOUN
dpc-1242	28	7	was	be	AUX
dpc-1242	28	8	an	an	DET
dpc-1242	28	9	8	8	NUM
dpc-1242	28	10	-	-	PUNCT
dpc-1242	28	11	week	week	NOUN
dpc-1242	28	12	,	,	PUNCT
dpc-1242	28	13	prospective	prospective	ADJ
dpc-1242	28	14	,	,	PUNCT
dpc-1242	28	15	randomized	randomize	VERB
dpc-1242	28	16	,	,	PUNCT
dpc-1242	28	17	and	and	CCONJ
dpc-1242	28	18	an	an	DET
dpc-1242	28	19	open	open	ADJ
dpc-1242	28	20	-	-	PUNCT
dpc-1242	28	21	label	label	NOUN
dpc-1242	28	22	study	study	NOUN
dpc-1242	28	23	conducted	conduct	VERB
dpc-1242	28	24	on	on	ADP
dpc-1242	28	25	37	37	NUM
dpc-1242	28	26	children	child	NOUN
dpc-1242	28	27	with	with	ADP
dpc-1242	28	28	ad	ad	NOUN
dpc-1242	28	29	in	in	ADP
dpc-1242	28	30	the	the	DET
dpc-1242	28	31	department	department	NOUN
dpc-1242	28	32	of	of	ADP
dpc-1242	28	33	pharmacology	pharmacology	NOUN
dpc-1242	28	34	in	in	ADP
dpc-1242	28	35	collaboration	collaboration	NOUN
dpc-1242	28	36	with	with	ADP
dpc-1242	28	37	the	the	DET
dpc-1242	28	38	department	department	NOUN
dpc-1242	28	39	of	of	ADP
dpc-1242	28	40	dermatology	dermatology	NOUN
dpc-1242	28	41	,	,	PUNCT
dpc-1242	28	42	upums	upums	PROPN
dpc-1242	28	43	saifai	saifai	PROPN
dpc-1242	28	44	,	,	PUNCT
dpc-1242	28	45	etawah	etawah	NOUN
dpc-1242	28	46	.	.	PUNCT
dpc-1242	29	1	the	the	DET
dpc-1242	29	2	study	study	NOUN
dpc-1242	29	3	was	be	AUX
dpc-1242	29	4	approved	approve	VERB
dpc-1242	29	5	by	by	ADP
dpc-1242	29	6	the	the	DET
dpc-1242	29	7	institutional	institutional	ADJ
dpc-1242	29	8	ethics	ethic	NOUN
dpc-1242	29	9	committee	committee	PROPN
dpc-1242	29	10	(	(	PUNCT
dpc-1242	29	11	ec	ec	PROPN
dpc-1242	29	12	no	no	INTJ
dpc-1242	29	13	.	.	PUNCT
dpc-1242	30	1	39/2018	39/2018	NUM
dpc-1242	30	2	)	)	PUNCT
dpc-1242	30	3	,	,	PUNCT
dpc-1242	31	1	and	and	CCONJ
dpc-1242	31	2	written	write	VERB
dpc-1242	31	3	informed	informed	ADJ
dpc-1242	31	4	consent	consent	NOUN
dpc-1242	31	5	from	from	ADP
dpc-1242	31	6	the	the	DET
dpc-1242	31	7	childrens	children	NOUN
dpc-1242	31	8	’	'	PUNCT
dpc-1242	31	9	parents	parent	NOUN
dpc-1242	31	10	was	be	AUX
dpc-1242	31	11	obtained	obtain	VERB
dpc-1242	31	12	after	after	ADP
dpc-1242	31	13	explaining	explain	VERB
dpc-1242	31	14	the	the	DET
dpc-1242	31	15	nature	nature	NOUN
dpc-1242	31	16	of	of	ADP
dpc-1242	31	17	the	the	DET
dpc-1242	31	18	proposed	propose	VERB
dpc-1242	31	19	medical	medical	ADJ
dpc-1242	31	20	intervention	intervention	NOUN
dpc-1242	31	21	and	and	CCONJ
dpc-1242	31	22	reasonable	reasonable	ADJ
dpc-1242	31	23	consequences	consequence	NOUN
dpc-1242	31	24	of	of	ADP
dpc-1242	31	25	their	their	PRON
dpc-1242	31	26	participation	participation	NOUN
dpc-1242	31	27	in	in	ADP
dpc-1242	31	28	the	the	DET
dpc-1242	31	29	study	study	NOUN
dpc-1242	31	30	.	.	PUNCT
dpc-1242	32	1	thirty	thirty	NUM
dpc-1242	32	2	-	-	PUNCT
dpc-1242	32	3	seven	seven	NUM
dpc-1242	32	4	children	child	NOUN
dpc-1242	32	5	who	who	PRON
dpc-1242	32	6	met	meet	VERB
dpc-1242	32	7	the	the	DET
dpc-1242	32	8	inclusion	inclusion	NOUN
dpc-1242	32	9	criteria	criterion	NOUN
dpc-1242	32	10	(	(	PUNCT
dpc-1242	32	11	age	age	NOUN
dpc-1242	32	12	2	2	NUM
dpc-1242	32	13	-	-	SYM
dpc-1242	32	14	16	16	NUM
dpc-1242	32	15	years	year	NOUN
dpc-1242	32	16	of	of	ADP
dpc-1242	32	17	either	either	DET
dpc-1242	32	18	gender	gender	NOUN
dpc-1242	32	19	,	,	PUNCT
dpc-1242	32	20	meeting	meet	VERB
dpc-1242	32	21	the	the	DET
dpc-1242	32	22	hanifin	hanifin	NOUN
dpc-1242	32	23	-	-	PUNCT
dpc-1242	32	24	rajka	rajka	NOUN
dpc-1242	32	25	clinical	clinical	ADJ
dpc-1242	32	26	criteria	criterion	NOUN
dpc-1242	32	27	for	for	ADP
dpc-1242	32	28	the	the	DET
dpc-1242	32	29	diagnosis	diagnosis	NOUN
dpc-1242	32	30	of	of	ADP
dpc-1242	32	31	ad	ad	NOUN
dpc-1242	32	32	[	[	X
dpc-1242	32	33	12	12	NUM
dpc-1242	32	34	]	]	PUNCT
dpc-1242	32	35	)	)	PUNCT
dpc-1242	32	36	were	be	AUX
dpc-1242	32	37	recruited	recruit	VERB
dpc-1242	32	38	for	for	ADP
dpc-1242	32	39	the	the	DET
dpc-1242	32	40	study	study	NOUN
dpc-1242	32	41	period	period	NOUN
dpc-1242	32	42	of	of	ADP
dpc-1242	32	43	56	56	NUM
dpc-1242	32	44	days	day	NOUN
dpc-1242	32	45	(	(	PUNCT
dpc-1242	32	46	a	a	DET
dpc-1242	32	47	4	4	NUM
dpc-1242	32	48	-	-	PUNCT
dpc-1242	32	49	week	week	NOUN
dpc-1242	32	50	acute	acute	NOUN
dpc-1242	32	51	flare	flare	NOUN
dpc-1242	32	52	-	-	PUNCT
dpc-1242	32	53	up	up	ADP
dpc-1242	32	54	phase	phase	NOUN
dpc-1242	32	55	followed	follow	VERB
dpc-1242	32	56	by	by	ADP
dpc-1242	32	57	a	a	DET
dpc-1242	32	58	4	4	NUM
dpc-1242	32	59	-	-	PUNCT
dpc-1242	32	60	week	week	NOUN
dpc-1242	32	61	maintenance	maintenance	NOUN
dpc-1242	32	62	phase	phase	NOUN
dpc-1242	32	63	)	)	PUNCT
dpc-1242	32	64	.	.	PUNCT
dpc-1242	33	1	any	any	DET
dpc-1242	33	2	form	form	NOUN
dpc-1242	33	3	of	of	ADP
dpc-1242	33	4	dermatitis	dermatitis	NOUN
dpc-1242	33	5	other	other	ADJ
dpc-1242	33	6	than	than	ADP
dpc-1242	33	7	ad	ad	NOUN
dpc-1242	33	8	,	,	PUNCT
dpc-1242	33	9	untreated	untreated	ADJ
dpc-1242	33	10	bacterial	bacterial	ADJ
dpc-1242	33	11	,	,	PUNCT
dpc-1242	33	12	fungal	fungal	ADJ
dpc-1242	33	13	or	or	CCONJ
dpc-1242	33	14	viral	viral	ADJ
dpc-1242	33	15	skin	skin	NOUN
dpc-1242	33	16	lesion	lesion	NOUN
dpc-1242	33	17	,	,	PUNCT
dpc-1242	33	18	or	or	CCONJ
dpc-1242	33	19	history	history	NOUN
dpc-1242	33	20	of	of	ADP
dpc-1242	33	21	allergic	allergic	ADJ
dpc-1242	33	22	reaction	reaction	NOUN
dpc-1242	33	23	in	in	ADP
dpc-1242	33	24	the	the	DET
dpc-1242	33	25	past	past	NOUN
dpc-1242	33	26	to	to	ADP
dpc-1242	33	27	topical	topical	ADJ
dpc-1242	33	28	medications	medication	NOUN
dpc-1242	33	29	employed	employ	VERB
dpc-1242	33	30	in	in	ADP
dpc-1242	33	31	this	this	DET
dpc-1242	33	32	study	study	NOUN
dpc-1242	33	33	were	be	AUX
dpc-1242	33	34	excluded	exclude	VERB
dpc-1242	33	35	.	.	PUNCT
dpc-1242	34	1	all	all	DET
dpc-1242	34	2	37	37	NUM
dpc-1242	34	3	children	child	NOUN
dpc-1242	34	4	were	be	AUX
dpc-1242	34	5	randomly	randomly	ADV
dpc-1242	34	6	assigned	assign	VERB
dpc-1242	34	7	in	in	ADP
dpc-1242	34	8	1:1	1:1	NUM
dpc-1242	34	9	ratio	ratio	NOUN
dpc-1242	34	10	to	to	ADP
dpc-1242	34	11	each	each	DET
dpc-1242	34	12	group	group	NOUN
dpc-1242	34	13	.	.	PUNCT
dpc-1242	35	1	group	group	NOUN
dpc-1242	35	2	1	1	NUM
dpc-1242	35	3	(	(	PUNCT
dpc-1242	35	4	n	n	NOUN
dpc-1242	35	5	=	=	SYM
dpc-1242	35	6	19	19	NUM
dpc-1242	35	7	)	)	PUNCT
dpc-1242	35	8	received	receive	VERB
dpc-1242	35	9	0.005	0.005	NUM
dpc-1242	35	10	%	%	NOUN
dpc-1242	35	11	fluticasone	fluticasone	NOUN
dpc-1242	35	12	ointment	ointment	NOUN
dpc-1242	35	13	twice	twice	ADV
dpc-1242	35	14	daily	daily	ADV
dpc-1242	35	15	and	and	CCONJ
dpc-1242	35	16	group	group	NOUN
dpc-1242	35	17	2	2	NUM
dpc-1242	35	18	(	(	PUNCT
dpc-1242	35	19	n	n	NOUN
dpc-1242	35	20	=	=	SYM
dpc-1242	35	21	18	18	NUM
dpc-1242	35	22	)	)	PUNCT
dpc-1242	35	23	received	receive	VERB
dpc-1242	35	24	0.03	0.03	NUM
dpc-1242	35	25	%	%	NOUN
dpc-1242	35	26	tacrolimus	tacrolimus	NOUN
dpc-1242	35	27	ointment	ointment	NOUN
dpc-1242	35	28	once	once	ADV
dpc-1242	35	29	daily	daily	ADV
dpc-1242	35	30	at	at	ADP
dpc-1242	35	31	night	night	NOUN
dpc-1242	35	32	before	before	ADP
dpc-1242	35	33	sleep	sleep	NOUN
dpc-1242	35	34	.	.	PUNCT
dpc-1242	36	1	in	in	ADP
dpc-1242	36	2	the	the	DET
dpc-1242	36	3	maintenance	maintenance	NOUN
dpc-1242	36	4	phase	phase	NOUN
dpc-1242	36	5	(	(	PUNCT
dpc-1242	36	6	n=35	n=35	PROPN
dpc-1242	36	7	)	)	PUNCT
dpc-1242	36	8	,	,	PUNCT
dpc-1242	36	9	both	both	DET
dpc-1242	36	10	groups	group	NOUN
dpc-1242	36	11	continued	continue	VERB
dpc-1242	36	12	the	the	DET
dpc-1242	36	13	same	same	ADJ
dpc-1242	36	14	topical	topical	ADJ
dpc-1242	36	15	medication	medication	NOUN
dpc-1242	36	16	twice	twice	ADV
dpc-1242	36	17	weekly	weekly	ADV
dpc-1242	36	18	on	on	ADP
dpc-1242	36	19	2	2	NUM
dpc-1242	36	20	consequent	consequent	ADJ
dpc-1242	36	21	nights	night	NOUN
dpc-1242	36	22	at	at	ADP
dpc-1242	36	23	bedtime	bedtime	NOUN
dpc-1242	36	24	.	.	PUNCT
dpc-1242	37	1	medicines	medicine	NOUN
dpc-1242	37	2	were	be	AUX
dpc-1242	37	3	applied	apply	VERB
dpc-1242	37	4	using	use	VERB
dpc-1242	37	5	the	the	DET
dpc-1242	37	6	fingertip	fingertip	NOUN
dpc-1242	37	7	unit	unit	NOUN
dpc-1242	37	8	(	(	PUNCT
dpc-1242	37	9	ftu	ftu	NOUN
dpc-1242	37	10	)	)	PUNCT
dpc-1242	37	11	method	method	NOUN
dpc-1242	37	12	[	[	X
dpc-1242	37	13	13	13	NUM
dpc-1242	37	14	]	]	PUNCT
dpc-1242	37	15	.	.	PUNCT
dpc-1242	38	1	the	the	DET
dpc-1242	38	2	primary	primary	ADJ
dpc-1242	38	3	outcome	outcome	NOUN
dpc-1242	38	4	comparing	compare	VERB
dpc-1242	38	5	the	the	DET
dpc-1242	38	6	efficacy	efficacy	NOUN
dpc-1242	38	7	of	of	ADP
dpc-1242	38	8	the	the	DET
dpc-1242	38	9	2	2	NUM
dpc-1242	38	10	drugs	drug	NOUN
dpc-1242	38	11	was	be	AUX
dpc-1242	38	12	measured	measure	VERB
dpc-1242	38	13	by	by	ADP
dpc-1242	38	14	the	the	DET
dpc-1242	38	15	scoring	scoring	NOUN
dpc-1242	38	16	atopic	atopic	NOUN
dpc-1242	38	17	dermatitis	dermatitis	NOUN
dpc-1242	38	18	(	(	PUNCT
dpc-1242	38	19	scorad	scorad	NOUN
dpc-1242	38	20	)	)	PUNCT
dpc-1242	38	21	index	index	NOUN
dpc-1242	38	22	[	[	X
dpc-1242	38	23	14	14	NUM
dpc-1242	38	24	]	]	PUNCT
dpc-1242	38	25	.	.	PUNCT
dpc-1242	39	1	the	the	DET
dpc-1242	39	2	scorad	scorad	PROPN
dpc-1242	39	3	index	index	NOUN
dpc-1242	39	4	consisted	consist	VERB
dpc-1242	39	5	of	of	ADP
dpc-1242	39	6	the	the	DET
dpc-1242	39	7	description	description	NOUN
dpc-1242	39	8	of	of	ADP
dpc-1242	39	9	the	the	DET
dpc-1242	39	10	extent	extent	NOUN
dpc-1242	39	11	,	,	PUNCT
dpc-1242	39	12	intensity	intensity	NOUN
dpc-1242	39	13	,	,	PUNCT
dpc-1242	39	14	and	and	CCONJ
dpc-1242	39	15	subjective	subjective	ADJ
dpc-1242	39	16	symptoms	symptom	NOUN
dpc-1242	39	17	.	.	PUNCT
dpc-1242	40	1	the	the	DET
dpc-1242	40	2	formula	formula	NOUN
dpc-1242	40	3	applied	apply	VERB
dpc-1242	40	4	for	for	ADP
dpc-1242	40	5	the	the	DET
dpc-1242	40	6	scorad	scorad	ADJ
dpc-1242	40	7	index	index	NOUN
dpc-1242	40	8	was	be	AUX
dpc-1242	40	9	:	:	PUNCT
dpc-1242	40	10	a/5	a/5	X
dpc-1242	40	11	+	+	CCONJ
dpc-1242	41	1	7b/2	7b/2	NUM
dpc-1242	42	1	+	+	CCONJ
dpc-1242	42	2	c.	c.	NOUN
dpc-1242	42	3	we	we	PRON
dpc-1242	42	4	used	use	VERB
dpc-1242	42	5	a	a	DET
dpc-1242	42	6	body	body	NOUN
dpc-1242	42	7	diagram	diagram	NOUN
dpc-1242	42	8	to	to	PART
dpc-1242	42	9	analyze	analyze	VERB
dpc-1242	42	10	the	the	DET
dpc-1242	42	11	area	area	NOUN
dpc-1242	42	12	affected	affect	VERB
dpc-1242	42	13	,	,	PUNCT
dpc-1242	42	14	and	and	CCONJ
dpc-1242	42	15	the	the	DET
dpc-1242	42	16	most	most	ADV
dpc-1242	42	17	representative	representative	ADJ
dpc-1242	42	18	lesion	lesion	NOUN
dpc-1242	42	19	was	be	AUX
dpc-1242	42	20	used	use	VERB
dpc-1242	42	21	for	for	ADP
dpc-1242	42	22	scoring	scoring	NOUN
dpc-1242	42	23	.	.	PUNCT
dpc-1242	43	1	the	the	DET
dpc-1242	43	2	intensity	intensity	NOUN
dpc-1242	43	3	element	element	NOUN
dpc-1242	43	4	of	of	ADP
dpc-1242	43	5	the	the	DET
dpc-1242	43	6	scorad	scorad	ADJ
dpc-1242	43	7	index	index	NOUN
dpc-1242	43	8	consisted	consist	VERB
dpc-1242	43	9	of	of	ADP
dpc-1242	43	10	6	6	NUM
dpc-1242	43	11	items	item	NOUN
dpc-1242	43	12	:	:	PUNCT
dpc-1242	43	13	erythema	erythema	ADJ
dpc-1242	43	14	,	,	PUNCT
dpc-1242	43	15	edema	edema	NOUN
dpc-1242	43	16	/	/	SYM
dpc-1242	43	17	papules	papule	NOUN
dpc-1242	43	18	,	,	PUNCT
dpc-1242	43	19	the	the	DET
dpc-1242	43	20	effect	effect	NOUN
dpc-1242	43	21	of	of	ADP
dpc-1242	43	22	excoriations	excoriation	NOUN
dpc-1242	43	23	,	,	PUNCT
dpc-1242	43	24	lichenification	lichenification	NOUN
dpc-1242	43	25	,	,	PUNCT
dpc-1242	43	26	oozing	oozing	ADJ
dpc-1242	43	27	/	/	SYM
dpc-1242	43	28	crust	crust	NOUN
dpc-1242	43	29	formation	formation	NOUN
dpc-1242	43	30	,	,	PUNCT
dpc-1242	43	31	and	and	CCONJ
dpc-1242	43	32	dryness	dryness	NOUN
dpc-1242	43	33	,	,	PUNCT
dpc-1242	43	34	and	and	CCONJ
dpc-1242	43	35	each	each	DET
dpc-1242	43	36	item	item	NOUN
dpc-1242	43	37	had	have	VERB
dpc-1242	43	38	4	4	NUM
dpc-1242	43	39	grades	grade	NOUN
dpc-1242	43	40	:	:	PUNCT
dpc-1242	43	41	0	0	NUM
dpc-1242	43	42	,	,	PUNCT
dpc-1242	43	43	1	1	NUM
dpc-1242	43	44	,	,	PUNCT
dpc-1242	43	45	2	2	NUM
dpc-1242	43	46	,	,	PUNCT
dpc-1242	43	47	and	and	CCONJ
dpc-1242	43	48	3	3	X
dpc-1242	43	49	.	.	X
dpc-1242	43	50	dryness	dryness	NOUN
dpc-1242	43	51	was	be	AUX
dpc-1242	43	52	assessed	assess	VERB
dpc-1242	43	53	in	in	ADP
dpc-1242	43	54	non	non	ADJ
dpc-1242	43	55	-	-	ADJ
dpc-1242	43	56	inflamed	inflamed	ADJ
dpc-1242	43	57	skin	skin	NOUN
dpc-1242	43	58	.	.	PUNCT
dpc-1242	44	1	during	during	ADP
dpc-1242	44	2	the	the	DET
dpc-1242	44	3	last	last	ADJ
dpc-1242	44	4	3	3	NUM
dpc-1242	44	5	days	day	NOUN
dpc-1242	44	6	,	,	PUNCT
dpc-1242	44	7	subjective	subjective	ADJ
dpc-1242	44	8	items	item	NOUN
dpc-1242	44	9	,	,	PUNCT
dpc-1242	44	10	that	that	PRON
dpc-1242	44	11	included	include	VERB
dpc-1242	44	12	daily	daily	ADJ
dpc-1242	44	13	pruritus	pruritus	NOUN
dpc-1242	44	14	and	and	CCONJ
dpc-1242	44	15	sleeplessness	sleeplessness	NOUN
dpc-1242	44	16	,	,	PUNCT
dpc-1242	44	17	were	be	AUX
dpc-1242	44	18	graded	grade	VERB
dpc-1242	44	19	on	on	ADP
dpc-1242	44	20	a	a	DET
dpc-1242	44	21	10	10	NUM
dpc-1242	44	22	-	-	PUNCT
dpc-1242	44	23	cm	cm	NOUN
dpc-1242	44	24	visual	visual	ADJ
dpc-1242	44	25	analogue	analogue	NOUN
dpc-1242	44	26	scale	scale	NOUN
dpc-1242	44	27	drawn	draw	VERB
dpc-1242	44	28	on	on	ADP
dpc-1242	44	29	the	the	DET
dpc-1242	44	30	scorad	scorad	NOUN
dpc-1242	44	31	form	form	NOUN
dpc-1242	44	32	.	.	PUNCT
dpc-1242	45	1	the	the	DET
dpc-1242	45	2	secondary	secondary	ADJ
dpc-1242	45	3	outcome	outcome	NOUN
dpc-1242	45	4	determining	determine	VERB
dpc-1242	45	5	the	the	DET
dpc-1242	45	6	change	change	NOUN
dpc-1242	45	7	in	in	ADP
dpc-1242	45	8	the	the	DET
dpc-1242	45	9	qol	qol	NOUN
dpc-1242	45	10	after	after	SCONJ
dpc-1242	45	11	treatment	treatment	NOUN
dpc-1242	45	12	was	be	AUX
dpc-1242	45	13	analyzed	analyze	VERB
dpc-1242	45	14	by	by	ADP
dpc-1242	45	15	the	the	DET
dpc-1242	45	16	children	child	NOUN
dpc-1242	45	17	’s	’s	PART
dpc-1242	45	18	dermatology	dermatology	NOUN
dpc-1242	45	19	life	life	NOUN
dpc-1242	45	20	quality	quality	NOUN
dpc-1242	45	21	index	index	NOUN
dpc-1242	45	22	(	(	PUNCT
dpc-1242	45	23	cdlqi	cdlqi	PROPN
dpc-1242	45	24	)	)	PUNCT
dpc-1242	45	25	.	.	PUNCT
dpc-1242	46	1	[	[	X
dpc-1242	46	2	15	15	X
dpc-1242	46	3	]	]	X
dpc-1242	46	4	both	both	PRON
dpc-1242	46	5	scorad	scorad	ADJ
dpc-1242	46	6	and	and	CCONJ
dpc-1242	46	7	cdlqi	cdlqi	NOUN
dpc-1242	46	8	scores	score	NOUN
dpc-1242	46	9	were	be	AUX
dpc-1242	46	10	noted	note	VERB
dpc-1242	46	11	on	on	ADP
dpc-1242	46	12	the	the	DET
dpc-1242	46	13	day	day	NOUN
dpc-1242	46	14	of	of	ADP
dpc-1242	46	15	enrollment	enrollment	NOUN
dpc-1242	46	16	and	and	CCONJ
dpc-1242	46	17	at	at	ADP
dpc-1242	46	18	the	the	DET
dpc-1242	46	19	end	end	NOUN
dpc-1242	46	20	of	of	ADP
dpc-1242	46	21	weeks	week	NOUN
dpc-1242	46	22	2	2	NUM
dpc-1242	46	23	,	,	PUNCT
dpc-1242	46	24	4	4	NUM
dpc-1242	46	25	,	,	PUNCT
dpc-1242	46	26	6	6	NUM
dpc-1242	46	27	,	,	PUNCT
dpc-1242	46	28	and	and	CCONJ
dpc-1242	47	1	8	8	NUM
dpc-1242	47	2	.	.	PUNCT
dpc-1242	47	3	introduction	introduction	NOUN
dpc-1242	47	4	atopic	atopic	NOUN
dpc-1242	47	5	dermatitis	dermatitis	PROPN
dpc-1242	47	6	(	(	PUNCT
dpc-1242	47	7	ad	ad	NOUN
dpc-1242	47	8	)	)	PUNCT
dpc-1242	47	9	is	be	AUX
dpc-1242	47	10	a	a	DET
dpc-1242	47	11	chronic	chronic	NOUN
dpc-1242	47	12	,	,	PUNCT
dpc-1242	47	13	recurrent	recurrent	ADJ
dpc-1242	47	14	inflammatory	inflammatory	ADJ
dpc-1242	47	15	skin	skin	NOUN
dpc-1242	47	16	condition	condition	NOUN
dpc-1242	47	17	,	,	PUNCT
dpc-1242	47	18	characterized	characterize	VERB
dpc-1242	47	19	by	by	ADP
dpc-1242	47	20	acute	acute	ADJ
dpc-1242	47	21	flare	flare	NOUN
dpc-1242	47	22	-	-	PUNCT
dpc-1242	47	23	ups	up	NOUN
dpc-1242	47	24	of	of	ADP
dpc-1242	47	25	pruritic	pruritic	ADJ
dpc-1242	47	26	lesions	lesion	NOUN
dpc-1242	47	27	,	,	PUNCT
dpc-1242	47	28	afflicting	afflict	VERB
dpc-1242	47	29	15%-20	15%-20	NUM
dpc-1242	47	30	%	%	NOUN
dpc-1242	47	31	of	of	ADP
dpc-1242	47	32	children	child	NOUN
dpc-1242	47	33	in	in	ADP
dpc-1242	47	34	developed	develop	VERB
dpc-1242	47	35	countries	country	NOUN
dpc-1242	47	36	[	[	X
dpc-1242	47	37	1	1	NUM
dpc-1242	47	38	]	]	PUNCT
dpc-1242	47	39	.	.	PUNCT
dpc-1242	48	1	it	it	PRON
dpc-1242	48	2	has	have	VERB
dpc-1242	48	3	no	no	DET
dpc-1242	48	4	known	know	VERB
dpc-1242	48	5	cure	cure	NOUN
dpc-1242	48	6	and	and	CCONJ
dpc-1242	48	7	adversely	adversely	ADV
dpc-1242	48	8	affects	affect	VERB
dpc-1242	48	9	the	the	DET
dpc-1242	48	10	quality	quality	NOUN
dpc-1242	48	11	of	of	ADP
dpc-1242	48	12	life	life	NOUN
dpc-1242	48	13	(	(	PUNCT
dpc-1242	48	14	qol	qol	NOUN
dpc-1242	48	15	)	)	PUNCT
dpc-1242	48	16	of	of	ADP
dpc-1242	48	17	patients	patient	NOUN
dpc-1242	48	18	and	and	CCONJ
dpc-1242	48	19	their	their	PRON
dpc-1242	48	20	families	family	NOUN
dpc-1242	48	21	[	[	X
dpc-1242	48	22	2,3	2,3	NUM
dpc-1242	48	23	]	]	PUNCT
dpc-1242	48	24	.	.	PUNCT
dpc-1242	49	1	management	management	NOUN
dpc-1242	49	2	of	of	ADP
dpc-1242	49	3	ad	ad	NOUN
dpc-1242	49	4	includes	include	VERB
dpc-1242	49	5	identifying	identify	VERB
dpc-1242	49	6	and	and	CCONJ
dpc-1242	49	7	eliminating	eliminate	VERB
dpc-1242	49	8	the	the	DET
dpc-1242	49	9	triggering	trigger	VERB
dpc-1242	49	10	factors	factor	NOUN
dpc-1242	49	11	,	,	PUNCT
dpc-1242	49	12	restoring	restore	VERB
dpc-1242	49	13	the	the	DET
dpc-1242	49	14	skin	skin	NOUN
dpc-1242	49	15	barrier	barrier	NOUN
dpc-1242	49	16	function	function	NOUN
dpc-1242	49	17	,	,	PUNCT
dpc-1242	49	18	reducing	reduce	VERB
dpc-1242	49	19	inflammation	inflammation	NOUN
dpc-1242	49	20	,	,	PUNCT
dpc-1242	49	21	and	and	CCONJ
dpc-1242	49	22	treating	treat	VERB
dpc-1242	49	23	secondary	secondary	ADJ
dpc-1242	49	24	infection	infection	NOUN
dpc-1242	49	25	with	with	ADP
dpc-1242	49	26	antibiotics	antibiotic	NOUN
dpc-1242	49	27	.	.	PUNCT
dpc-1242	50	1	among	among	ADP
dpc-1242	50	2	topical	topical	ADJ
dpc-1242	50	3	treatments	treatment	NOUN
dpc-1242	50	4	there	there	PRON
dpc-1242	50	5	are	be	VERB
dpc-1242	50	6	bathing	bathe	VERB
dpc-1242	50	7	,	,	PUNCT
dpc-1242	50	8	emollients	emollient	NOUN
dpc-1242	50	9	,	,	PUNCT
dpc-1242	50	10	topical	topical	ADJ
dpc-1242	50	11	corticosteroids	corticosteroid	NOUN
dpc-1242	50	12	(	(	PUNCT
dpc-1242	50	13	tcs	tcs	NOUN
dpc-1242	50	14	)	)	PUNCT
dpc-1242	50	15	,	,	PUNCT
dpc-1242	50	16	and	and	CCONJ
dpc-1242	50	17	topical	topical	ADJ
dpc-1242	50	18	calcineurin	calcineurin	NOUN
dpc-1242	50	19	inhibitors	inhibitor	NOUN
dpc-1242	50	20	(	(	PUNCT
dpc-1242	50	21	tci	tci	NOUN
dpc-1242	50	22	)	)	PUNCT
dpc-1242	51	1	[	[	X
dpc-1242	51	2	4	4	NUM
dpc-1242	51	3	]	]	PUNCT
dpc-1242	51	4	.	.	PUNCT
dpc-1242	52	1	proper	proper	ADJ
dpc-1242	52	2	bathing	bathing	NOUN
dpc-1242	52	3	followed	follow	VERB
dpc-1242	52	4	by	by	ADP
dpc-1242	52	5	the	the	DET
dpc-1242	52	6	regular	regular	ADJ
dpc-1242	52	7	use	use	NOUN
dpc-1242	52	8	of	of	ADP
dpc-1242	52	9	skin	skin	NOUN
dpc-1242	52	10	emollients	emollient	NOUN
dpc-1242	52	11	for	for	ADP
dpc-1242	52	12	restoring	restore	VERB
dpc-1242	52	13	hydration	hydration	NOUN
dpc-1242	52	14	and	and	CCONJ
dpc-1242	52	15	identifying	identify	VERB
dpc-1242	52	16	and	and	CCONJ
dpc-1242	52	17	eliminating	eliminate	VERB
dpc-1242	52	18	trigger	trigger	NOUN
dpc-1242	52	19	factors	factor	NOUN
dpc-1242	52	20	may	may	AUX
dpc-1242	52	21	be	be	AUX
dpc-1242	52	22	helpful	helpful	ADJ
dpc-1242	52	23	in	in	ADP
dpc-1242	52	24	the	the	DET
dpc-1242	52	25	treatment	treatment	NOUN
dpc-1242	52	26	of	of	ADP
dpc-1242	52	27	acute	acute	ADJ
dpc-1242	52	28	flare	flare	NOUN
dpc-1242	52	29	-	-	PUNCT
dpc-1242	52	30	ups	up	NOUN
dpc-1242	52	31	,	,	PUNCT
dpc-1242	52	32	but	but	CCONJ
dpc-1242	52	33	they	they	PRON
dpc-1242	52	34	do	do	AUX
dpc-1242	52	35	not	not	PART
dpc-1242	52	36	sufficiently	sufficiently	ADV
dpc-1242	52	37	suppress	suppress	VERB
dpc-1242	52	38	the	the	DET
dpc-1242	52	39	inflammation	inflammation	NOUN
dpc-1242	52	40	occurring	occur	VERB
dpc-1242	52	41	deep	deep	ADV
dpc-1242	52	42	at	at	ADP
dpc-1242	52	43	the	the	DET
dpc-1242	52	44	molecular	molecular	ADJ
dpc-1242	52	45	level	level	NOUN
dpc-1242	52	46	to	to	PART
dpc-1242	52	47	prevent	prevent	VERB
dpc-1242	52	48	future	future	ADJ
dpc-1242	52	49	exacerbations	exacerbation	NOUN
dpc-1242	52	50	.	.	PUNCT
dpc-1242	53	1	topical	topical	ADJ
dpc-1242	53	2	treatments	treatment	NOUN
dpc-1242	53	3	like	like	ADP
dpc-1242	53	4	tcs	tcs	NOUN
dpc-1242	54	1	[	[	X
dpc-1242	54	2	5,6	5,6	NUM
dpc-1242	54	3	]	]	PUNCT
dpc-1242	54	4	and	and	CCONJ
dpc-1242	54	5	tci	tci	X
dpc-1242	55	1	[	[	PUNCT
dpc-1242	55	2	7,8	7,8	NUM
dpc-1242	55	3	]	]	PUNCT
dpc-1242	55	4	help	help	VERB
dpc-1242	55	5	to	to	PART
dpc-1242	55	6	reduce	reduce	VERB
dpc-1242	55	7	inflammation	inflammation	NOUN
dpc-1242	55	8	by	by	ADP
dpc-1242	55	9	blocking	block	VERB
dpc-1242	55	10	various	various	ADJ
dpc-1242	55	11	inflammatory	inflammatory	ADJ
dpc-1242	55	12	cytokine	cytokine	NOUN
dpc-1242	55	13	productions	production	NOUN
dpc-1242	55	14	at	at	ADP
dpc-1242	55	15	different	different	ADJ
dpc-1242	55	16	levels	level	NOUN
dpc-1242	55	17	of	of	ADP
dpc-1242	55	18	pathophysiology	pathophysiology	NOUN
dpc-1242	55	19	.	.	PUNCT
dpc-1242	56	1	both	both	DET
dpc-1242	56	2	tcs	tcs	NOUN
dpc-1242	56	3	and	and	CCONJ
dpc-1242	56	4	tci	tci	PROPN
dpc-1242	56	5	are	be	AUX
dpc-1242	56	6	first	first	ADJ
dpc-1242	56	7	-	-	PUNCT
dpc-1242	56	8	line	line	NOUN
dpc-1242	56	9	therapy	therapy	NOUN
dpc-1242	56	10	for	for	ADP
dpc-1242	56	11	ad	ad	NOUN
dpc-1242	56	12	and	and	CCONJ
dpc-1242	56	13	are	be	AUX
dpc-1242	56	14	proven	prove	VERB
dpc-1242	56	15	to	to	PART
dpc-1242	56	16	be	be	AUX
dpc-1242	56	17	useful	useful	ADJ
dpc-1242	56	18	in	in	ADP
dpc-1242	56	19	both	both	DET
dpc-1242	56	20	acute	acute	ADJ
dpc-1242	56	21	flare	flare	NOUN
dpc-1242	56	22	-	-	PUNCT
dpc-1242	56	23	ups	up	NOUN
dpc-1242	56	24	and	and	CCONJ
dpc-1242	56	25	maintenance	maintenance	NOUN
dpc-1242	56	26	therapy	therapy	NOUN
dpc-1242	56	27	.	.	PUNCT
dpc-1242	57	1	however	however	ADV
dpc-1242	57	2	,	,	PUNCT
dpc-1242	57	3	the	the	DET
dpc-1242	57	4	major	major	ADJ
dpc-1242	57	5	drawback	drawback	NOUN
dpc-1242	57	6	encountered	encounter	VERB
dpc-1242	57	7	with	with	ADP
dpc-1242	57	8	tcs	tcs	NOUN
dpc-1242	57	9	is	be	AUX
dpc-1242	57	10	the	the	DET
dpc-1242	57	11	adverse	adverse	ADJ
dpc-1242	57	12	effects	effect	NOUN
dpc-1242	57	13	associated	associate	VERB
dpc-1242	57	14	with	with	ADP
dpc-1242	57	15	chronic	chronic	ADJ
dpc-1242	57	16	use	use	NOUN
dpc-1242	57	17	.	.	PUNCT
dpc-1242	58	1	tci	tci	PROPN
dpc-1242	58	2	are	be	AUX
dpc-1242	58	3	an	an	DET
dpc-1242	58	4	excellent	excellent	ADJ
dpc-1242	58	5	alternative	alternative	NOUN
dpc-1242	58	6	with	with	ADP
dpc-1242	58	7	no	no	DET
dpc-1242	58	8	steroid	steroid	NOUN
dpc-1242	58	9	-	-	PUNCT
dpc-1242	58	10	related	relate	VERB
dpc-1242	58	11	side	side	NOUN
dpc-1242	58	12	effects	effect	NOUN
dpc-1242	58	13	,	,	PUNCT
dpc-1242	58	14	and	and	CCONJ
dpc-1242	58	15	they	they	PRON
dpc-1242	58	16	are	be	AUX
dpc-1242	58	17	safer	safe	ADJ
dpc-1242	58	18	to	to	PART
dpc-1242	58	19	use	use	VERB
dpc-1242	58	20	on	on	ADP
dpc-1242	58	21	thinner	thin	ADJ
dpc-1242	58	22	skin	skin	NOUN
dpc-1242	58	23	[	[	X
dpc-1242	58	24	9	9	NUM
dpc-1242	58	25	]	]	PUNCT
dpc-1242	58	26	.	.	PUNCT
dpc-1242	59	1	they	they	PRON
dpc-1242	59	2	are	be	AUX
dpc-1242	59	3	either	either	ADV
dpc-1242	59	4	used	use	VERB
dpc-1242	59	5	alone	alone	ADV
dpc-1242	59	6	or	or	CCONJ
dpc-1242	59	7	in	in	ADP
dpc-1242	59	8	combination	combination	NOUN
dpc-1242	59	9	with	with	ADP
dpc-1242	59	10	tcs	tcs	NOUN
dpc-1242	59	11	and	and	CCONJ
dpc-1242	59	12	have	have	AUX
dpc-1242	59	13	proven	prove	VERB
dpc-1242	59	14	to	to	PART
dpc-1242	59	15	reduce	reduce	VERB
dpc-1242	59	16	frequency	frequency	NOUN
dpc-1242	59	17	and	and	CCONJ
dpc-1242	59	18	severity	severity	NOUN
dpc-1242	59	19	of	of	ADP
dpc-1242	59	20	flare	flare	NOUN
dpc-1242	59	21	-	-	PUNCT
dpc-1242	59	22	ups	up	NOUN
dpc-1242	59	23	.	.	PUNCT
dpc-1242	60	1	although	although	SCONJ
dpc-1242	60	2	tcs	tcs	PROPN
dpc-1242	60	3	and	and	CCONJ
dpc-1242	60	4	tci	tci	PROPN
dpc-1242	60	5	are	be	AUX
dpc-1242	60	6	routinely	routinely	ADV
dpc-1242	60	7	prescribed	prescribe	VERB
dpc-1242	60	8	topical	topical	ADJ
dpc-1242	60	9	treatments	treatment	NOUN
dpc-1242	60	10	for	for	ADP
dpc-1242	60	11	ad	ad	NOUN
dpc-1242	60	12	in	in	ADP
dpc-1242	60	13	outpatient	outpatient	NOUN
dpc-1242	60	14	settings	setting	NOUN
dpc-1242	60	15	,	,	PUNCT
dpc-1242	60	16	tci	tci	PROPN
dpc-1242	60	17	are	be	AUX
dpc-1242	60	18	often	often	ADV
dpc-1242	60	19	selected	select	VERB
dpc-1242	60	20	for	for	ADP
dpc-1242	60	21	patients	patient	NOUN
dpc-1242	60	22	who	who	PRON
dpc-1242	60	23	do	do	AUX
dpc-1242	60	24	not	not	PART
dpc-1242	60	25	respond	respond	VERB
dpc-1242	60	26	to	to	ADP
dpc-1242	60	27	tcs	tcs	NOUN
dpc-1242	60	28	and	and	CCONJ
dpc-1242	60	29	when	when	SCONJ
dpc-1242	60	30	the	the	DET
dpc-1242	60	31	proactive	proactive	ADJ
dpc-1242	60	32	approach	approach	NOUN
dpc-1242	60	33	is	be	AUX
dpc-1242	60	34	not	not	PART
dpc-1242	60	35	a	a	DET
dpc-1242	60	36	routinely	routinely	ADV
dpc-1242	60	37	followed	follow	VERB
dpc-1242	60	38	strategy	strategy	NOUN
dpc-1242	60	39	.	.	PUNCT
dpc-1242	61	1	available	available	ADJ
dpc-1242	61	2	clinical	clinical	ADJ
dpc-1242	61	3	studies	study	NOUN
dpc-1242	61	4	neither	neither	CCONJ
dpc-1242	61	5	reflect	reflect	VERB
dpc-1242	61	6	the	the	DET
dpc-1242	61	7	common	common	ADJ
dpc-1242	61	8	clinical	clinical	ADJ
dpc-1242	61	9	practice	practice	NOUN
dpc-1242	61	10	nor	nor	CCONJ
dpc-1242	61	11	the	the	DET
dpc-1242	61	12	need	need	NOUN
dpc-1242	61	13	for	for	ADP
dpc-1242	61	14	long	long	ADJ
dpc-1242	61	15	-	-	PUNCT
dpc-1242	61	16	term	term	NOUN
dpc-1242	61	17	treatment	treatment	NOUN
dpc-1242	61	18	of	of	ADP
dpc-1242	61	19	ad	ad	NOUN
dpc-1242	61	20	in	in	ADP
dpc-1242	61	21	the	the	DET
dpc-1242	61	22	indian	indian	ADJ
dpc-1242	61	23	population	population	NOUN
dpc-1242	61	24	.	.	PUNCT
dpc-1242	62	1	a	a	DET
dpc-1242	62	2	study	study	NOUN
dpc-1242	62	3	by	by	ADP
dpc-1242	62	4	berth	berth	NOUN
dpc-1242	62	5	-	-	PUNCT
dpc-1242	62	6	jones	jones	NOUN
dpc-1242	62	7	et	et	PROPN
dpc-1242	62	8	al	al	PROPN
dpc-1242	63	1	[	[	X
dpc-1242	63	2	10	10	NUM
dpc-1242	63	3	]	]	PUNCT
dpc-1242	63	4	compared	compare	VERB
dpc-1242	63	5	different	different	ADJ
dpc-1242	63	6	formulations	formulation	NOUN
dpc-1242	63	7	of	of	ADP
dpc-1242	63	8	fluticasone	fluticasone	NOUN
dpc-1242	63	9	with	with	ADP
dpc-1242	63	10	placebo	placebo	NOUN
dpc-1242	63	11	in	in	ADP
dpc-1242	63	12	a	a	DET
dpc-1242	63	13	16	16	NUM
dpc-1242	63	14	-	-	PUNCT
dpc-1242	63	15	week	week	NOUN
dpc-1242	63	16	proactive	proactive	ADJ
dpc-1242	63	17	regimen	regiman	NOUN
dpc-1242	63	18	.	.	PUNCT
dpc-1242	64	1	after	after	ADP
dpc-1242	64	2	the	the	DET
dpc-1242	64	3	amelioration	amelioration	NOUN
dpc-1242	64	4	in	in	ADP
dpc-1242	64	5	the	the	DET
dpc-1242	64	6	acute	acute	NOUN
dpc-1242	64	7	phase	phase	NOUN
dpc-1242	64	8	,	,	PUNCT
dpc-1242	64	9	the	the	DET
dpc-1242	64	10	risk	risk	NOUN
dpc-1242	64	11	of	of	ADP
dpc-1242	64	12	ad	ad	NOUN
dpc-1242	64	13	flare	flare	NOUN
dpc-1242	64	14	was	be	AUX
dpc-1242	64	15	1.9	1.9	NUM
dpc-1242	64	16	times	time	NOUN
dpc-1242	64	17	lower	low	ADJ
dpc-1242	64	18	with	with	ADP
dpc-1242	64	19	fluticasone	fluticasone	NOUN
dpc-1242	64	20	ointment	ointment	NOUN
dpc-1242	64	21	than	than	ADP
dpc-1242	64	22	under	under	ADP
dpc-1242	64	23	placebo	placebo	NOUN
dpc-1242	64	24	.	.	PUNCT
dpc-1242	65	1	breneman	breneman	PROPN
dpc-1242	65	2	et	et	PROPN
dpc-1242	65	3	al	al	PROPN
dpc-1242	66	1	[	[	X
dpc-1242	66	2	11	11	NUM
dpc-1242	66	3	]	]	PUNCT
dpc-1242	66	4	in	in	ADP
dpc-1242	66	5	a	a	DET
dpc-1242	66	6	randomized	randomized	ADJ
dpc-1242	66	7	study	study	NOUN
dpc-1242	66	8	tested	test	VERB
dpc-1242	66	9	the	the	DET
dpc-1242	66	10	proactive	proactive	ADJ
dpc-1242	66	11	use	use	NOUN
dpc-1242	66	12	of	of	ADP
dpc-1242	66	13	tacrolimus	tacrolimus	NOUN
dpc-1242	66	14	0.03	0.03	NUM
dpc-1242	66	15	%	%	NOUN
dpc-1242	66	16	ointment	ointment	NOUN
dpc-1242	66	17	3	3	NUM
dpc-1242	66	18	times	time	NOUN
dpc-1242	66	19	weekly	weekly	ADJ
dpc-1242	66	20	in	in	ADP
dpc-1242	66	21	children	child	NOUN
dpc-1242	66	22	that	that	PRON
dpc-1242	66	23	showed	show	VERB
dpc-1242	66	24	a	a	DET
dpc-1242	66	25	longer	long	ADJ
dpc-1242	66	26	median	median	ADJ
dpc-1242	66	27	flare	flare	NOUN
dpc-1242	66	28	-	-	PUNCT
dpc-1242	66	29	free	free	ADJ
dpc-1242	66	30	period	period	NOUN
dpc-1242	66	31	in	in	ADP
dpc-1242	66	32	the	the	DET
dpc-1242	66	33	proactive	proactive	ADJ
dpc-1242	66	34	treatment	treatment	NOUN
dpc-1242	66	35	group	group	NOUN
dpc-1242	66	36	than	than	ADP
dpc-1242	66	37	in	in	ADP
dpc-1242	66	38	the	the	DET
dpc-1242	66	39	control	control	NOUN
dpc-1242	66	40	group	group	NOUN
dpc-1242	66	41	.	.	PUNCT
dpc-1242	67	1	the	the	DET
dpc-1242	67	2	differences	difference	NOUN
dpc-1242	67	3	in	in	ADP
dpc-1242	67	4	the	the	DET
dpc-1242	67	5	study	study	NOUN
dpc-1242	67	6	population	population	NOUN
dpc-1242	67	7	,	,	PUNCT
dpc-1242	67	8	drug	drug	NOUN
dpc-1242	67	9	application	application	NOUN
dpc-1242	67	10	schedule	schedule	NOUN
dpc-1242	67	11	,	,	PUNCT
dpc-1242	67	12	and	and	CCONJ
dpc-1242	67	13	study	study	VERB
dpc-1242	67	14	duration	duration	NOUN
dpc-1242	67	15	make	make	VERB
dpc-1242	67	16	a	a	DET
dpc-1242	67	17	direct	direct	ADJ
dpc-1242	67	18	comparison	comparison	NOUN
dpc-1242	67	19	with	with	ADP
dpc-1242	67	20	various	various	ADJ
dpc-1242	67	21	drugs	drug	NOUN
dpc-1242	67	22	a	a	DET
dpc-1242	67	23	difficult	difficult	ADJ
dpc-1242	67	24	task	task	NOUN
dpc-1242	67	25	.	.	PUNCT
dpc-1242	68	1	we	we	PRON
dpc-1242	68	2	chose	choose	VERB
dpc-1242	68	3	to	to	PART
dpc-1242	68	4	study	study	VERB
dpc-1242	68	5	tcs	tcs	NOUN
dpc-1242	68	6	and	and	CCONJ
dpc-1242	68	7	tci	tci	NOUN
dpc-1242	68	8	as	as	ADP
dpc-1242	68	9	first	first	ADJ
dpc-1242	68	10	-	-	PUNCT
dpc-1242	68	11	line	line	NOUN
dpc-1242	68	12	treatment	treatment	NOUN
dpc-1242	68	13	both	both	PRON
dpc-1242	68	14	for	for	ADP
dpc-1242	68	15	reactive	reactive	ADJ
dpc-1242	68	16	and	and	CCONJ
dpc-1242	68	17	proactive	proactive	ADJ
dpc-1242	68	18	therapy	therapy	NOUN
dpc-1242	68	19	.	.	PUNCT
dpc-1242	69	1	we	we	PRON
dpc-1242	69	2	divided	divide	VERB
dpc-1242	69	3	our	our	PRON
dpc-1242	69	4	study	study	NOUN
dpc-1242	69	5	into	into	ADP
dpc-1242	69	6	2	2	NUM
dpc-1242	69	7	phases	phase	NOUN
dpc-1242	69	8	in	in	ADP
dpc-1242	69	9	order	order	NOUN
dpc-1242	69	10	to	to	PART
dpc-1242	69	11	assess	assess	VERB
dpc-1242	69	12	the	the	DET
dpc-1242	69	13	efficacy	efficacy	NOUN
dpc-1242	69	14	and	and	CCONJ
dpc-1242	69	15	safety	safety	NOUN
dpc-1242	69	16	of	of	ADP
dpc-1242	69	17	topical	topical	ADJ
dpc-1242	69	18	treatment	treatment	NOUN
dpc-1242	69	19	in	in	ADP
dpc-1242	69	20	the	the	DET
dpc-1242	69	21	acute	acute	NOUN
dpc-1242	69	22	flare	flare	NOUN
dpc-1242	69	23	-	-	PUNCT
dpc-1242	69	24	up	up	ADP
dpc-1242	69	25	phase	phase	NOUN
dpc-1242	69	26	followed	follow	VERB
dpc-1242	69	27	by	by	ADP
dpc-1242	69	28	a	a	DET
dpc-1242	69	29	4	4	NUM
dpc-1242	69	30	-	-	PUNCT
dpc-1242	69	31	week	week	NOUN
dpc-1242	69	32	maintenance	maintenance	NOUN
dpc-1242	69	33	phase	phase	NOUN
dpc-1242	69	34	.	.	PUNCT
dpc-1242	70	1	the	the	DET
dpc-1242	70	2	primary	primary	ADJ
dpc-1242	70	3	objective	objective	NOUN
dpc-1242	70	4	of	of	ADP
dpc-1242	70	5	the	the	DET
dpc-1242	70	6	study	study	NOUN
dpc-1242	70	7	was	be	AUX
dpc-1242	70	8	to	to	PART
dpc-1242	70	9	compare	compare	VERB
dpc-1242	70	10	the	the	DET
dpc-1242	70	11	efficacy	efficacy	NOUN
dpc-1242	70	12	of	of	ADP
dpc-1242	70	13	topical	topical	ADJ
dpc-1242	70	14	preparations	preparation	NOUN
dpc-1242	70	15	of	of	ADP
dpc-1242	70	16	0.005	0.005	NUM
dpc-1242	70	17	%	%	NOUN
dpc-1242	70	18	fluticasone	fluticasone	NOUN
dpc-1242	70	19	versus	versus	ADP
dpc-1242	70	20	0.03	0.03	NUM
dpc-1242	70	21	%	%	NOUN
dpc-1242	70	22	tacrolimus	tacrolimus	NOUN
dpc-1242	70	23	ointment	ointment	NOUN
dpc-1242	70	24	in	in	ADP
dpc-1242	70	25	the	the	DET
dpc-1242	70	26	treatment	treatment	NOUN
dpc-1242	70	27	of	of	ADP
dpc-1242	70	28	research	research	NOUN
dpc-1242	70	29	|	|	ADV
dpc-1242	70	30	dermatol	dermatol	ADJ
dpc-1242	70	31	pract	pract	NOUN
dpc-1242	70	32	concept	concept	NOUN
dpc-1242	70	33	2020;10(4):e2020094	2020;10(4):e2020094	NUM
dpc-1242	70	34	3	3	NUM
dpc-1242	70	35	results	result	NOUN
dpc-1242	70	36	table	table	NOUN
dpc-1242	70	37	1	1	NUM
dpc-1242	70	38	shows	show	VERB
dpc-1242	70	39	the	the	DET
dpc-1242	70	40	baseline	baseline	ADJ
dpc-1242	70	41	demographic	demographic	ADJ
dpc-1242	70	42	data	datum	NOUN
dpc-1242	70	43	pf	pf	NOUN
dpc-1242	70	44	gender	gender	NOUN
dpc-1242	70	45	details	detail	NOUN
dpc-1242	70	46	,	,	PUNCT
dpc-1242	70	47	age	age	NOUN
dpc-1242	70	48	-	-	PUNCT
dpc-1242	70	49	wise	wise	ADJ
dpc-1242	70	50	distribution	distribution	NOUN
dpc-1242	70	51	of	of	ADP
dpc-1242	70	52	cases	case	NOUN
dpc-1242	70	53	,	,	PUNCT
dpc-1242	70	54	extent	extent	NOUN
dpc-1242	70	55	,	,	PUNCT
dpc-1242	70	56	intensity	intensity	NOUN
dpc-1242	70	57	,	,	PUNCT
dpc-1242	70	58	subjective	subjective	ADJ
dpc-1242	70	59	symptoms	symptom	NOUN
dpc-1242	70	60	,	,	PUNCT
dpc-1242	70	61	scorad	scorad	NOUN
dpc-1242	70	62	and	and	CCONJ
dpc-1242	70	63	qol	qol	PROPN
dpc-1242	70	64	scores	score	NOUN
dpc-1242	70	65	.	.	PUNCT
dpc-1242	71	1	we	we	PRON
dpc-1242	71	2	screened	screen	VERB
dpc-1242	71	3	a	a	DET
dpc-1242	71	4	total	total	NOUN
dpc-1242	71	5	of	of	ADP
dpc-1242	71	6	37	37	NUM
dpc-1242	71	7	children	child	NOUN
dpc-1242	71	8	with	with	ADP
dpc-1242	71	9	moderately	moderately	ADV
dpc-1242	71	10	active	active	ADJ
dpc-1242	71	11	ad	ad	NOUN
dpc-1242	71	12	.	.	PUNCT
dpc-1242	72	1	the	the	DET
dpc-1242	72	2	mean	mean	ADJ
dpc-1242	72	3	±sd	±sd	PRON
dpc-1242	72	4	age	age	NOUN
dpc-1242	72	5	of	of	ADP
dpc-1242	72	6	all	all	DET
dpc-1242	72	7	37	37	NUM
dpc-1242	72	8	children	child	NOUN
dpc-1242	72	9	recruited	recruit	VERB
dpc-1242	72	10	for	for	ADP
dpc-1242	72	11	the	the	DET
dpc-1242	72	12	study	study	NOUN
dpc-1242	72	13	was	be	AUX
dpc-1242	72	14	10.13	10.13	NUM
dpc-1242	72	15	±3.61	±3.61	NOUN
dpc-1242	72	16	years	year	NOUN
dpc-1242	72	17	.	.	PUNCT
dpc-1242	73	1	group	group	NOUN
dpc-1242	73	2	wise	wise	ADJ
dpc-1242	73	3	(	(	PUNCT
dpc-1242	73	4	mean	mean	PROPN
dpc-1242	73	5	±	±	NUM
dpc-1242	73	6	sd	sd	NOUN
dpc-1242	73	7	)	)	PUNCT
dpc-1242	73	8	age	age	NOUN
dpc-1242	73	9	was	be	AUX
dpc-1242	73	10	9.84	9.84	NUM
dpc-1242	73	11	±	±	NUM
dpc-1242	73	12	3.78	3.78	NUM
dpc-1242	73	13	years	year	NOUN
dpc-1242	73	14	and	and	CCONJ
dpc-1242	73	15	10.44	10.44	NUM
dpc-1242	73	16	±	±	NUM
dpc-1242	73	17	3.50	3.50	NUM
dpc-1242	73	18	years	year	NOUN
dpc-1242	73	19	with	with	ADP
dpc-1242	73	20	no	no	DET
dpc-1242	73	21	significant	significant	ADJ
dpc-1242	73	22	difference	difference	NOUN
dpc-1242	73	23	between	between	ADP
dpc-1242	73	24	groups	group	NOUN
dpc-1242	73	25	.	.	PUNCT
dpc-1242	74	1	approximately	approximately	ADV
dpc-1242	74	2	81	81	NUM
dpc-1242	74	3	%	%	NOUN
dpc-1242	74	4	of	of	ADP
dpc-1242	74	5	children	child	NOUN
dpc-1242	74	6	with	with	ADP
dpc-1242	74	7	ad	ad	NOUN
dpc-1242	74	8	had	have	VERB
dpc-1242	74	9	a	a	DET
dpc-1242	74	10	personal	personal	ADJ
dpc-1242	74	11	or	or	CCONJ
dpc-1242	74	12	family	family	NOUN
dpc-1242	74	13	history	history	NOUN
dpc-1242	74	14	of	of	ADP
dpc-1242	74	15	atopy	atopy	NOUN
dpc-1242	74	16	.	.	PUNCT
dpc-1242	75	1	at	at	ADP
dpc-1242	75	2	the	the	DET
dpc-1242	75	3	end	end	NOUN
dpc-1242	75	4	of	of	ADP
dpc-1242	75	5	statistics	statistic	NOUN
dpc-1242	75	6	age	age	NOUN
dpc-1242	75	7	and	and	CCONJ
dpc-1242	75	8	gender	gender	NOUN
dpc-1242	75	9	values	value	NOUN
dpc-1242	75	10	of	of	ADP
dpc-1242	75	11	recruited	recruit	VERB
dpc-1242	75	12	children	child	NOUN
dpc-1242	75	13	were	be	AUX
dpc-1242	75	14	analyzed	analyze	VERB
dpc-1242	75	15	with	with	ADP
dpc-1242	75	16	the	the	DET
dpc-1242	75	17	chi	chi	ADJ
dpc-1242	75	18	-	-	PUNCT
dpc-1242	75	19	square	square	ADJ
dpc-1242	75	20	test	test	NOUN
dpc-1242	75	21	.	.	PUNCT
dpc-1242	76	1	data	datum	NOUN
dpc-1242	76	2	analysis	analysis	NOUN
dpc-1242	76	3	for	for	ADP
dpc-1242	76	4	efficacy	efficacy	NOUN
dpc-1242	76	5	,	,	PUNCT
dpc-1242	76	6	as	as	SCONJ
dpc-1242	76	7	measured	measure	VERB
dpc-1242	76	8	by	by	ADP
dpc-1242	76	9	scorad	scorad	NOUN
dpc-1242	76	10	and	and	CCONJ
dpc-1242	76	11	qol	qol	NOUN
dpc-1242	76	12	of	of	ADP
dpc-1242	76	13	ad	ad	NOUN
dpc-1242	76	14	children	child	NOUN
dpc-1242	76	15	using	use	VERB
dpc-1242	76	16	the	the	DET
dpc-1242	76	17	cdlqi	cdlqi	PROPN
dpc-1242	76	18	index	index	NOUN
dpc-1242	76	19	,	,	PUNCT
dpc-1242	76	20	was	be	AUX
dpc-1242	76	21	performed	perform	VERB
dpc-1242	76	22	by	by	ADP
dpc-1242	76	23	repeated	repeat	VERB
dpc-1242	76	24	measures	measure	NOUN
dpc-1242	76	25	anova	anova	PROPN
dpc-1242	76	26	.	.	PUNCT
dpc-1242	77	1	the	the	DET
dpc-1242	77	2	association	association	NOUN
dpc-1242	77	3	between	between	ADP
dpc-1242	77	4	scorad	scorad	PROPN
dpc-1242	77	5	and	and	CCONJ
dpc-1242	77	6	cdlqi	cdlqi	NOUN
dpc-1242	77	7	was	be	AUX
dpc-1242	77	8	conducted	conduct	VERB
dpc-1242	77	9	by	by	ADP
dpc-1242	77	10	pearson	pearson	PROPN
dpc-1242	77	11	’s	’s	PART
dpc-1242	77	12	correlation	correlation	NOUN
dpc-1242	77	13	and	and	CCONJ
dpc-1242	77	14	linear	linear	ADJ
dpc-1242	77	15	regression	regression	NOUN
dpc-1242	77	16	.	.	PUNCT
dpc-1242	78	1	the	the	DET
dpc-1242	78	2	analysis	analysis	NOUN
dpc-1242	78	3	was	be	AUX
dpc-1242	78	4	conducted	conduct	VERB
dpc-1242	78	5	on	on	ADP
dpc-1242	78	6	spss	spss	PROPN
dpc-1242	78	7	software	software	NOUN
dpc-1242	78	8	,	,	PUNCT
dpc-1242	78	9	and	and	CCONJ
dpc-1242	78	10	a	a	DET
dpc-1242	78	11	p	p	NOUN
dpc-1242	78	12	value	value	NOUN
dpc-1242	78	13	of	of	ADP
dpc-1242	78	14	<	<	NOUN
dpc-1242	78	15	0.05	0.05	NUM
dpc-1242	78	16	was	be	AUX
dpc-1242	78	17	considered	consider	VERB
dpc-1242	78	18	statistically	statistically	ADV
dpc-1242	78	19	significant	significant	ADJ
dpc-1242	78	20	.	.	PUNCT
dpc-1242	79	1	table	table	NOUN
dpc-1242	79	2	1	1	NUM
dpc-1242	79	3	.	.	PUNCT
dpc-1242	79	4	demographic	demographic	ADJ
dpc-1242	79	5	and	and	CCONJ
dpc-1242	79	6	disease	disease	NOUN
dpc-1242	79	7	characteristics	characteristic	NOUN
dpc-1242	79	8	in	in	ADP
dpc-1242	79	9	children	child	NOUN
dpc-1242	79	10	with	with	ADP
dpc-1242	79	11	atopic	atopic	NOUN
dpc-1242	79	12	dermatitis	dermatitis	NOUN
dpc-1242	79	13	treatment	treatment	NOUN
dpc-1242	79	14	groups	group	NOUN
dpc-1242	79	15	fluticasone	fluticasone	PROPN
dpc-1242	79	16	group	group	NOUN
dpc-1242	79	17	(	(	PUNCT
dpc-1242	79	18	n=19	n=19	PROPN
dpc-1242	79	19	)	)	PUNCT
dpc-1242	79	20	tacrolimus	tacrolimus	NOUN
dpc-1242	79	21	group	group	NOUN
dpc-1242	79	22	(	(	PUNCT
dpc-1242	79	23	n=18	n=18	ADJ
dpc-1242	79	24	)	)	PUNCT
dpc-1242	79	25	male	male	NOUN
dpc-1242	79	26	:	:	PUNCT
dpc-1242	79	27	female	female	ADJ
dpc-1242	79	28	12:7	12:7	NUM
dpc-1242	79	29	9:9	9:9	NUM
dpc-1242	79	30	2	2	NUM
dpc-1242	79	31	-	-	SYM
dpc-1242	79	32	5	5	NUM
dpc-1242	79	33	years	year	NOUN
dpc-1242	79	34	(	(	PUNCT
dpc-1242	79	35	m	m	NOUN
dpc-1242	79	36	/	/	SYM
dpc-1242	79	37	f	f	X
dpc-1242	79	38	)	)	PUNCT
dpc-1242	79	39	2/2	2/2	NUM
dpc-1242	79	40	1/1	1/1	NUM
dpc-1242	79	41	6	6	NUM
dpc-1242	79	42	-	-	SYM
dpc-1242	79	43	10	10	NUM
dpc-1242	79	44	years	year	NOUN
dpc-1242	79	45	(	(	PUNCT
dpc-1242	79	46	m	m	NOUN
dpc-1242	79	47	/	/	SYM
dpc-1242	79	48	f	f	X
dpc-1242	79	49	)	)	PUNCT
dpc-1242	79	50	4/3	4/3	NUM
dpc-1242	79	51	2/5	2/5	NUM
dpc-1242	79	52	≥11	≥11	NUM
dpc-1242	79	53	years	year	NOUN
dpc-1242	79	54	(	(	PUNCT
dpc-1242	79	55	m	m	NOUN
dpc-1242	79	56	/	/	SYM
dpc-1242	79	57	f	f	X
dpc-1242	79	58	)	)	PUNCT
dpc-1242	79	59	6/2	6/2	NUM
dpc-1242	79	60	6/3	6/3	NUM
dpc-1242	79	61	age	age	NOUN
dpc-1242	79	62	years	year	NOUN
dpc-1242	79	63	±	±	NUM
dpc-1242	79	64	sd	sd	ADP
dpc-1242	79	65	9.84	9.84	NUM
dpc-1242	79	66	±	±	NUM
dpc-1242	79	67	3.78	3.78	NUM
dpc-1242	79	68	10.44	10.44	NUM
dpc-1242	79	69	±	±	NUM
dpc-1242	79	70	3.50	3.50	NUM
dpc-1242	79	71	affected	affect	VERB
dpc-1242	79	72	sites	site	NOUN
dpc-1242	79	73	—	—	PUNCT
dpc-1242	79	74	number	number	NOUN
dpc-1242	79	75	of	of	ADP
dpc-1242	79	76	children	child	NOUN
dpc-1242	79	77	that	that	PRON
dpc-1242	79	78	presented	present	VERB
dpc-1242	79	79	the	the	DET
dpc-1242	79	80	body	body	NOUN
dpc-1242	79	81	area	area	NOUN
dpc-1242	79	82	involved	involve	VERB
dpc-1242	79	83	in	in	ADP
dpc-1242	79	84	ad	ad	NOUN
dpc-1242	79	85	head	head	NOUN
dpc-1242	79	86	and	and	CCONJ
dpc-1242	79	87	neck	neck	NOUN
dpc-1242	79	88	8	8	NUM
dpc-1242	79	89	3	3	NUM
dpc-1242	79	90	extremities	extremity	NOUN
dpc-1242	79	91	15	15	NUM
dpc-1242	79	92	14	14	NUM
dpc-1242	79	93	trunk	trunk	NOUN
dpc-1242	79	94	and	and	CCONJ
dpc-1242	79	95	back	back	ADV
dpc-1242	79	96	13	13	NUM
dpc-1242	79	97	15	15	NUM
dpc-1242	79	98	genitals	genital	NOUN
dpc-1242	79	99	3	3	NUM
dpc-1242	79	100	3	3	NUM
dpc-1242	79	101	total	total	ADJ
dpc-1242	79	102	affected	affect	VERB
dpc-1242	79	103	bsa	bsa	PROPN
dpc-1242	79	104	bsa	bsa	PROPN
dpc-1242	79	105	±	±	PROPN
dpc-1242	79	106	sd	sd	ADP
dpc-1242	79	107	37.57	37.57	NUM
dpc-1242	79	108	±	±	NUM
dpc-1242	79	109	8.94	8.94	NUM
dpc-1242	79	110	36.66	36.66	NUM
dpc-1242	79	111	±	±	NUM
dpc-1242	79	112	10.35	10.35	NUM
dpc-1242	79	113	0	0	NUM
dpc-1242	79	114	to	to	PART
dpc-1242	79	115	≤25	≤25	VERB
dpc-1242	79	116	%	%	NOUN
dpc-1242	79	117	2	2	NUM
dpc-1242	79	118	0	0	NUM
dpc-1242	79	119	>	>	SYM
dpc-1242	79	120	25	25	NUM
dpc-1242	79	121	to	to	PART
dpc-1242	79	122	≤50	≤50	PROPN
dpc-1242	79	123	%	%	NOUN
dpc-1242	79	124	13	13	NUM
dpc-1242	79	125	3	3	NUM
dpc-1242	79	126	>	>	SYM
dpc-1242	79	127	50	50	NUM
dpc-1242	79	128	to	to	PART
dpc-1242	79	129	≤75	≤75	ADJ
dpc-1242	79	130	%	%	NOUN
dpc-1242	79	131	4	4	NUM
dpc-1242	79	132	9	9	NUM
dpc-1242	79	133	>	>	SYM
dpc-1242	79	134	75	75	NUM
dpc-1242	79	135	to	to	PART
dpc-1242	79	136	≤100	≤100	VERB
dpc-1242	79	137	%	%	NOUN
dpc-1242	79	138	0	0	NUM
dpc-1242	79	139	6	6	NUM
dpc-1242	79	140	severity	severity	NOUN
dpc-1242	79	141	of	of	ADP
dpc-1242	79	142	ad	ad	NOUN
dpc-1242	79	143	scorad	scorad	NOUN
dpc-1242	79	144	38.75	38.75	NUM
dpc-1242	79	145	±	±	NUM
dpc-1242	79	146	4.13	4.13	NUM
dpc-1242	79	147	36.60	36.60	NUM
dpc-1242	79	148	±	±	NUM
dpc-1242	79	149	4.45	4.45	NUM
dpc-1242	79	150	mild	mild	ADJ
dpc-1242	79	151	(	(	PUNCT
dpc-1242	79	152	<	<	X
dpc-1242	79	153	25	25	NUM
dpc-1242	79	154	)	)	SYM
dpc-1242	79	155	1	1	NUM
dpc-1242	79	156	2	2	NUM
dpc-1242	79	157	moderate	moderate	ADJ
dpc-1242	79	158	(	(	PUNCT
dpc-1242	79	159	25	25	NUM
dpc-1242	79	160	to	to	PART
dpc-1242	79	161	≤50	≤50	PROPN
dpc-1242	79	162	)	)	PUNCT
dpc-1242	79	163	16	16	NUM
dpc-1242	79	164	14	14	NUM
dpc-1242	79	165	severe	severe	ADJ
dpc-1242	79	166	(	(	PUNCT
dpc-1242	79	167	>	>	X
dpc-1242	79	168	51	51	NUM
dpc-1242	79	169	)	)	PUNCT
dpc-1242	79	170	2	2	NUM
dpc-1242	79	171	2	2	NUM
dpc-1242	79	172	intensity	intensity	NOUN
dpc-1242	79	173	erythema	erythema	VERB
dpc-1242	79	174	1.78	1.78	NUM
dpc-1242	79	175	±	±	NOUN
dpc-1242	79	176	0.71	0.71	NUM
dpc-1242	79	177	1.55	1.55	NUM
dpc-1242	79	178	±	±	NOUN
dpc-1242	79	179	0.70	0.70	NUM
dpc-1242	79	180	edema	edema	NOUN
dpc-1242	79	181	/	/	SYM
dpc-1242	79	182	papules	papule	NOUN
dpc-1242	79	183	0.89	0.89	NUM
dpc-1242	79	184	±	±	NUM
dpc-1242	79	185	0.73	0.73	NUM
dpc-1242	79	186	0.66	0.66	NUM
dpc-1242	79	187	±	±	NUM
dpc-1242	79	188	0.59	0.59	NUM
dpc-1242	79	189	oozing	oozing	NOUN
dpc-1242	79	190	/	/	SYM
dpc-1242	79	191	crusting	crust	VERB
dpc-1242	79	192	0.78	0.78	NUM
dpc-1242	79	193	±	±	NOUN
dpc-1242	79	194	0.63	0.63	NUM
dpc-1242	79	195	0.88	0.88	NUM
dpc-1242	79	196	±	±	NUM
dpc-1242	79	197	0.67	0.67	NUM
dpc-1242	79	198	excoriation	excoriation	NOUN
dpc-1242	79	199	0.63	0.63	NUM
dpc-1242	79	200	±	±	NUM
dpc-1242	79	201	0.76	0.76	NUM
dpc-1242	79	202	0.55	0.55	NUM
dpc-1242	79	203	±	±	NUM
dpc-1242	79	204	0.61	0.61	NUM
dpc-1242	79	205	lichenification	lichenification	NOUN
dpc-1242	79	206	0.52	0.52	NUM
dpc-1242	79	207	±	±	NUM
dpc-1242	79	208	0.51	0.51	NUM
dpc-1242	79	209	0.50	0.50	NUM
dpc-1242	79	210	±	±	NUM
dpc-1242	79	211	0.70	0.70	NUM
dpc-1242	79	212	dryness	dryness	NOUN
dpc-1242	79	213	1.84	1.84	NUM
dpc-1242	79	214	±	±	NUM
dpc-1242	79	215	0.68	0.68	NUM
dpc-1242	79	216	1.83	1.83	NUM
dpc-1242	79	217	±	±	NUM
dpc-1242	79	218	0.51	0.51	NUM
dpc-1242	79	219	subjective	subjective	ADJ
dpc-1242	79	220	symptoms	symptom	NOUN
dpc-1242	79	221	pruritus	pruritus	VERB
dpc-1242	79	222	6.10	6.10	NUM
dpc-1242	79	223	±	±	NUM
dpc-1242	79	224	0.99	0.99	NUM
dpc-1242	79	225	5.83	5.83	NUM
dpc-1242	79	226	±	±	NOUN
dpc-1242	79	227	0.70	0.70	NUM
dpc-1242	79	228	sleeplessness	sleeplessness	NOUN
dpc-1242	79	229	6.00	6.00	NUM
dpc-1242	79	230	±	±	NUM
dpc-1242	79	231	0.94	0.94	NUM
dpc-1242	79	232	6.05	6.05	NUM
dpc-1242	79	233	±	±	NUM
dpc-1242	79	234	0.63	0.63	NUM
dpc-1242	79	235	(	(	PUNCT
dpc-1242	79	236	table	table	NOUN
dpc-1242	79	237	1	1	NUM
dpc-1242	79	238	continues	continue	VERB
dpc-1242	79	239	)	)	PUNCT
dpc-1242	80	1	4	4	NUM
dpc-1242	80	2	research	research	NOUN
dpc-1242	80	3	|	|	ADV
dpc-1242	80	4	dermatol	dermatol	NOUN
dpc-1242	80	5	pract	pract	NOUN
dpc-1242	80	6	concept	concept	NOUN
dpc-1242	80	7	2020;10(4):e2020094	2020;10(4):e2020094	NUM
dpc-1242	80	8	treatment	treatment	NOUN
dpc-1242	80	9	groups	group	NOUN
dpc-1242	80	10	fluticasone	fluticasone	PROPN
dpc-1242	80	11	group	group	NOUN
dpc-1242	80	12	(	(	PUNCT
dpc-1242	80	13	n=19	n=19	PROPN
dpc-1242	80	14	)	)	PUNCT
dpc-1242	80	15	tacrolimus	tacrolimus	NOUN
dpc-1242	80	16	group	group	NOUN
dpc-1242	80	17	(	(	PUNCT
dpc-1242	80	18	n=18	n=18	ADJ
dpc-1242	80	19	)	)	PUNCT
dpc-1242	80	20	quality	quality	NOUN
dpc-1242	80	21	of	of	ADP
dpc-1242	80	22	life	life	NOUN
dpc-1242	80	23	cdlqi	cdlqi	VERB
dpc-1242	80	24	10.05	10.05	NUM
dpc-1242	80	25	±	±	NUM
dpc-1242	80	26	4.27	4.27	NUM
dpc-1242	80	27	10.77±	10.77±	NUM
dpc-1242	80	28	3.84	3.84	NUM
dpc-1242	80	29	none	none	NOUN
dpc-1242	80	30	or	or	CCONJ
dpc-1242	80	31	small	small	ADJ
dpc-1242	80	32	11	11	NUM
dpc-1242	80	33	9	9	NUM
dpc-1242	80	34	moderate	moderate	ADJ
dpc-1242	80	35	8	8	NUM
dpc-1242	80	36	9	9	NUM
dpc-1242	80	37	severe	severe	ADJ
dpc-1242	80	38	0	0	NUM
dpc-1242	80	39	0	0	NUM
dpc-1242	80	40	domains	domain	NOUN
dpc-1242	80	41	of	of	ADP
dpc-1242	80	42	the	the	DET
dpc-1242	80	43	cdlqi	cdlqi	NOUN
dpc-1242	80	44	symptoms	symptom	NOUN
dpc-1242	80	45	/	/	SYM
dpc-1242	80	46	feelings	feeling	NOUN
dpc-1242	80	47	3.10	3.10	NUM
dpc-1242	80	48	±	±	NUM
dpc-1242	80	49	1.24	1.24	NUM
dpc-1242	80	50	3.05	3.05	NUM
dpc-1242	80	51	±	±	NUM
dpc-1242	80	52	1.25	1.25	NUM
dpc-1242	80	53	leisure	leisure	NOUN
dpc-1242	80	54	2.05	2.05	NUM
dpc-1242	80	55	±	±	NUM
dpc-1242	80	56	1.80	1.80	NUM
dpc-1242	80	57	2.44	2.44	NUM
dpc-1242	80	58	±	±	NUM
dpc-1242	80	59	1.58	1.58	NUM
dpc-1242	80	60	school	school	NOUN
dpc-1242	80	61	/	/	SYM
dpc-1242	80	62	holidays	holidays	PROPN
dpc-1242	80	63	0.84	0.84	NUM
dpc-1242	80	64	±	±	NUM
dpc-1242	80	65	0.68	0.68	NUM
dpc-1242	80	66	0.83	0.83	NUM
dpc-1242	80	67	±	±	NUM
dpc-1242	80	68	0.78	0.78	NUM
dpc-1242	80	69	relationships	relationship	NOUN
dpc-1242	80	70	2.00	2.00	NUM
dpc-1242	80	71	±	±	NUM
dpc-1242	80	72	1.41	1.41	NUM
dpc-1242	80	73	2.22	2.22	NUM
dpc-1242	80	74	±	±	NOUN
dpc-1242	80	75	1.00	1.00	NUM
dpc-1242	80	76	sleep	sleep	NOUN
dpc-1242	80	77	1.73	1.73	NUM
dpc-1242	80	78	±	±	NUM
dpc-1242	80	79	0.80	0.80	NUM
dpc-1242	80	80	1.44	1.44	NUM
dpc-1242	80	81	±	±	NUM
dpc-1242	80	82	0.61	0.61	NUM
dpc-1242	80	83	treatment	treatment	NOUN
dpc-1242	80	84	0.31	0.31	NUM
dpc-1242	80	85	±	±	NUM
dpc-1242	80	86	0.47	0.47	NUM
dpc-1242	80	87	0.77	0.77	NUM
dpc-1242	80	88	±	±	NUM
dpc-1242	80	89	0.64	0.64	NUM
dpc-1242	80	90	medical	medical	ADJ
dpc-1242	80	91	history	history	NOUN
dpc-1242	80	92	—	—	PUNCT
dpc-1242	80	93	number	number	NOUN
dpc-1242	80	94	(	(	PUNCT
dpc-1242	80	95	%	%	NOUN
dpc-1242	80	96	)	)	PUNCT
dpc-1242	80	97	of	of	ADP
dpc-1242	80	98	children	child	NOUN
dpc-1242	80	99	with	with	ADP
dpc-1242	80	100	known	know	VERB
dpc-1242	80	101	trigger	trigger	NOUN
dpc-1242	80	102	factors	factor	NOUN
dpc-1242	80	103	personal	personal	ADJ
dpc-1242	80	104	and	and	CCONJ
dpc-1242	80	105	family	family	NOUN
dpc-1242	80	106	history	history	NOUN
dpc-1242	80	107	of	of	ADP
dpc-1242	80	108	atopy	atopy	NOUN
dpc-1242	80	109	15	15	NUM
dpc-1242	80	110	(	(	PUNCT
dpc-1242	80	111	78.94	78.94	NUM
dpc-1242	80	112	)	)	PUNCT
dpc-1242	80	113	15	15	NUM
dpc-1242	80	114	(	(	PUNCT
dpc-1242	80	115	83.33	83.33	NUM
dpc-1242	80	116	)	)	PUNCT
dpc-1242	80	117	seasonal	seasonal	ADJ
dpc-1242	80	118	variations	variation	NOUN
dpc-1242	80	119	(	(	PUNCT
dpc-1242	80	120	%	%	INTJ
dpc-1242	80	121	)	)	PUNCT
dpc-1242	80	122	11	11	NUM
dpc-1242	80	123	(	(	PUNCT
dpc-1242	80	124	57.89	57.89	NUM
dpc-1242	80	125	)	)	PUNCT
dpc-1242	80	126	12	12	NUM
dpc-1242	80	127	(	(	PUNCT
dpc-1242	80	128	66.66	66.66	NUM
dpc-1242	80	129	)	)	PUNCT
dpc-1242	80	130	comparable	comparable	ADJ
dpc-1242	80	131	.	.	PUNCT
dpc-1242	81	1	in	in	ADP
dpc-1242	81	2	the	the	DET
dpc-1242	81	3	acute	acute	ADJ
dpc-1242	81	4	phase	phase	NOUN
dpc-1242	81	5	treatment	treatment	NOUN
dpc-1242	81	6	,	,	PUNCT
dpc-1242	81	7	there	there	PRON
dpc-1242	81	8	was	be	VERB
dpc-1242	81	9	a	a	DET
dpc-1242	81	10	reduction	reduction	NOUN
dpc-1242	81	11	in	in	ADP
dpc-1242	81	12	the	the	DET
dpc-1242	81	13	scorad	scorad	NOUN
dpc-1242	81	14	by	by	ADP
dpc-1242	81	15	42.60	42.60	NUM
dpc-1242	81	16	%	%	NOUN
dpc-1242	81	17	and	and	CCONJ
dpc-1242	81	18	69.29	69.29	NUM
dpc-1242	81	19	%	%	NOUN
dpc-1242	81	20	at	at	ADP
dpc-1242	81	21	weeks	week	NOUN
dpc-1242	81	22	2	2	NUM
dpc-1242	81	23	and	and	CCONJ
dpc-1242	81	24	4	4	NUM
dpc-1242	81	25	visits	visit	NOUN
dpc-1242	81	26	respectively	respectively	ADV
dpc-1242	81	27	when	when	SCONJ
dpc-1242	81	28	compared	compare	VERB
dpc-1242	81	29	to	to	PART
dpc-1242	81	30	baseline	baseline	VERB
dpc-1242	81	31	in	in	ADP
dpc-1242	81	32	the	the	DET
dpc-1242	81	33	fluticasone	fluticasone	NOUN
dpc-1242	81	34	group	group	NOUN
dpc-1242	81	35	and	and	CCONJ
dpc-1242	81	36	by	by	ADP
dpc-1242	81	37	42.34	42.34	NUM
dpc-1242	81	38	%	%	NOUN
dpc-1242	81	39	and	and	CCONJ
dpc-1242	81	40	64.20	64.20	NUM
dpc-1242	81	41	%	%	NOUN
dpc-1242	81	42	in	in	ADP
dpc-1242	81	43	the	the	DET
dpc-1242	81	44	tacrolimus	tacrolimus	NOUN
dpc-1242	81	45	group	group	NOUN
dpc-1242	81	46	.	.	PUNCT
dpc-1242	82	1	significant	significant	ADJ
dpc-1242	82	2	reductions	reduction	NOUN
dpc-1242	82	3	(	(	PUNCT
dpc-1242	82	4	p	p	X
dpc-1242	82	5	<	<	X
dpc-1242	82	6	0.001	0.001	NUM
dpc-1242	82	7	)	)	PUNCT
dpc-1242	82	8	were	be	AUX
dpc-1242	82	9	observed	observe	VERB
dpc-1242	82	10	in	in	ADP
dpc-1242	82	11	both	both	CCONJ
dpc-1242	82	12	scorad	scorad	NOUN
dpc-1242	82	13	and	and	CCONJ
dpc-1242	82	14	cdlqi	cdlqi	NOUN
dpc-1242	82	15	at	at	ADP
dpc-1242	82	16	week	week	NOUN
dpc-1242	82	17	2	2	NUM
dpc-1242	82	18	and	and	CCONJ
dpc-1242	82	19	at	at	ADP
dpc-1242	82	20	end	end	NOUN
dpc-1242	82	21	of	of	ADP
dpc-1242	82	22	the	the	DET
dpc-1242	82	23	acute	acute	ADJ
dpc-1242	82	24	phase	phase	NOUN
dpc-1242	82	25	in	in	ADP
dpc-1242	82	26	both	both	DET
dpc-1242	82	27	treatment	treatment	NOUN
dpc-1242	82	28	groups	group	NOUN
dpc-1242	82	29	.	.	PUNCT
dpc-1242	83	1	in	in	ADP
dpc-1242	83	2	the	the	DET
dpc-1242	83	3	maintenance	maintenance	NOUN
dpc-1242	83	4	phase	phase	NOUN
dpc-1242	83	5	,	,	PUNCT
dpc-1242	83	6	no	no	DET
dpc-1242	83	7	significant	significant	ADJ
dpc-1242	83	8	change	change	NOUN
dpc-1242	83	9	in	in	ADP
dpc-1242	83	10	scorad	scorad	NOUN
dpc-1242	83	11	was	be	AUX
dpc-1242	83	12	observed	observe	VERB
dpc-1242	83	13	in	in	ADP
dpc-1242	83	14	either	either	PRON
dpc-1242	83	15	of	of	ADP
dpc-1242	83	16	the	the	DET
dpc-1242	83	17	acute	acute	ADJ
dpc-1242	83	18	phase	phase	NOUN
dpc-1242	83	19	,	,	PUNCT
dpc-1242	83	20	35	35	NUM
dpc-1242	83	21	children	child	NOUN
dpc-1242	83	22	entered	enter	VERB
dpc-1242	83	23	into	into	ADP
dpc-1242	83	24	the	the	DET
dpc-1242	83	25	4	4	NUM
dpc-1242	83	26	-	-	PUNCT
dpc-1242	83	27	week	week	NOUN
dpc-1242	83	28	maintenance	maintenance	NOUN
dpc-1242	83	29	phase	phase	NOUN
dpc-1242	83	30	;	;	PUNCT
dpc-1242	83	31	2	2	NUM
dpc-1242	83	32	children	child	NOUN
dpc-1242	83	33	from	from	ADP
dpc-1242	83	34	group	group	NOUN
dpc-1242	83	35	1	1	NUM
dpc-1242	83	36	discontinued	discontinue	VERB
dpc-1242	83	37	the	the	DET
dpc-1242	83	38	study	study	NOUN
dpc-1242	83	39	,	,	PUNCT
dpc-1242	83	40	as	as	SCONJ
dpc-1242	83	41	they	they	PRON
dpc-1242	83	42	were	be	AUX
dpc-1242	83	43	satisfied	satisfied	ADJ
dpc-1242	83	44	with	with	ADP
dpc-1242	83	45	lesion	lesion	NOUN
dpc-1242	83	46	improvements	improvement	NOUN
dpc-1242	83	47	and	and	CCONJ
dpc-1242	83	48	did	do	AUX
dpc-1242	83	49	not	not	PART
dpc-1242	83	50	show	show	VERB
dpc-1242	83	51	interest	interest	NOUN
dpc-1242	83	52	in	in	ADP
dpc-1242	83	53	continuing	continue	VERB
dpc-1242	83	54	the	the	DET
dpc-1242	83	55	treatment	treatment	NOUN
dpc-1242	83	56	for	for	ADP
dpc-1242	83	57	one	one	NUM
dpc-1242	83	58	additional	additional	ADJ
dpc-1242	83	59	month	month	NOUN
dpc-1242	83	60	.	.	PUNCT
dpc-1242	84	1	figures	figure	NOUN
dpc-1242	84	2	1	1	NUM
dpc-1242	84	3	and	and	CCONJ
dpc-1242	84	4	2	2	NUM
dpc-1242	84	5	show	show	VERB
dpc-1242	84	6	the	the	DET
dpc-1242	84	7	changes	change	NOUN
dpc-1242	84	8	in	in	ADP
dpc-1242	84	9	scorad	scorad	NOUN
dpc-1242	84	10	and	and	CCONJ
dpc-1242	84	11	cdlqi	cdlqi	NOUN
dpc-1242	84	12	in	in	ADP
dpc-1242	84	13	both	both	DET
dpc-1242	84	14	groups	group	NOUN
dpc-1242	84	15	.	.	PUNCT
dpc-1242	85	1	the	the	DET
dpc-1242	85	2	intergroup	intergroup	ADJ
dpc-1242	85	3	comparison	comparison	NOUN
dpc-1242	85	4	of	of	ADP
dpc-1242	85	5	scorad	scorad	NOUN
dpc-1242	85	6	and	and	CCONJ
dpc-1242	85	7	cdlqi	cdlqi	NOUN
dpc-1242	85	8	at	at	ADP
dpc-1242	85	9	respective	respective	ADJ
dpc-1242	85	10	baseline	baseline	NOUN
dpc-1242	85	11	and	and	CCONJ
dpc-1242	85	12	all	all	DET
dpc-1242	85	13	follow	follow	VERB
dpc-1242	85	14	-	-	PUNCT
dpc-1242	85	15	up	up	ADP
dpc-1242	85	16	intervals	interval	NOUN
dpc-1242	85	17	were	be	AUX
dpc-1242	85	18	table	table	NOUN
dpc-1242	85	19	1	1	NUM
dpc-1242	85	20	.	.	PUNCT
dpc-1242	85	21	demographic	demographic	ADJ
dpc-1242	85	22	and	and	CCONJ
dpc-1242	85	23	disease	disease	NOUN
dpc-1242	85	24	characteristics	characteristic	NOUN
dpc-1242	85	25	in	in	ADP
dpc-1242	85	26	children	child	NOUN
dpc-1242	85	27	with	with	ADP
dpc-1242	85	28	atopic	atopic	NOUN
dpc-1242	85	29	dermatitis	dermatitis	NOUN
dpc-1242	85	30	(	(	PUNCT
dpc-1242	85	31	continued	continued	ADJ
dpc-1242	85	32	)	)	PUNCT
dpc-1242	85	33	ad	ad	NOUN
dpc-1242	85	34	=	=	SYM
dpc-1242	85	35	atopic	atopic	NOUN
dpc-1242	85	36	dermatitis	dermatitis	NOUN
dpc-1242	85	37	;	;	PUNCT
dpc-1242	85	38	bsa	bsa	PROPN
dpc-1242	85	39	=	=	PROPN
dpc-1242	85	40	body	body	PROPN
dpc-1242	85	41	surface	surface	NOUN
dpc-1242	85	42	area	area	NOUN
dpc-1242	85	43	;	;	PUNCT
dpc-1242	85	44	scorad	scorad	NOUN
dpc-1242	85	45	=	=	PUNCT
dpc-1242	85	46	scoring	score	VERB
dpc-1242	85	47	atopic	atopic	NOUN
dpc-1242	85	48	dermatitis	dermatitis	NOUN
dpc-1242	85	49	;	;	PUNCT
dpc-1242	85	50	cdlqi	cdlqi	NOUN
dpc-1242	85	51	=	=	PUNCT
dpc-1242	85	52	children	child	NOUN
dpc-1242	85	53	’s	’s	PART
dpc-1242	85	54	dermatology	dermatology	NOUN
dpc-1242	85	55	life	life	NOUN
dpc-1242	85	56	quality	quality	PROPN
dpc-1242	85	57	index	index	NOUN
dpc-1242	85	58	.	.	PUNCT
dpc-1242	86	1	figure	figure	NOUN
dpc-1242	86	2	1	1	NUM
dpc-1242	86	3	.	.	PUNCT
dpc-1242	87	1	changes	change	NOUN
dpc-1242	87	2	in	in	ADP
dpc-1242	87	3	scorad	scorad	NOUN
dpc-1242	87	4	in	in	ADP
dpc-1242	87	5	both	both	DET
dpc-1242	87	6	treatment	treatment	NOUN
dpc-1242	87	7	groups	group	NOUN
dpc-1242	87	8	at	at	ADP
dpc-1242	87	9	week	week	NOUN
dpc-1242	87	10	0	0	NUM
dpc-1242	87	11	(	(	PUNCT
dpc-1242	87	12	baseline	baseline	NOUN
dpc-1242	87	13	)	)	PUNCT
dpc-1242	87	14	,	,	PUNCT
dpc-1242	87	15	2	2	NUM
dpc-1242	87	16	,	,	PUNCT
dpc-1242	87	17	4	4	NUM
dpc-1242	87	18	(	(	PUNCT
dpc-1242	87	19	end	end	NOUN
dpc-1242	87	20	of	of	ADP
dpc-1242	87	21	acute	acute	ADJ
dpc-1242	87	22	phase	phase	NOUN
dpc-1242	87	23	)	)	PUNCT
dpc-1242	87	24	,	,	PUNCT
dpc-1242	87	25	6	6	NUM
dpc-1242	87	26	,	,	PUNCT
dpc-1242	87	27	and	and	CCONJ
dpc-1242	87	28	8	8	NUM
dpc-1242	87	29	(	(	PUNCT
dpc-1242	87	30	end	end	NOUN
dpc-1242	87	31	of	of	ADP
dpc-1242	87	32	maintenance	maintenance	NOUN
dpc-1242	87	33	phase	phase	NOUN
dpc-1242	87	34	)	)	PUNCT
dpc-1242	88	1	[	[	X
dpc-1242	88	2	mean	mean	X
dpc-1242	88	3	±	±	NUM
dpc-1242	88	4	sem	sem	NOUN
dpc-1242	88	5	]	]	PUNCT
dpc-1242	88	6	.	.	PUNCT
dpc-1242	89	1	scorad	scorad	NOUN
dpc-1242	89	2	=	=	PUNCT
dpc-1242	89	3	scoring	score	VERB
dpc-1242	89	4	atopic	atopic	NOUN
dpc-1242	89	5	dermatitis	dermatitis	NOUN
dpc-1242	89	6	.	.	PUNCT
dpc-1242	90	1	research	research	NOUN
dpc-1242	90	2	|	|	ADV
dpc-1242	90	3	dermatol	dermatol	NOUN
dpc-1242	90	4	pract	pract	NOUN
dpc-1242	90	5	concept	concept	NOUN
dpc-1242	90	6	2020;10(4):e2020094	2020;10(4):e2020094	NUM
dpc-1242	90	7	5	5	NUM
dpc-1242	90	8	subjective	subjective	ADJ
dpc-1242	90	9	scores	score	NOUN
dpc-1242	90	10	at	at	ADV
dpc-1242	90	11	all	all	ADV
dpc-1242	90	12	follow	follow	VERB
dpc-1242	90	13	-	-	PUNCT
dpc-1242	90	14	up	up	ADP
dpc-1242	90	15	visits	visit	NOUN
dpc-1242	90	16	in	in	ADP
dpc-1242	90	17	both	both	DET
dpc-1242	90	18	treatment	treatment	NOUN
dpc-1242	90	19	groups	group	NOUN
dpc-1242	90	20	.	.	PUNCT
dpc-1242	91	1	in	in	ADP
dpc-1242	91	2	the	the	DET
dpc-1242	91	3	maintenance	maintenance	NOUN
dpc-1242	91	4	phase	phase	NOUN
dpc-1242	91	5	,	,	PUNCT
dpc-1242	91	6	a	a	DET
dpc-1242	91	7	significant	significant	ADJ
dpc-1242	91	8	mean	mean	ADJ
dpc-1242	91	9	difference	difference	NOUN
dpc-1242	91	10	for	for	ADP
dpc-1242	91	11	subjective	subjective	ADJ
dpc-1242	91	12	symptoms	symptom	NOUN
dpc-1242	91	13	was	be	AUX
dpc-1242	91	14	observed	observe	VERB
dpc-1242	91	15	within	within	ADP
dpc-1242	91	16	the	the	DET
dpc-1242	91	17	tacrolimus	tacrolimus	NOUN
dpc-1242	91	18	group	group	NOUN
dpc-1242	91	19	at	at	ADP
dpc-1242	91	20	week	week	NOUN
dpc-1242	91	21	6	6	NUM
dpc-1242	91	22	.	.	PUNCT
dpc-1242	92	1	figure	figure	NOUN
dpc-1242	92	2	5	5	NUM
dpc-1242	92	3	shows	show	VERB
dpc-1242	92	4	the	the	DET
dpc-1242	92	5	association	association	NOUN
dpc-1242	92	6	between	between	ADP
dpc-1242	92	7	the	the	DET
dpc-1242	92	8	severity	severity	NOUN
dpc-1242	92	9	of	of	ADP
dpc-1242	92	10	the	the	DET
dpc-1242	92	11	disease	disease	NOUN
dpc-1242	92	12	(	(	PUNCT
dpc-1242	92	13	scorad	scorad	NOUN
dpc-1242	92	14	)	)	PUNCT
dpc-1242	92	15	and	and	CCONJ
dpc-1242	92	16	cdlqi	cdlqi	PROPN
dpc-1242	92	17	.	.	PUNCT
dpc-1242	93	1	the	the	DET
dpc-1242	93	2	analysis	analysis	NOUN
dpc-1242	93	3	revealed	reveal	VERB
dpc-1242	93	4	statistical	statistical	ADJ
dpc-1242	93	5	significance	significance	NOUN
dpc-1242	93	6	with	with	ADP
dpc-1242	93	7	p	p	NOUN
dpc-1242	93	8	=	=	NOUN
dpc-1242	93	9	0.004	0.004	NUM
dpc-1242	93	10	,	,	PUNCT
dpc-1242	93	11	indicating	indicate	VERB
dpc-1242	93	12	the	the	DET
dpc-1242	93	13	existence	existence	NOUN
dpc-1242	93	14	of	of	ADP
dpc-1242	93	15	a	a	DET
dpc-1242	93	16	positive	positive	ADJ
dpc-1242	93	17	moderate	moderate	ADJ
dpc-1242	93	18	correlation	correlation	NOUN
dpc-1242	93	19	(	(	PUNCT
dpc-1242	93	20	r	r	NOUN
dpc-1242	93	21	=	=	SYM
dpc-1242	93	22	0.4668	0.4668	NUM
dpc-1242	93	23	)	)	PUNCT
dpc-1242	93	24	between	between	ADP
dpc-1242	93	25	the	the	DET
dpc-1242	93	26	2	2	NUM
dpc-1242	93	27	instruments	instrument	NOUN
dpc-1242	93	28	.	.	PUNCT
dpc-1242	94	1	the	the	DET
dpc-1242	94	2	most	most	ADV
dpc-1242	94	3	common	common	ADJ
dpc-1242	94	4	adverse	adverse	ADJ
dpc-1242	94	5	drug	drug	NOUN
dpc-1242	94	6	reaction	reaction	NOUN
dpc-1242	94	7	(	(	PUNCT
dpc-1242	94	8	adr	adr	PROPN
dpc-1242	94	9	)	)	PUNCT
dpc-1242	94	10	was	be	AUX
dpc-1242	94	11	a	a	DET
dpc-1242	94	12	sensation	sensation	NOUN
dpc-1242	94	13	of	of	ADP
dpc-1242	94	14	skin	skin	NOUN
dpc-1242	94	15	burning	burn	VERB
dpc-1242	94	16	.	.	PUNCT
dpc-1242	95	1	it	it	PRON
dpc-1242	95	2	was	be	AUX
dpc-1242	95	3	observed	observe	VERB
dpc-1242	95	4	in	in	ADP
dpc-1242	95	5	3	3	NUM
dpc-1242	95	6	(	(	PUNCT
dpc-1242	95	7	8	8	NUM
dpc-1242	95	8	%	%	NOUN
dpc-1242	95	9	)	)	PUNCT
dpc-1242	95	10	of	of	ADP
dpc-1242	95	11	all	all	DET
dpc-1242	95	12	children	child	NOUN
dpc-1242	95	13	receiving	receive	VERB
dpc-1242	95	14	tacrolimus	tacrolimus	NOUN
dpc-1242	95	15	.	.	PUNCT
dpc-1242	96	1	no	no	DET
dpc-1242	96	2	adr	adr	PROPN
dpc-1242	96	3	was	be	AUX
dpc-1242	96	4	found	find	VERB
dpc-1242	96	5	with	with	ADP
dpc-1242	96	6	the	the	DET
dpc-1242	96	7	use	use	NOUN
dpc-1242	96	8	of	of	ADP
dpc-1242	96	9	fluticasone	fluticasone	NOUN
dpc-1242	96	10	.	.	PUNCT
dpc-1242	97	1	the	the	DET
dpc-1242	97	2	treatment	treatment	NOUN
dpc-1242	97	3	groups	group	NOUN
dpc-1242	97	4	.	.	PUNCT
dpc-1242	98	1	however	however	ADV
dpc-1242	98	2	,	,	PUNCT
dpc-1242	98	3	the	the	DET
dpc-1242	98	4	change	change	NOUN
dpc-1242	98	5	in	in	ADP
dpc-1242	98	6	cdlqi	cdlqi	NOUN
dpc-1242	98	7	was	be	AUX
dpc-1242	98	8	significant	significant	ADJ
dpc-1242	98	9	(	(	PUNCT
dpc-1242	98	10	p	p	X
dpc-1242	98	11	<	<	X
dpc-1242	98	12	0.05	0.05	NUM
dpc-1242	98	13	)	)	PUNCT
dpc-1242	98	14	at	at	ADP
dpc-1242	98	15	week	week	NOUN
dpc-1242	98	16	8	8	NUM
dpc-1242	98	17	when	when	SCONJ
dpc-1242	98	18	compared	compare	VERB
dpc-1242	98	19	to	to	ADP
dpc-1242	98	20	baseline	baseline	VERB
dpc-1242	98	21	(	(	PUNCT
dpc-1242	98	22	week	week	NOUN
dpc-1242	98	23	4	4	NUM
dpc-1242	98	24	)	)	PUNCT
dpc-1242	98	25	within	within	ADP
dpc-1242	98	26	the	the	DET
dpc-1242	98	27	fluticasone	fluticasone	NOUN
dpc-1242	98	28	group	group	NOUN
dpc-1242	98	29	,	,	PUNCT
dpc-1242	98	30	and	and	CCONJ
dpc-1242	98	31	in	in	ADP
dpc-1242	98	32	the	the	DET
dpc-1242	98	33	tacrolimus	tacrolimus	NOUN
dpc-1242	98	34	group	group	NOUN
dpc-1242	98	35	the	the	DET
dpc-1242	98	36	change	change	NOUN
dpc-1242	98	37	was	be	AUX
dpc-1242	98	38	significant	significant	ADJ
dpc-1242	98	39	at	at	ADP
dpc-1242	98	40	weeks	week	NOUN
dpc-1242	98	41	6	6	NUM
dpc-1242	98	42	and	and	CCONJ
dpc-1242	98	43	8	8	NUM
dpc-1242	98	44	when	when	SCONJ
dpc-1242	98	45	compared	compare	VERB
dpc-1242	98	46	to	to	PART
dpc-1242	98	47	baseline	baseline	VERB
dpc-1242	98	48	(	(	PUNCT
dpc-1242	98	49	p	p	X
dpc-1242	98	50	<	<	X
dpc-1242	98	51	0.05	0.05	NUM
dpc-1242	98	52	)	)	PUNCT
dpc-1242	98	53	.	.	PUNCT
dpc-1242	99	1	figures	figure	NOUN
dpc-1242	99	2	3	3	NUM
dpc-1242	99	3	and	and	CCONJ
dpc-1242	99	4	4	4	NUM
dpc-1242	99	5	show	show	NOUN
dpc-1242	99	6	changes	change	NOUN
dpc-1242	99	7	in	in	ADP
dpc-1242	99	8	the	the	DET
dpc-1242	99	9	body	body	NOUN
dpc-1242	99	10	surface	surface	NOUN
dpc-1242	99	11	area	area	NOUN
dpc-1242	99	12	(	(	PUNCT
dpc-1242	99	13	bsa	bsa	PROPN
dpc-1242	99	14	)	)	PUNCT
dpc-1242	99	15	and	and	CCONJ
dpc-1242	99	16	subjective	subjective	ADJ
dpc-1242	99	17	scores	score	NOUN
dpc-1242	99	18	.	.	PUNCT
dpc-1242	100	1	the	the	DET
dpc-1242	100	2	mean	mean	ADJ
dpc-1242	100	3	extent	extent	NOUN
dpc-1242	100	4	of	of	ADP
dpc-1242	100	5	lesions	lesion	NOUN
dpc-1242	100	6	and	and	CCONJ
dpc-1242	100	7	subjective	subjective	ADJ
dpc-1242	100	8	symptoms	symptom	NOUN
dpc-1242	100	9	at	at	ADP
dpc-1242	100	10	the	the	DET
dpc-1242	100	11	time	time	NOUN
dpc-1242	100	12	of	of	ADP
dpc-1242	100	13	recruitment	recruitment	NOUN
dpc-1242	100	14	was	be	AUX
dpc-1242	100	15	comparable	comparable	ADJ
dpc-1242	100	16	between	between	ADP
dpc-1242	100	17	both	both	DET
dpc-1242	100	18	treatment	treatment	NOUN
dpc-1242	100	19	groups	group	NOUN
dpc-1242	100	20	.	.	PUNCT
dpc-1242	101	1	however	however	ADV
dpc-1242	101	2	,	,	PUNCT
dpc-1242	101	3	there	there	PRON
dpc-1242	101	4	was	be	VERB
dpc-1242	101	5	significant	significant	ADJ
dpc-1242	101	6	(	(	PUNCT
dpc-1242	101	7	p	p	X
dpc-1242	101	8	<	<	X
dpc-1242	101	9	0.05	0.05	NUM
dpc-1242	101	10	)	)	PUNCT
dpc-1242	101	11	reduction	reduction	NOUN
dpc-1242	101	12	in	in	ADP
dpc-1242	101	13	the	the	DET
dpc-1242	101	14	tacrolimus	tacrolimus	NOUN
dpc-1242	101	15	group	group	NOUN
dpc-1242	101	16	at	at	ADP
dpc-1242	101	17	week	week	NOUN
dpc-1242	101	18	8	8	NUM
dpc-1242	101	19	than	than	ADP
dpc-1242	101	20	in	in	ADP
dpc-1242	101	21	the	the	DET
dpc-1242	101	22	fluticasone	fluticasone	NOUN
dpc-1242	101	23	group	group	NOUN
dpc-1242	101	24	.	.	PUNCT
dpc-1242	102	1	at	at	ADP
dpc-1242	102	2	the	the	DET
dpc-1242	102	3	end	end	NOUN
dpc-1242	102	4	of	of	ADP
dpc-1242	102	5	the	the	DET
dpc-1242	102	6	acute	acute	ADJ
dpc-1242	102	7	phase	phase	NOUN
dpc-1242	102	8	,	,	PUNCT
dpc-1242	102	9	there	there	PRON
dpc-1242	102	10	was	be	VERB
dpc-1242	102	11	significant	significant	ADJ
dpc-1242	102	12	reduction	reduction	NOUN
dpc-1242	102	13	of	of	ADP
dpc-1242	102	14	mean	mean	ADJ
dpc-1242	102	15	extent	extent	NOUN
dpc-1242	102	16	and	and	CCONJ
dpc-1242	102	17	figure	figure	NOUN
dpc-1242	102	18	2	2	NUM
dpc-1242	102	19	.	.	PUNCT
dpc-1242	102	20	changes	change	NOUN
dpc-1242	102	21	in	in	ADP
dpc-1242	102	22	cdlqi	cdlqi	NOUN
dpc-1242	102	23	in	in	ADP
dpc-1242	102	24	both	both	DET
dpc-1242	102	25	treatment	treatment	NOUN
dpc-1242	102	26	groups	group	NOUN
dpc-1242	102	27	at	at	ADP
dpc-1242	102	28	week	week	NOUN
dpc-1242	102	29	0	0	NUM
dpc-1242	102	30	(	(	PUNCT
dpc-1242	102	31	baseline	baseline	NOUN
dpc-1242	102	32	)	)	PUNCT
dpc-1242	102	33	,	,	PUNCT
dpc-1242	102	34	2	2	NUM
dpc-1242	102	35	,	,	PUNCT
dpc-1242	102	36	4	4	NUM
dpc-1242	102	37	(	(	PUNCT
dpc-1242	102	38	end	end	NOUN
dpc-1242	102	39	of	of	ADP
dpc-1242	102	40	acute	acute	ADJ
dpc-1242	102	41	phase	phase	NOUN
dpc-1242	102	42	)	)	PUNCT
dpc-1242	102	43	,	,	PUNCT
dpc-1242	102	44	6	6	NUM
dpc-1242	102	45	,	,	PUNCT
dpc-1242	102	46	and	and	CCONJ
dpc-1242	102	47	8	8	NUM
dpc-1242	102	48	(	(	PUNCT
dpc-1242	102	49	end	end	NOUN
dpc-1242	102	50	of	of	ADP
dpc-1242	102	51	maintenance	maintenance	NOUN
dpc-1242	102	52	phase	phase	NOUN
dpc-1242	102	53	)	)	PUNCT
dpc-1242	103	1	[	[	X
dpc-1242	103	2	mean	mean	X
dpc-1242	103	3	±	±	NUM
dpc-1242	103	4	sem	sem	NOUN
dpc-1242	103	5	]	]	PUNCT
dpc-1242	103	6	.	.	PUNCT
dpc-1242	104	1	cdlqi	cdlqi	PROPN
dpc-1242	104	2	=	=	PUNCT
dpc-1242	104	3	children	child	NOUN
dpc-1242	104	4	’s	’s	PART
dpc-1242	104	5	dermatology	dermatology	NOUN
dpc-1242	104	6	life	life	NOUN
dpc-1242	104	7	quality	quality	PROPN
dpc-1242	104	8	index	index	PROPN
dpc-1242	104	9	.	.	PUNCT
dpc-1242	105	1	figure	figure	NOUN
dpc-1242	105	2	3	3	NUM
dpc-1242	105	3	.	.	PUNCT
dpc-1242	105	4	changes	change	NOUN
dpc-1242	105	5	in	in	ADP
dpc-1242	105	6	the	the	DET
dpc-1242	105	7	extent	extent	NOUN
dpc-1242	105	8	of	of	ADP
dpc-1242	105	9	lesions	lesion	NOUN
dpc-1242	105	10	(	(	PUNCT
dpc-1242	105	11	bsa	bsa	PROPN
dpc-1242	105	12	)	)	PUNCT
dpc-1242	105	13	in	in	ADP
dpc-1242	105	14	both	both	DET
dpc-1242	105	15	treatment	treatment	NOUN
dpc-1242	105	16	groups	group	NOUN
dpc-1242	105	17	at	at	ADP
dpc-1242	105	18	week	week	NOUN
dpc-1242	105	19	0	0	NUM
dpc-1242	105	20	(	(	PUNCT
dpc-1242	105	21	baseline	baseline	NOUN
dpc-1242	105	22	)	)	PUNCT
dpc-1242	105	23	,	,	PUNCT
dpc-1242	105	24	2	2	NUM
dpc-1242	105	25	,	,	PUNCT
dpc-1242	105	26	4	4	NUM
dpc-1242	105	27	(	(	PUNCT
dpc-1242	105	28	end	end	NOUN
dpc-1242	105	29	of	of	ADP
dpc-1242	105	30	acute	acute	ADJ
dpc-1242	105	31	phase	phase	NOUN
dpc-1242	105	32	)	)	PUNCT
dpc-1242	105	33	,	,	PUNCT
dpc-1242	105	34	6	6	NUM
dpc-1242	105	35	,	,	PUNCT
dpc-1242	105	36	and	and	CCONJ
dpc-1242	105	37	8	8	NUM
dpc-1242	105	38	(	(	PUNCT
dpc-1242	105	39	end	end	NOUN
dpc-1242	105	40	of	of	ADP
dpc-1242	105	41	maintenance	maintenance	NOUN
dpc-1242	105	42	phase	phase	NOUN
dpc-1242	105	43	)	)	PUNCT
dpc-1242	106	1	[	[	X
dpc-1242	106	2	mean	mean	X
dpc-1242	106	3	±	±	NUM
dpc-1242	106	4	sem	sem	NOUN
dpc-1242	106	5	]	]	PUNCT
dpc-1242	106	6	.	.	PUNCT
dpc-1242	107	1	bsa	bsa	PROPN
dpc-1242	107	2	=	=	SYM
dpc-1242	107	3	body	body	PROPN
dpc-1242	107	4	surface	surface	NOUN
dpc-1242	107	5	area	area	NOUN
dpc-1242	107	6	.	.	PUNCT
dpc-1242	108	1	6	6	NUM
dpc-1242	108	2	research	research	NOUN
dpc-1242	108	3	|	|	ADV
dpc-1242	108	4	dermatol	dermatol	NOUN
dpc-1242	108	5	pract	pract	NOUN
dpc-1242	108	6	concept	concept	NOUN
dpc-1242	108	7	2020;10(4):e2020094	2020;10(4):e2020094	NUM
dpc-1242	108	8	begin	begin	VERB
dpc-1242	108	9	early	early	ADV
dpc-1242	108	10	in	in	ADP
dpc-1242	108	11	age	age	NOUN
dpc-1242	108	12	.	.	PUNCT
dpc-1242	109	1	about	about	ADV
dpc-1242	109	2	65	65	NUM
dpc-1242	109	3	%	%	NOUN
dpc-1242	109	4	develop	develop	VERB
dpc-1242	109	5	symptoms	symptom	NOUN
dpc-1242	109	6	at	at	ADP
dpc-1242	109	7	1	1	NUM
dpc-1242	109	8	year	year	NOUN
dpc-1242	109	9	of	of	ADP
dpc-1242	109	10	age	age	NOUN
dpc-1242	109	11	,	,	PUNCT
dpc-1242	109	12	and	and	CCONJ
dpc-1242	109	13	90	90	NUM
dpc-1242	109	14	%	%	NOUN
dpc-1242	109	15	of	of	ADP
dpc-1242	109	16	affected	affect	VERB
dpc-1242	109	17	individuals	individual	NOUN
dpc-1242	109	18	are	be	AUX
dpc-1242	109	19	younger	young	ADJ
dpc-1242	109	20	than	than	ADP
dpc-1242	109	21	5	5	NUM
dpc-1242	109	22	years	year	NOUN
dpc-1242	109	23	[	[	X
dpc-1242	109	24	17	17	NUM
dpc-1242	109	25	]	]	PUNCT
dpc-1242	109	26	.	.	PUNCT
dpc-1242	110	1	the	the	DET
dpc-1242	110	2	disparity	disparity	NOUN
dpc-1242	110	3	in	in	ADP
dpc-1242	110	4	the	the	DET
dpc-1242	110	5	age	age	NOUN
dpc-1242	110	6	of	of	ADP
dpc-1242	110	7	presentation	presentation	NOUN
dpc-1242	110	8	in	in	ADP
dpc-1242	110	9	our	our	PRON
dpc-1242	110	10	study	study	NOUN
dpc-1242	110	11	could	could	AUX
dpc-1242	110	12	be	be	AUX
dpc-1242	110	13	due	due	ADJ
dpc-1242	110	14	to	to	ADP
dpc-1242	110	15	the	the	DET
dpc-1242	110	16	inclusion	inclusion	NOUN
dpc-1242	110	17	criteria	criterion	NOUN
dpc-1242	110	18	of	of	ADP
dpc-1242	110	19	recruiting	recruit	VERB
dpc-1242	110	20	children	child	NOUN
dpc-1242	110	21	younger	young	ADJ
dpc-1242	110	22	than	than	ADP
dpc-1242	110	23	2	2	NUM
dpc-1242	110	24	years	year	NOUN
dpc-1242	110	25	of	of	ADP
dpc-1242	110	26	age	age	NOUN
dpc-1242	110	27	.	.	PUNCT
dpc-1242	111	1	the	the	DET
dpc-1242	111	2	present	present	ADJ
dpc-1242	111	3	study	study	NOUN
dpc-1242	111	4	found	find	VERB
dpc-1242	111	5	that	that	SCONJ
dpc-1242	111	6	both	both	DET
dpc-1242	111	7	treatment	treatment	NOUN
dpc-1242	111	8	groups	group	NOUN
dpc-1242	111	9	had	have	VERB
dpc-1242	111	10	a	a	DET
dpc-1242	111	11	significantly	significantly	ADV
dpc-1242	111	12	reduced	reduce	VERB
dpc-1242	111	13	scorad	scorad	NOUN
dpc-1242	111	14	as	as	ADV
dpc-1242	111	15	early	early	ADV
dpc-1242	111	16	as	as	ADP
dpc-1242	111	17	week	week	NOUN
dpc-1242	111	18	2	2	NUM
dpc-1242	111	19	.	.	PUNCT
dpc-1242	112	1	at	at	ADP
dpc-1242	112	2	week	week	NOUN
dpc-1242	112	3	2	2	NUM
dpc-1242	112	4	follow	follow	NOUN
dpc-1242	112	5	-	-	PUNCT
dpc-1242	112	6	up	up	NOUN
dpc-1242	112	7	,	,	PUNCT
dpc-1242	112	8	only	only	ADV
dpc-1242	112	9	1	1	NUM
dpc-1242	112	10	child	child	NOUN
dpc-1242	112	11	had	have	VERB
dpc-1242	112	12	moderate	moderate	ADJ
dpc-1242	112	13	ad	ad	NOUN
dpc-1242	112	14	in	in	ADP
dpc-1242	112	15	the	the	DET
dpc-1242	112	16	fluticasone	fluticasone	NOUN
dpc-1242	112	17	group	group	NOUN
dpc-1242	112	18	.	.	PUNCT
dpc-1242	113	1	in	in	ADP
dpc-1242	113	2	the	the	DET
dpc-1242	113	3	rest	rest	NOUN
dpc-1242	113	4	of	of	ADP
dpc-1242	113	5	the	the	DET
dpc-1242	113	6	children	child	NOUN
dpc-1242	113	7	,	,	PUNCT
dpc-1242	113	8	scorad	scorad	NOUN
dpc-1242	113	9	had	have	AUX
dpc-1242	113	10	decreased	decrease	VERB
dpc-1242	113	11	into	into	ADP
dpc-1242	113	12	the	the	DET
dpc-1242	113	13	mild	mild	ADJ
dpc-1242	113	14	severity	severity	NOUN
dpc-1242	113	15	range	range	NOUN
dpc-1242	113	16	.	.	PUNCT
dpc-1242	114	1	the	the	DET
dpc-1242	114	2	results	result	NOUN
dpc-1242	114	3	of	of	ADP
dpc-1242	114	4	this	this	DET
dpc-1242	114	5	study	study	NOUN
dpc-1242	114	6	show	show	VERB
dpc-1242	114	7	that	that	SCONJ
dpc-1242	114	8	both	both	DET
dpc-1242	114	9	fluticasone	fluticasone	NOUN
dpc-1242	114	10	and	and	CCONJ
dpc-1242	114	11	tacrolimus	tacrolimus	PROPN
dpc-1242	114	12	had	have	VERB
dpc-1242	114	13	similar	similar	ADJ
dpc-1242	114	14	efficacy	efficacy	NOUN
dpc-1242	114	15	in	in	ADP
dpc-1242	114	16	the	the	DET
dpc-1242	114	17	acute	acute	ADJ
dpc-1242	114	18	treatment	treatment	NOUN
dpc-1242	114	19	phase	phase	NOUN
dpc-1242	114	20	.	.	PUNCT
dpc-1242	115	1	in	in	ADP
dpc-1242	115	2	the	the	DET
dpc-1242	115	3	maintenance	maintenance	NOUN
dpc-1242	115	4	phase	phase	NOUN
dpc-1242	115	5	,	,	PUNCT
dpc-1242	115	6	the	the	DET
dpc-1242	115	7	scorad	scorad	NOUN
dpc-1242	115	8	had	have	AUX
dpc-1242	115	9	risen	rise	VERB
dpc-1242	115	10	in	in	ADP
dpc-1242	115	11	the	the	DET
dpc-1242	115	12	fluticasone	fluticasone	NOUN
dpc-1242	115	13	group	group	NOUN
dpc-1242	115	14	by	by	ADP
dpc-1242	115	15	a	a	DET
dpc-1242	115	16	mean	mean	ADJ
dpc-1242	115	17	difference	difference	NOUN
dpc-1242	115	18	of	of	ADP
dpc-1242	115	19	0.8	0.8	NUM
dpc-1242	115	20	,	,	PUNCT
dpc-1242	115	21	while	while	SCONJ
dpc-1242	115	22	in	in	ADP
dpc-1242	115	23	tacrolimus	tacrolimus	NOUN
dpc-1242	115	24	it	it	PRON
dpc-1242	115	25	decreased	decrease	VERB
dpc-1242	115	26	by	by	ADP
dpc-1242	115	27	0.99	0.99	NUM
dpc-1242	115	28	.	.	PUNCT
dpc-1242	116	1	due	due	ADP
dpc-1242	116	2	to	to	ADP
dpc-1242	116	3	the	the	DET
dpc-1242	116	4	lack	lack	NOUN
dpc-1242	116	5	of	of	ADP
dpc-1242	116	6	head	head	NOUN
dpc-1242	116	7	-	-	PUNCT
dpc-1242	116	8	to	to	ADP
dpc-1242	116	9	-	-	PUNCT
dpc-1242	116	10	head	head	NOUN
dpc-1242	116	11	comparison	comparison	NOUN
dpc-1242	116	12	of	of	ADP
dpc-1242	116	13	tcs	tcs	NOUN
dpc-1242	116	14	and	and	CCONJ
dpc-1242	116	15	tci	tci	PROPN
dpc-1242	116	16	,	,	PUNCT
dpc-1242	116	17	it	it	PRON
dpc-1242	116	18	was	be	AUX
dpc-1242	116	19	difficult	difficult	ADJ
dpc-1242	116	20	for	for	SCONJ
dpc-1242	116	21	us	we	PRON
dpc-1242	116	22	to	to	PART
dpc-1242	116	23	compare	compare	VERB
dpc-1242	116	24	our	our	PRON
dpc-1242	116	25	results	result	NOUN
dpc-1242	116	26	with	with	ADP
dpc-1242	116	27	previous	previous	ADJ
dpc-1242	116	28	reports	report	NOUN
dpc-1242	116	29	.	.	PUNCT
dpc-1242	117	1	however	however	ADV
dpc-1242	117	2	,	,	PUNCT
dpc-1242	117	3	our	our	PRON
dpc-1242	117	4	result	result	NOUN
dpc-1242	117	5	is	be	AUX
dpc-1242	117	6	comparable	comparable	ADJ
dpc-1242	117	7	to	to	ADP
dpc-1242	117	8	the	the	DET
dpc-1242	117	9	longer	long	ADJ
dpc-1242	117	10	median	median	ADJ
dpc-1242	117	11	time	time	NOUN
dpc-1242	117	12	to	to	PART
dpc-1242	117	13	flare	flare	VERB
dpc-1242	117	14	-	-	PUNCT
dpc-1242	117	15	up	up	NOUN
dpc-1242	117	16	seen	see	VERB
dpc-1242	117	17	in	in	ADP
dpc-1242	117	18	2	2	NUM
dpc-1242	117	19	studies	study	NOUN
dpc-1242	117	20	using	use	VERB
dpc-1242	117	21	fluticasone	fluticasone	NOUN
dpc-1242	117	22	and	and	CCONJ
dpc-1242	117	23	tacrolimus	tacrolimus	VERB
dpc-1242	117	24	separately	separately	ADV
dpc-1242	118	1	[	[	X
dpc-1242	118	2	10,11	10,11	NOUN
dpc-1242	118	3	]	]	X
dpc-1242	118	4	at	at	ADP
dpc-1242	118	5	approximately	approximately	ADV
dpc-1242	118	6	16	16	NUM
dpc-1242	118	7	weeks	week	NOUN
dpc-1242	118	8	with	with	ADP
dpc-1242	118	9	use	use	NOUN
dpc-1242	118	10	of	of	ADP
dpc-1242	118	11	fluticasone	fluticasone	NOUN
dpc-1242	118	12	and	and	CCONJ
dpc-1242	118	13	24	24	NUM
dpc-1242	118	14	weeks	week	NOUN
dpc-1242	118	15	with	with	ADP
dpc-1242	118	16	tacrolimus	tacrolimus	NOUN
dpc-1242	118	17	ointment	ointment	NOUN
dpc-1242	118	18	.	.	PUNCT
dpc-1242	119	1	however	however	ADV
dpc-1242	119	2	,	,	PUNCT
dpc-1242	119	3	the	the	DET
dpc-1242	119	4	disease	disease	NOUN
dpc-1242	119	5	severity	severity	NOUN
dpc-1242	119	6	in	in	ADP
dpc-1242	119	7	our	our	PRON
dpc-1242	119	8	study	study	NOUN
dpc-1242	119	9	population	population	NOUN
dpc-1242	119	10	was	be	AUX
dpc-1242	119	11	maintained	maintain	VERB
dpc-1242	119	12	in	in	ADP
dpc-1242	119	13	low	low	ADJ
dpc-1242	119	14	range	range	NOUN
dpc-1242	119	15	in	in	ADP
dpc-1242	119	16	both	both	DET
dpc-1242	119	17	treatment	treatment	NOUN
dpc-1242	119	18	groups	group	NOUN
dpc-1242	119	19	,	,	PUNCT
dpc-1242	119	20	and	and	CCONJ
dpc-1242	119	21	there	there	PRON
dpc-1242	119	22	were	be	VERB
dpc-1242	119	23	no	no	DET
dpc-1242	119	24	flare	flare	NOUN
dpc-1242	119	25	-	-	PUNCT
dpc-1242	119	26	up	up	ADP
dpc-1242	119	27	events	event	NOUN
dpc-1242	119	28	observed	observe	VERB
dpc-1242	119	29	within	within	ADP
dpc-1242	119	30	8	8	NUM
dpc-1242	119	31	weeks	week	NOUN
dpc-1242	119	32	.	.	PUNCT
dpc-1242	120	1	clinically	clinically	ADV
dpc-1242	120	2	and	and	CCONJ
dpc-1242	120	3	statistically	statistically	ADV
dpc-1242	120	4	speaking	speak	VERB
dpc-1242	120	5	,	,	PUNCT
dpc-1242	120	6	the	the	DET
dpc-1242	120	7	difference	difference	NOUN
dpc-1242	120	8	in	in	ADP
dpc-1242	120	9	scorad	scorad	NOUN
dpc-1242	120	10	was	be	AUX
dpc-1242	120	11	not	not	PART
dpc-1242	120	12	significant	significant	ADJ
dpc-1242	120	13	in	in	ADP
dpc-1242	120	14	the	the	DET
dpc-1242	120	15	present	present	ADJ
dpc-1242	120	16	study	study	NOUN
dpc-1242	120	17	,	,	PUNCT
dpc-1242	120	18	and	and	CCONJ
dpc-1242	120	19	it	it	PRON
dpc-1242	120	20	can	can	AUX
dpc-1242	120	21	be	be	AUX
dpc-1242	120	22	concluded	conclude	VERB
dpc-1242	120	23	that	that	SCONJ
dpc-1242	120	24	both	both	DET
dpc-1242	120	25	treatments	treatment	NOUN
dpc-1242	120	26	are	be	AUX
dpc-1242	120	27	efficacious	efficacious	ADJ
dpc-1242	120	28	during	during	ADP
dpc-1242	120	29	the	the	DET
dpc-1242	120	30	intermittent	intermittent	ADJ
dpc-1242	120	31	maintenance	maintenance	NOUN
dpc-1242	120	32	phase	phase	NOUN
dpc-1242	120	33	to	to	PART
dpc-1242	120	34	prevent	prevent	VERB
dpc-1242	120	35	acute	acute	ADJ
dpc-1242	120	36	exacerbations	exacerbation	NOUN
dpc-1242	120	37	.	.	PUNCT
dpc-1242	121	1	a	a	DET
dpc-1242	121	2	randomized	randomized	ADJ
dpc-1242	121	3	,	,	PUNCT
dpc-1242	121	4	multicenter	multicenter	ADJ
dpc-1242	121	5	study	study	NOUN
dpc-1242	121	6	determining	determine	VERB
dpc-1242	121	7	the	the	DET
dpc-1242	121	8	antipruritic	antipruritic	ADJ
dpc-1242	121	9	efficacy	efficacy	NOUN
dpc-1242	121	10	of	of	ADP
dpc-1242	121	11	0.03	0.03	NUM
dpc-1242	121	12	%	%	NOUN
dpc-1242	121	13	topical	topical	ADJ
dpc-1242	121	14	tacrolimus	tacrolimus	NOUN
dpc-1242	121	15	(	(	PUNCT
dpc-1242	121	16	for	for	ADP
dpc-1242	121	17	children	child	NOUN
dpc-1242	121	18	<	<	X
dpc-1242	121	19	16	16	NUM
dpc-1242	121	20	years	year	NOUN
dpc-1242	121	21	old	old	ADJ
dpc-1242	121	22	)	)	PUNCT
dpc-1242	121	23	and	and	CCONJ
dpc-1242	121	24	0.1	0.1	NUM
dpc-1242	121	25	%	%	NOUN
dpc-1242	121	26	(	(	PUNCT
dpc-1242	121	27	for	for	ADP
dpc-1242	121	28	adults	adult	NOUN
dpc-1242	121	29	>	>	SYM
dpc-1242	121	30	16	16	NUM
dpc-1242	121	31	years	year	NOUN
dpc-1242	121	32	old	old	ADJ
dpc-1242	121	33	)	)	PUNCT
dpc-1242	121	34	reported	report	VERB
dpc-1242	121	35	discussion	discussion	NOUN
dpc-1242	121	36	this	this	DET
dpc-1242	121	37	study	study	NOUN
dpc-1242	121	38	evaluates	evaluate	VERB
dpc-1242	121	39	the	the	DET
dpc-1242	121	40	efficacy	efficacy	NOUN
dpc-1242	121	41	of	of	ADP
dpc-1242	121	42	an	an	DET
dpc-1242	121	43	intermediate	intermediate	ADJ
dpc-1242	121	44	potent	potent	ADJ
dpc-1242	121	45	tcs	tcs	NOUN
dpc-1242	121	46	,	,	PUNCT
dpc-1242	121	47	fluticasone	fluticasone	NOUN
dpc-1242	121	48	0.005	0.005	NUM
dpc-1242	121	49	%	%	NOUN
dpc-1242	121	50	ointment	ointment	NOUN
dpc-1242	121	51	and	and	CCONJ
dpc-1242	121	52	a	a	DET
dpc-1242	121	53	tci	tci	NOUN
dpc-1242	121	54	,	,	PUNCT
dpc-1242	121	55	tacrolimus	tacrolimus	NOUN
dpc-1242	121	56	0.03	0.03	NUM
dpc-1242	121	57	%	%	NOUN
dpc-1242	121	58	ointment	ointment	NOUN
dpc-1242	121	59	for	for	ADP
dpc-1242	121	60	treatment	treatment	NOUN
dpc-1242	121	61	of	of	ADP
dpc-1242	121	62	moderate	moderate	ADJ
dpc-1242	121	63	to	to	ADP
dpc-1242	121	64	severe	severe	ADJ
dpc-1242	121	65	ad	ad	NOUN
dpc-1242	121	66	in	in	ADP
dpc-1242	121	67	indian	indian	ADJ
dpc-1242	121	68	children	child	NOUN
dpc-1242	121	69	.	.	PUNCT
dpc-1242	122	1	in	in	ADP
dpc-1242	122	2	this	this	DET
dpc-1242	122	3	study	study	NOUN
dpc-1242	122	4	,	,	PUNCT
dpc-1242	122	5	we	we	PRON
dpc-1242	122	6	included	include	VERB
dpc-1242	122	7	a	a	DET
dpc-1242	122	8	total	total	NOUN
dpc-1242	122	9	of	of	ADP
dpc-1242	122	10	37	37	NUM
dpc-1242	122	11	children	child	NOUN
dpc-1242	122	12	with	with	ADP
dpc-1242	122	13	moderately	moderately	ADV
dpc-1242	122	14	active	active	ADJ
dpc-1242	122	15	ad	ad	NOUN
dpc-1242	122	16	.	.	PUNCT
dpc-1242	123	1	the	the	DET
dpc-1242	123	2	boy	boy	NOUN
dpc-1242	123	3	-	-	PUNCT
dpc-1242	123	4	to	to	ADP
dpc-1242	123	5	-	-	PUNCT
dpc-1242	123	6	girl	girl	NOUN
dpc-1242	123	7	ratio	ratio	NOUN
dpc-1242	123	8	in	in	ADP
dpc-1242	123	9	the	the	DET
dpc-1242	123	10	present	present	ADJ
dpc-1242	123	11	study	study	NOUN
dpc-1242	123	12	was	be	AUX
dpc-1242	123	13	1.31:1	1.31:1	NUM
dpc-1242	123	14	,	,	PUNCT
dpc-1242	123	15	which	which	PRON
dpc-1242	123	16	is	be	AUX
dpc-1242	123	17	comparable	comparable	ADJ
dpc-1242	123	18	to	to	ADP
dpc-1242	123	19	a	a	DET
dpc-1242	123	20	clinico	clinico	NOUN
dpc-1242	123	21	-	-	PUNCT
dpc-1242	123	22	epidemiological	epidemiological	ADJ
dpc-1242	123	23	study	study	NOUN
dpc-1242	123	24	of	of	ADP
dpc-1242	123	25	ad	ad	NOUN
dpc-1242	123	26	in	in	ADP
dpc-1242	123	27	north	north	PROPN
dpc-1242	123	28	india	india	PROPN
dpc-1242	123	29	,	,	PUNCT
dpc-1242	123	30	where	where	SCONJ
dpc-1242	123	31	male	male	ADJ
dpc-1242	123	32	predominance	predominance	NOUN
dpc-1242	123	33	was	be	AUX
dpc-1242	123	34	noted	note	VERB
dpc-1242	123	35	with	with	ADP
dpc-1242	123	36	2.25:1	2.25:1	NUM
dpc-1242	123	37	in	in	ADP
dpc-1242	123	38	infants	infant	NOUN
dpc-1242	123	39	and	and	CCONJ
dpc-1242	123	40	1.3:1	1.3:1	NUM
dpc-1242	123	41	in	in	ADP
dpc-1242	123	42	children	child	NOUN
dpc-1242	123	43	[	[	X
dpc-1242	123	44	16	16	NUM
dpc-1242	123	45	]	]	PUNCT
dpc-1242	123	46	.	.	PUNCT
dpc-1242	124	1	the	the	DET
dpc-1242	124	2	age	age	NOUN
dpc-1242	124	3	distribution	distribution	NOUN
dpc-1242	124	4	within	within	ADP
dpc-1242	124	5	0	0	NUM
dpc-1242	124	6	-	-	SYM
dpc-1242	124	7	5	5	NUM
dpc-1242	124	8	years	year	NOUN
dpc-1242	124	9	,	,	PUNCT
dpc-1242	124	10	6	6	NUM
dpc-1242	124	11	-	-	SYM
dpc-1242	124	12	10	10	NUM
dpc-1242	124	13	years	year	NOUN
dpc-1242	124	14	,	,	PUNCT
dpc-1242	124	15	and	and	CCONJ
dpc-1242	124	16	≥11	≥11	NUM
dpc-1242	124	17	years	year	NOUN
dpc-1242	124	18	were	be	AUX
dpc-1242	124	19	4	4	NUM
dpc-1242	124	20	,	,	PUNCT
dpc-1242	124	21	7	7	NUM
dpc-1242	124	22	,	,	PUNCT
dpc-1242	124	23	8	8	NUM
dpc-1242	124	24	and	and	CCONJ
dpc-1242	124	25	2	2	NUM
dpc-1242	124	26	,	,	PUNCT
dpc-1242	124	27	7	7	NUM
dpc-1242	124	28	,	,	PUNCT
dpc-1242	124	29	9	9	NUM
dpc-1242	124	30	children	child	NOUN
dpc-1242	124	31	in	in	ADP
dpc-1242	124	32	the	the	DET
dpc-1242	124	33	2	2	NUM
dpc-1242	124	34	groups	group	NOUN
dpc-1242	124	35	respectively	respectively	ADV
dpc-1242	124	36	.	.	PUNCT
dpc-1242	125	1	there	there	PRON
dpc-1242	125	2	was	be	VERB
dpc-1242	125	3	a	a	DET
dpc-1242	125	4	greater	great	ADJ
dpc-1242	125	5	proportion	proportion	NOUN
dpc-1242	125	6	of	of	ADP
dpc-1242	125	7	children	child	NOUN
dpc-1242	125	8	within	within	ADP
dpc-1242	125	9	the	the	DET
dpc-1242	125	10	≥	≥	NUM
dpc-1242	125	11	11	11	NUM
dpc-1242	125	12	-	-	PUNCT
dpc-1242	125	13	years	year	NOUN
dpc-1242	125	14	age	age	NOUN
dpc-1242	125	15	group	group	NOUN
dpc-1242	125	16	,	,	PUNCT
dpc-1242	125	17	although	although	SCONJ
dpc-1242	125	18	the	the	DET
dpc-1242	125	19	disease	disease	NOUN
dpc-1242	125	20	is	be	AUX
dpc-1242	125	21	known	know	VERB
dpc-1242	125	22	to	to	PART
dpc-1242	125	23	figure	figure	VERB
dpc-1242	125	24	4	4	NUM
dpc-1242	125	25	.	.	PUNCT
dpc-1242	126	1	changes	change	NOUN
dpc-1242	126	2	in	in	ADP
dpc-1242	126	3	the	the	DET
dpc-1242	126	4	subjective	subjective	ADJ
dpc-1242	126	5	symptoms	symptom	NOUN
dpc-1242	126	6	in	in	ADP
dpc-1242	126	7	both	both	DET
dpc-1242	126	8	treatment	treatment	NOUN
dpc-1242	126	9	groups	group	NOUN
dpc-1242	126	10	at	at	ADP
dpc-1242	126	11	week	week	NOUN
dpc-1242	126	12	0	0	NUM
dpc-1242	126	13	(	(	PUNCT
dpc-1242	126	14	baseline	baseline	NOUN
dpc-1242	126	15	)	)	PUNCT
dpc-1242	126	16	,	,	PUNCT
dpc-1242	126	17	2	2	NUM
dpc-1242	126	18	,	,	PUNCT
dpc-1242	126	19	4	4	NUM
dpc-1242	126	20	(	(	PUNCT
dpc-1242	126	21	end	end	NOUN
dpc-1242	126	22	of	of	ADP
dpc-1242	126	23	acute	acute	ADJ
dpc-1242	126	24	phase	phase	NOUN
dpc-1242	126	25	)	)	PUNCT
dpc-1242	126	26	,	,	PUNCT
dpc-1242	126	27	6	6	NUM
dpc-1242	126	28	,	,	PUNCT
dpc-1242	126	29	and	and	CCONJ
dpc-1242	126	30	8	8	NUM
dpc-1242	126	31	(	(	PUNCT
dpc-1242	126	32	end	end	NOUN
dpc-1242	126	33	of	of	ADP
dpc-1242	126	34	maintenance	maintenance	NOUN
dpc-1242	126	35	phase	phase	NOUN
dpc-1242	126	36	)	)	PUNCT
dpc-1242	127	1	[	[	X
dpc-1242	127	2	mean	mean	X
dpc-1242	127	3	±	±	NUM
dpc-1242	127	4	sem	sem	NOUN
dpc-1242	127	5	]	]	PUNCT
dpc-1242	127	6	.	.	PUNCT
dpc-1242	128	1	figure	figure	NOUN
dpc-1242	128	2	5	5	NUM
dpc-1242	128	3	.	.	PUNCT
dpc-1242	129	1	association	association	NOUN
dpc-1242	129	2	between	between	ADP
dpc-1242	129	3	scoring	score	VERB
dpc-1242	129	4	atopic	atopic	NOUN
dpc-1242	129	5	dermatitis	dermatitis	NOUN
dpc-1242	129	6	(	(	PUNCT
dpc-1242	129	7	scorad	scorad	NOUN
dpc-1242	129	8	)	)	PUNCT
dpc-1242	129	9	and	and	CCONJ
dpc-1242	129	10	children	child	NOUN
dpc-1242	129	11	’s	’s	PART
dpc-1242	129	12	dermatology	dermatology	NOUN
dpc-1242	129	13	life	life	NOUN
dpc-1242	129	14	quality	quality	NOUN
dpc-1242	129	15	index	index	NOUN
dpc-1242	129	16	(	(	PUNCT
dpc-1242	129	17	cdlqi	cdlqi	PROPN
dpc-1242	129	18	)	)	PUNCT
dpc-1242	129	19	.	.	PUNCT
dpc-1242	130	1	research	research	NOUN
dpc-1242	130	2	|	|	ADV
dpc-1242	130	3	dermatol	dermatol	NOUN
dpc-1242	130	4	pract	pract	NOUN
dpc-1242	130	5	concept	concept	NOUN
dpc-1242	130	6	2020;10(4):e2020094	2020;10(4):e2020094	NUM
dpc-1242	130	7	7	7	NUM
dpc-1242	130	8	most	most	ADJ
dpc-1242	130	9	episodes	episode	NOUN
dpc-1242	130	10	of	of	ADP
dpc-1242	130	11	a	a	DET
dpc-1242	130	12	skin	skin	NOUN
dpc-1242	130	13	-	-	PUNCT
dpc-1242	130	14	burning	burn	VERB
dpc-1242	130	15	sensation	sensation	NOUN
dpc-1242	130	16	lasted	last	VERB
dpc-1242	130	17	less	less	ADJ
dpc-1242	130	18	than	than	ADP
dpc-1242	130	19	15	15	NUM
dpc-1242	130	20	minutes	minute	NOUN
dpc-1242	130	21	.	.	PUNCT
dpc-1242	131	1	similarly	similarly	ADV
dpc-1242	131	2	,	,	PUNCT
dpc-1242	131	3	most	most	ADJ
dpc-1242	131	4	episodes	episode	NOUN
dpc-1242	131	5	of	of	ADP
dpc-1242	131	6	pruritus	pruritus	PROPN
dpc-1242	131	7	lasted	last	VERB
dpc-1242	131	8	less	less	ADJ
dpc-1242	131	9	than	than	ADP
dpc-1242	131	10	2	2	NUM
dpc-1242	131	11	hours	hour	NOUN
dpc-1242	131	12	.	.	PUNCT
dpc-1242	132	1	limitations	limitation	NOUN
dpc-1242	132	2	our	our	PRON
dpc-1242	132	3	study	study	NOUN
dpc-1242	132	4	has	have	VERB
dpc-1242	132	5	certain	certain	ADJ
dpc-1242	132	6	limitations	limitation	NOUN
dpc-1242	132	7	,	,	PUNCT
dpc-1242	132	8	and	and	CCONJ
dpc-1242	132	9	the	the	DET
dpc-1242	132	10	findings	finding	NOUN
dpc-1242	132	11	in	in	ADP
dpc-1242	132	12	this	this	DET
dpc-1242	132	13	study	study	NOUN
dpc-1242	132	14	should	should	AUX
dpc-1242	132	15	be	be	AUX
dpc-1242	132	16	interpreted	interpret	VERB
dpc-1242	132	17	with	with	ADP
dpc-1242	132	18	caution	caution	NOUN
dpc-1242	132	19	.	.	PUNCT
dpc-1242	133	1	first	first	ADV
dpc-1242	133	2	,	,	PUNCT
dpc-1242	133	3	the	the	DET
dpc-1242	133	4	study	study	NOUN
dpc-1242	133	5	had	have	VERB
dpc-1242	133	6	no	no	DET
dpc-1242	133	7	wash	wash	NOUN
dpc-1242	133	8	-	-	PUNCT
dpc-1242	133	9	out	out	ADP
dpc-1242	133	10	period	period	NOUN
dpc-1242	133	11	,	,	PUNCT
dpc-1242	133	12	and	and	CCONJ
dpc-1242	133	13	the	the	DET
dpc-1242	133	14	drugs	drug	NOUN
dpc-1242	133	15	were	be	AUX
dpc-1242	133	16	initiated	initiate	VERB
dpc-1242	133	17	on	on	ADP
dpc-1242	133	18	the	the	DET
dpc-1242	133	19	first	first	ADJ
dpc-1242	133	20	visit	visit	NOUN
dpc-1242	133	21	to	to	ADP
dpc-1242	133	22	the	the	DET
dpc-1242	133	23	outpatient	outpatient	NOUN
dpc-1242	133	24	department	department	NOUN
dpc-1242	133	25	once	once	SCONJ
dpc-1242	133	26	the	the	DET
dpc-1242	133	27	diagnosis	diagnosis	NOUN
dpc-1242	133	28	was	be	AUX
dpc-1242	133	29	made	make	VERB
dpc-1242	133	30	.	.	PUNCT
dpc-1242	134	1	second	second	ADJ
dpc-1242	134	2	,	,	PUNCT
dpc-1242	134	3	since	since	SCONJ
dpc-1242	134	4	the	the	DET
dpc-1242	134	5	scoring	scoring	NOUN
dpc-1242	134	6	system	system	NOUN
dpc-1242	134	7	used	use	VERB
dpc-1242	134	8	for	for	ADP
dpc-1242	134	9	outcome	outcome	NOUN
dpc-1242	134	10	measures	measure	NOUN
dpc-1242	134	11	included	include	VERB
dpc-1242	134	12	objective	objective	ADJ
dpc-1242	134	13	and	and	CCONJ
dpc-1242	134	14	subjective	subjective	ADJ
dpc-1242	134	15	symptoms	symptom	NOUN
dpc-1242	134	16	,	,	PUNCT
dpc-1242	134	17	the	the	DET
dpc-1242	134	18	final	final	ADJ
dpc-1242	134	19	score	score	NOUN
dpc-1242	134	20	may	may	AUX
dpc-1242	134	21	have	have	AUX
dpc-1242	134	22	been	be	AUX
dpc-1242	134	23	influenced	influence	VERB
dpc-1242	134	24	by	by	ADP
dpc-1242	134	25	parents	parent	NOUN
dpc-1242	134	26	,	,	PUNCT
dpc-1242	134	27	guardians	guardian	NOUN
dpc-1242	134	28	,	,	PUNCT
dpc-1242	134	29	or	or	CCONJ
dpc-1242	134	30	by	by	ADP
dpc-1242	134	31	the	the	DET
dpc-1242	134	32	children	child	NOUN
dpc-1242	134	33	themselves	themselves	PRON
dpc-1242	134	34	.	.	PUNCT
dpc-1242	135	1	furthermore	furthermore	ADV
dpc-1242	135	2	,	,	PUNCT
dpc-1242	135	3	we	we	PRON
dpc-1242	135	4	did	do	AUX
dpc-1242	135	5	not	not	PART
dpc-1242	135	6	estimate	estimate	VERB
dpc-1242	135	7	cost	cost	NOUN
dpc-1242	135	8	effectiveness	effectiveness	NOUN
dpc-1242	135	9	.	.	PUNCT
dpc-1242	136	1	the	the	DET
dpc-1242	136	2	other	other	ADJ
dpc-1242	136	3	shortcomings	shortcoming	NOUN
dpc-1242	136	4	of	of	ADP
dpc-1242	136	5	the	the	DET
dpc-1242	136	6	study	study	NOUN
dpc-1242	136	7	are	be	AUX
dpc-1242	136	8	the	the	DET
dpc-1242	136	9	small	small	ADJ
dpc-1242	136	10	sample	sample	NOUN
dpc-1242	136	11	size	size	NOUN
dpc-1242	136	12	and	and	CCONJ
dpc-1242	136	13	short	short	ADJ
dpc-1242	136	14	study	study	NOUN
dpc-1242	136	15	duration	duration	NOUN
dpc-1242	136	16	in	in	ADP
dpc-1242	136	17	the	the	DET
dpc-1242	136	18	maintenance	maintenance	NOUN
dpc-1242	136	19	phase	phase	NOUN
dpc-1242	136	20	.	.	PUNCT
dpc-1242	137	1	thus	thus	ADV
dpc-1242	137	2	,	,	PUNCT
dpc-1242	137	3	it	it	PRON
dpc-1242	137	4	is	be	AUX
dpc-1242	137	5	not	not	PART
dpc-1242	137	6	possible	possible	ADJ
dpc-1242	137	7	to	to	PART
dpc-1242	137	8	convincingly	convincingly	ADV
dpc-1242	137	9	comment	comment	VERB
dpc-1242	137	10	on	on	ADP
dpc-1242	137	11	time	time	NOUN
dpc-1242	137	12	to	to	PART
dpc-1242	137	13	flare	flare	NOUN
dpc-1242	137	14	-	-	PUNCT
dpc-1242	137	15	up	up	NOUN
dpc-1242	137	16	and	and	CCONJ
dpc-1242	137	17	the	the	DET
dpc-1242	137	18	long	long	ADJ
dpc-1242	137	19	-	-	PUNCT
dpc-1242	137	20	term	term	NOUN
dpc-1242	137	21	safety	safety	NOUN
dpc-1242	137	22	of	of	ADP
dpc-1242	137	23	both	both	DET
dpc-1242	137	24	treatments	treatment	NOUN
dpc-1242	137	25	.	.	PUNCT
dpc-1242	138	1	another	another	DET
dpc-1242	138	2	demerit	demerit	NOUN
dpc-1242	138	3	is	be	AUX
dpc-1242	138	4	that	that	SCONJ
dpc-1242	138	5	it	it	PRON
dpc-1242	138	6	was	be	AUX
dpc-1242	138	7	an	an	DET
dpc-1242	138	8	open	open	ADJ
dpc-1242	138	9	label	label	NOUN
dpc-1242	138	10	study	study	NOUN
dpc-1242	138	11	.	.	PUNCT
dpc-1242	139	1	a	a	DET
dpc-1242	139	2	longer	long	ADJ
dpc-1242	139	3	duration	duration	NOUN
dpc-1242	139	4	,	,	PUNCT
dpc-1242	139	5	single	single	ADJ
dpc-1242	139	6	or	or	CCONJ
dpc-1242	139	7	double	double	ADJ
dpc-1242	139	8	-	-	PUNCT
dpc-1242	139	9	blind	blind	ADJ
dpc-1242	139	10	study	study	NOUN
dpc-1242	139	11	,	,	PUNCT
dpc-1242	139	12	and	and	CCONJ
dpc-1242	139	13	a	a	DET
dpc-1242	139	14	larger	large	ADJ
dpc-1242	139	15	sample	sample	NOUN
dpc-1242	139	16	size	size	NOUN
dpc-1242	139	17	would	would	AUX
dpc-1242	139	18	be	be	AUX
dpc-1242	139	19	helpful	helpful	ADJ
dpc-1242	139	20	in	in	ADP
dpc-1242	139	21	covering	cover	VERB
dpc-1242	139	22	these	these	DET
dpc-1242	139	23	shortcomings	shortcoming	NOUN
dpc-1242	139	24	.	.	PUNCT
dpc-1242	140	1	conclusions	conclusion	NOUN
dpc-1242	140	2	both	both	CCONJ
dpc-1242	140	3	fluticasone	fluticasone	PROPN
dpc-1242	140	4	and	and	CCONJ
dpc-1242	140	5	tacrolimus	tacrolimus	NOUN
dpc-1242	140	6	are	be	AUX
dpc-1242	140	7	equally	equally	ADV
dpc-1242	140	8	efficacious	efficacious	ADJ
dpc-1242	140	9	in	in	ADP
dpc-1242	140	10	reducing	reduce	VERB
dpc-1242	140	11	severity	severity	NOUN
dpc-1242	140	12	of	of	ADP
dpc-1242	140	13	disease	disease	NOUN
dpc-1242	140	14	and	and	CCONJ
dpc-1242	140	15	preventing	prevent	VERB
dpc-1242	140	16	flare	flare	NOUN
dpc-1242	140	17	-	-	PUNCT
dpc-1242	140	18	ups	up	NOUN
dpc-1242	140	19	in	in	ADP
dpc-1242	140	20	children	child	NOUN
dpc-1242	140	21	suffering	suffer	VERB
dpc-1242	140	22	from	from	ADP
dpc-1242	140	23	moderate	moderate	ADJ
dpc-1242	140	24	to	to	ADP
dpc-1242	140	25	severe	severe	ADJ
dpc-1242	140	26	ad	ad	NOUN
dpc-1242	140	27	.	.	PUNCT
dpc-1242	141	1	at	at	ADP
dpc-1242	141	2	week	week	NOUN
dpc-1242	141	3	8	8	NUM
dpc-1242	141	4	,	,	PUNCT
dpc-1242	141	5	tacrolimus	tacrolimus	NOUN
dpc-1242	141	6	is	be	AUX
dpc-1242	141	7	more	more	ADV
dpc-1242	141	8	efficacious	efficacious	ADJ
dpc-1242	141	9	than	than	ADP
dpc-1242	141	10	fluticasone	fluticasone	NOUN
dpc-1242	141	11	in	in	ADP
dpc-1242	141	12	improving	improve	VERB
dpc-1242	141	13	the	the	DET
dpc-1242	141	14	extent	extent	NOUN
dpc-1242	141	15	of	of	ADP
dpc-1242	141	16	ad	ad	NOUN
dpc-1242	141	17	.	.	PUNCT
dpc-1242	142	1	however	however	ADV
dpc-1242	142	2	,	,	PUNCT
dpc-1242	142	3	in	in	ADP
dpc-1242	142	4	both	both	DET
dpc-1242	142	5	groups	group	NOUN
dpc-1242	142	6	the	the	DET
dpc-1242	142	7	fluticasone	fluticasone	NOUN
dpc-1242	142	8	and	and	CCONJ
dpc-1242	142	9	tacrolimus	tacrolimus	NOUN
dpc-1242	142	10	were	be	AUX
dpc-1242	142	11	equally	equally	ADV
dpc-1242	142	12	efficacious	efficacious	ADJ
dpc-1242	142	13	in	in	ADP
dpc-1242	142	14	reducing	reduce	VERB
dpc-1242	142	15	subjective	subjective	ADJ
dpc-1242	142	16	scores	score	NOUN
dpc-1242	142	17	and	and	CCONJ
dpc-1242	142	18	improving	improve	VERB
dpc-1242	142	19	qol	qol	NOUN
dpc-1242	142	20	in	in	ADP
dpc-1242	142	21	ad	ad	NOUN
dpc-1242	142	22	patients	patient	NOUN
dpc-1242	142	23	.	.	PUNCT
dpc-1242	143	1	positive	positive	ADJ
dpc-1242	143	2	correlation	correlation	NOUN
dpc-1242	143	3	exists	exist	VERB
dpc-1242	143	4	between	between	ADP
dpc-1242	143	5	the	the	DET
dpc-1242	143	6	severity	severity	NOUN
dpc-1242	143	7	of	of	ADP
dpc-1242	143	8	the	the	DET
dpc-1242	143	9	disease	disease	NOUN
dpc-1242	143	10	and	and	CCONJ
dpc-1242	143	11	children	child	NOUN
dpc-1242	143	12	’s	’s	PART
dpc-1242	143	13	quality	quality	NOUN
dpc-1242	143	14	of	of	ADP
dpc-1242	143	15	life	life	NOUN
dpc-1242	143	16	.	.	PUNCT
dpc-1242	144	1	references	reference	NOUN
dpc-1242	144	2	1	1	NUM
dpc-1242	144	3	.	.	PUNCT
dpc-1242	144	4	williams	williams	PROPN
dpc-1242	144	5	h	h	PROPN
dpc-1242	144	6	,	,	PUNCT
dpc-1242	144	7	robertson	robertson	PROPN
dpc-1242	144	8	c	c	PROPN
dpc-1242	144	9	,	,	PUNCT
dpc-1242	144	10	stewart	stewart	PROPN
dpc-1242	144	11	a	a	PROPN
dpc-1242	144	12	,	,	PUNCT
dpc-1242	144	13	et	et	PROPN
dpc-1242	144	14	al	al	PROPN
dpc-1242	144	15	.	.	PROPN
dpc-1242	145	1	worldwide	worldwide	PROPN
dpc-1242	145	2	variations	variation	NOUN
dpc-1242	145	3	in	in	ADP
dpc-1242	145	4	the	the	DET
dpc-1242	145	5	prevalence	prevalence	NOUN
dpc-1242	145	6	of	of	ADP
dpc-1242	145	7	symptoms	symptom	NOUN
dpc-1242	145	8	of	of	ADP
dpc-1242	145	9	atopic	atopic	NOUN
dpc-1242	145	10	dermatitis	dermatitis	NOUN
dpc-1242	145	11	in	in	ADP
dpc-1242	145	12	the	the	DET
dpc-1242	145	13	international	international	ADJ
dpc-1242	145	14	study	study	NOUN
dpc-1242	145	15	of	of	ADP
dpc-1242	145	16	asthma	asthma	NOUN
dpc-1242	145	17	and	and	CCONJ
dpc-1242	145	18	allergies	allergy	NOUN
dpc-1242	145	19	in	in	ADP
dpc-1242	145	20	childhood	childhood	NOUN
dpc-1242	145	21	.	.	PUNCT
dpc-1242	146	1	j	j	PROPN
dpc-1242	146	2	allergy	allergy	PROPN
dpc-1242	146	3	clin	clin	PROPN
dpc-1242	146	4	immunol	immunol	PROPN
dpc-1242	146	5	.	.	PUNCT
dpc-1242	147	1	1999;103(1	1999;103(1	NUM
dpc-1242	147	2	pt	pt	NOUN
dpc-1242	147	3	1):125	1):125	NUM
dpc-1242	147	4	-	-	PUNCT
dpc-1242	147	5	138	138	NUM
dpc-1242	147	6	.	.	PUNCT
dpc-1242	148	1	doi	doi	NOUN
dpc-1242	148	2	:	:	PUNCT
dpc-1242	148	3	10.1016/	10.1016/	NUM
dpc-1242	148	4	s0091	s0091	NOUN
dpc-1242	148	5	-	-	PUNCT
dpc-1242	148	6	6749(99)70536	6749(99)70536	NOUN
dpc-1242	148	7	-	-	PUNCT
dpc-1242	148	8	1	1	NUM
dpc-1242	148	9	.	.	NOUN
dpc-1242	148	10	2	2	NUM
dpc-1242	148	11	.	.	X
dpc-1242	148	12	su	su	PROPN
dpc-1242	148	13	jc	jc	PROPN
dpc-1242	148	14	,	,	PUNCT
dpc-1242	148	15	kemp	kemp	PROPN
dpc-1242	148	16	as	as	ADP
dpc-1242	148	17	,	,	PUNCT
dpc-1242	148	18	varigos	varigos	PROPN
dpc-1242	148	19	ga	ga	PROPN
dpc-1242	148	20	,	,	PUNCT
dpc-1242	148	21	nolan	nolan	PROPN
dpc-1242	148	22	tm	tm	PROPN
dpc-1242	148	23	.	.	PUNCT
dpc-1242	148	24	atopic	atopic	PROPN
dpc-1242	148	25	eczema	eczema	NOUN
dpc-1242	148	26	:	:	PUNCT
dpc-1242	148	27	its	its	PRON
dpc-1242	148	28	impact	impact	NOUN
dpc-1242	148	29	on	on	ADP
dpc-1242	148	30	the	the	DET
dpc-1242	148	31	family	family	NOUN
dpc-1242	148	32	and	and	CCONJ
dpc-1242	148	33	financial	financial	ADJ
dpc-1242	148	34	cost	cost	NOUN
dpc-1242	148	35	.	.	PUNCT
dpc-1242	149	1	arch	arch	NOUN
dpc-1242	149	2	dis	dis	PROPN
dpc-1242	149	3	child	child	NOUN
dpc-1242	149	4	.	.	PUNCT
dpc-1242	150	1	1997;76(2):159	1997;76(2):159	NUM
dpc-1242	150	2	-	-	PUNCT
dpc-1242	150	3	162	162	NUM
dpc-1242	150	4	.	.	PUNCT
dpc-1242	151	1	doi	doi	NOUN
dpc-1242	151	2	:	:	PUNCT
dpc-1242	151	3	10.1136	10.1136	NUM
dpc-1242	151	4	/	/	SYM
dpc-1242	151	5	adc.76.2.159	adc.76.2.159	NOUN
dpc-1242	151	6	.	.	PUNCT
dpc-1242	152	1	3	3	X
dpc-1242	152	2	.	.	X
dpc-1242	152	3	filanovsky	filanovsky	PROPN
dpc-1242	152	4	mg	mg	PROPN
dpc-1242	152	5	,	,	PUNCT
dpc-1242	152	6	pootongkam	pootongkam	NOUN
dpc-1242	152	7	s	s	PROPN
dpc-1242	152	8	,	,	PUNCT
dpc-1242	152	9	tamburro	tamburro	PROPN
dpc-1242	152	10	je	je	PROPN
dpc-1242	152	11	,	,	PUNCT
dpc-1242	152	12	smith	smith	PROPN
dpc-1242	152	13	mc	mc	PROPN
dpc-1242	152	14	,	,	PUNCT
dpc-1242	152	15	ganocy	ganocy	PROPN
dpc-1242	152	16	sj	sj	PROPN
dpc-1242	152	17	,	,	PUNCT
dpc-1242	152	18	nedorost	nedorost	PROPN
dpc-1242	152	19	st	st	PROPN
dpc-1242	152	20	.	.	PROPN
dpc-1242	153	1	the	the	DET
dpc-1242	153	2	financial	financial	ADJ
dpc-1242	153	3	and	and	CCONJ
dpc-1242	153	4	emotional	emotional	ADJ
dpc-1242	153	5	impact	impact	NOUN
dpc-1242	153	6	of	of	ADP
dpc-1242	153	7	atopic	atopic	NOUN
dpc-1242	153	8	dermatitis	dermatitis	NOUN
dpc-1242	153	9	on	on	ADP
dpc-1242	153	10	children	child	NOUN
dpc-1242	153	11	and	and	CCONJ
dpc-1242	153	12	their	their	PRON
dpc-1242	153	13	families	family	NOUN
dpc-1242	153	14	.	.	PUNCT
dpc-1242	154	1	j	j	PROPN
dpc-1242	154	2	pediatr	pediatr	PROPN
dpc-1242	154	3	.	.	PUNCT
dpc-1242	154	4	2016;169:285	2016;169:285	NUM
dpc-1242	154	5	-	-	SYM
dpc-1242	154	6	290	290	NUM
dpc-1242	154	7	.	.	PUNCT
dpc-1242	155	1	doi	doi	NOUN
dpc-1242	155	2	:	:	PUNCT
dpc-1242	155	3	10.1016	10.1016	NUM
dpc-1242	155	4	/	/	SYM
dpc-1242	155	5	j.jpeds.2015.10.077	j.jpeds.2015.10.077	PROPN
dpc-1242	155	6	.	.	PROPN
dpc-1242	156	1	4	4	NUM
dpc-1242	156	2	.	.	X
dpc-1242	156	3	rajagopalan	rajagopalan	PROPN
dpc-1242	156	4	m	m	PROPN
dpc-1242	156	5	,	,	PUNCT
dpc-1242	156	6	de	de	PROPN
dpc-1242	156	7	a	a	X
dpc-1242	156	8	,	,	PUNCT
dpc-1242	156	9	godse	godse	PROPN
dpc-1242	156	10	k	k	PROPN
dpc-1242	156	11	,	,	PUNCT
dpc-1242	156	12	et	et	PROPN
dpc-1242	156	13	al	al	PROPN
dpc-1242	156	14	.	.	PUNCT
dpc-1242	156	15	guidelines	guideline	NOUN
dpc-1242	156	16	on	on	ADP
dpc-1242	156	17	management	management	NOUN
dpc-1242	156	18	of	of	ADP
dpc-1242	156	19	atopic	atopic	NOUN
dpc-1242	156	20	dermatitis	dermatitis	NOUN
dpc-1242	156	21	in	in	ADP
dpc-1242	156	22	india	india	PROPN
dpc-1242	156	23	:	:	PUNCT
dpc-1242	156	24	an	an	DET
dpc-1242	156	25	evidence	evidence	NOUN
dpc-1242	156	26	-	-	PUNCT
dpc-1242	156	27	based	base	VERB
dpc-1242	156	28	review	review	NOUN
dpc-1242	156	29	and	and	CCONJ
dpc-1242	156	30	an	an	DET
dpc-1242	156	31	expert	expert	NOUN
dpc-1242	156	32	consensus	consensus	NOUN
dpc-1242	156	33	.	.	PUNCT
dpc-1242	157	1	indian	indian	PROPN
dpc-1242	157	2	j	j	PROPN
dpc-1242	157	3	dermatol	dermatol	NOUN
dpc-1242	157	4	.	.	PUNCT
dpc-1242	158	1	2019;64(3):166181	2019;64(3):166181	NUM
dpc-1242	158	2	.	.	PUNCT
dpc-1242	159	1	doi	doi	NOUN
dpc-1242	159	2	:	:	PUNCT
dpc-1242	159	3	10.4103	10.4103	NUM
dpc-1242	159	4	/	/	SYM
dpc-1242	159	5	ijd.ijd_683_18	ijd.ijd_683_18	ADJ
dpc-1242	159	6	.	.	PUNCT
dpc-1242	160	1	5	5	X
dpc-1242	160	2	.	.	X
dpc-1242	160	3	ahluwalia	ahluwalia	PROPN
dpc-1242	160	4	a.	a.	PROPN
dpc-1242	160	5	topical	topical	ADJ
dpc-1242	160	6	glucocorticoids	glucocorticoid	NOUN
dpc-1242	160	7	and	and	CCONJ
dpc-1242	160	8	the	the	DET
dpc-1242	160	9	skin	skin	NOUN
dpc-1242	160	10	—	—	PUNCT
dpc-1242	160	11	mechaa	mechaa	NOUN
dpc-1242	160	12	mean	mean	NOUN
dpc-1242	160	13	scorad	scorad	NOUN
dpc-1242	160	14	decrease	decrease	NOUN
dpc-1242	160	15	from	from	ADP
dpc-1242	160	16	29.1	29.1	NUM
dpc-1242	160	17	to	to	ADP
dpc-1242	160	18	17.3	17.3	NUM
dpc-1242	160	19	with	with	ADP
dpc-1242	160	20	a	a	DET
dpc-1242	160	21	mean	mean	ADJ
dpc-1242	160	22	difference	difference	NOUN
dpc-1242	160	23	of	of	ADP
dpc-1242	160	24	11.8	11.8	NUM
dpc-1242	160	25	(	(	PUNCT
dpc-1242	160	26	p	p	X
dpc-1242	160	27	<	<	X
dpc-1242	160	28	0.0001	0.0001	NUM
dpc-1242	160	29	)	)	PUNCT
dpc-1242	160	30	after	after	ADP
dpc-1242	160	31	4	4	NUM
dpc-1242	160	32	weeks	week	NOUN
dpc-1242	160	33	[	[	X
dpc-1242	160	34	18	18	NUM
dpc-1242	160	35	]	]	PUNCT
dpc-1242	160	36	.	.	PUNCT
dpc-1242	161	1	in	in	ADP
dpc-1242	161	2	another	another	DET
dpc-1242	161	3	study	study	NOUN
dpc-1242	161	4	where	where	SCONJ
dpc-1242	161	5	0.1	0.1	NUM
dpc-1242	161	6	%	%	NOUN
dpc-1242	161	7	tacrolimus	tacrolimus	NOUN
dpc-1242	161	8	ointment	ointment	NOUN
dpc-1242	161	9	was	be	AUX
dpc-1242	161	10	given	give	VERB
dpc-1242	161	11	twice	twice	DET
dpc-1242	161	12	a	a	DET
dpc-1242	161	13	day	day	NOUN
dpc-1242	161	14	,	,	PUNCT
dpc-1242	161	15	the	the	DET
dpc-1242	161	16	drug	drug	NOUN
dpc-1242	161	17	showed	show	VERB
dpc-1242	161	18	20.72	20.72	NUM
dpc-1242	161	19	%	%	NOUN
dpc-1242	161	20	and	and	CCONJ
dpc-1242	161	21	64.05	64.05	NUM
dpc-1242	161	22	%	%	NOUN
dpc-1242	161	23	reduction	reduction	NOUN
dpc-1242	161	24	in	in	ADP
dpc-1242	161	25	scorad	scorad	NOUN
dpc-1242	161	26	at	at	ADP
dpc-1242	161	27	the	the	DET
dpc-1242	161	28	end	end	NOUN
dpc-1242	161	29	of	of	ADP
dpc-1242	161	30	weeks	week	NOUN
dpc-1242	161	31	2	2	NUM
dpc-1242	161	32	and	and	CCONJ
dpc-1242	161	33	4	4	NUM
dpc-1242	161	34	respectively	respectively	ADV
dpc-1242	161	35	[	[	X
dpc-1242	161	36	19	19	NUM
dpc-1242	161	37	]	]	PUNCT
dpc-1242	161	38	.	.	PUNCT
dpc-1242	162	1	the	the	DET
dpc-1242	162	2	efficacy	efficacy	NOUN
dpc-1242	162	3	in	in	ADP
dpc-1242	162	4	our	our	PRON
dpc-1242	162	5	study	study	NOUN
dpc-1242	162	6	was	be	AUX
dpc-1242	162	7	approximately	approximately	ADV
dpc-1242	162	8	the	the	DET
dpc-1242	162	9	same	same	ADJ
dpc-1242	162	10	at	at	ADP
dpc-1242	162	11	week	week	NOUN
dpc-1242	162	12	4	4	NUM
dpc-1242	162	13	.	.	PUNCT
dpc-1242	163	1	however	however	ADV
dpc-1242	163	2	,	,	PUNCT
dpc-1242	163	3	at	at	ADP
dpc-1242	163	4	week	week	NOUN
dpc-1242	163	5	2	2	NUM
dpc-1242	163	6	,	,	PUNCT
dpc-1242	163	7	we	we	PRON
dpc-1242	163	8	had	have	VERB
dpc-1242	163	9	a	a	DET
dpc-1242	163	10	greater	great	ADJ
dpc-1242	163	11	scorad	scorad	NOUN
dpc-1242	163	12	reduction	reduction	NOUN
dpc-1242	163	13	by	by	ADP
dpc-1242	163	14	a	a	DET
dpc-1242	163	15	difference	difference	NOUN
dpc-1242	163	16	of	of	ADP
dpc-1242	163	17	21.62	21.62	NUM
dpc-1242	163	18	%	%	NOUN
dpc-1242	163	19	.	.	PUNCT
dpc-1242	164	1	similarly	similarly	ADV
dpc-1242	164	2	,	,	PUNCT
dpc-1242	164	3	the	the	DET
dpc-1242	164	4	scorad	scorad	NOUN
dpc-1242	164	5	reduction	reduction	NOUN
dpc-1242	164	6	was	be	AUX
dpc-1242	164	7	greater	great	ADJ
dpc-1242	164	8	by	by	ADP
dpc-1242	164	9	a	a	DET
dpc-1242	164	10	difference	difference	NOUN
dpc-1242	164	11	of	of	ADP
dpc-1242	164	12	23.65	23.65	NUM
dpc-1242	164	13	%	%	NOUN
dpc-1242	164	14	at	at	ADP
dpc-1242	164	15	week	week	NOUN
dpc-1242	164	16	4	4	NUM
dpc-1242	164	17	compared	compare	VERB
dpc-1242	164	18	to	to	ADP
dpc-1242	164	19	the	the	DET
dpc-1242	164	20	earlier	early	ADJ
dpc-1242	164	21	study	study	NOUN
dpc-1242	164	22	.	.	PUNCT
dpc-1242	165	1	the	the	DET
dpc-1242	165	2	disparity	disparity	NOUN
dpc-1242	165	3	in	in	ADP
dpc-1242	165	4	the	the	DET
dpc-1242	165	5	results	result	NOUN
dpc-1242	165	6	could	could	AUX
dpc-1242	165	7	be	be	AUX
dpc-1242	165	8	due	due	ADJ
dpc-1242	165	9	to	to	ADP
dpc-1242	165	10	the	the	DET
dpc-1242	165	11	different	different	ADJ
dpc-1242	165	12	concentrations	concentration	NOUN
dpc-1242	165	13	of	of	ADP
dpc-1242	165	14	ointment	ointment	NOUN
dpc-1242	165	15	used	use	VERB
dpc-1242	165	16	and	and	CCONJ
dpc-1242	165	17	the	the	DET
dpc-1242	165	18	selection	selection	NOUN
dpc-1242	165	19	of	of	ADP
dpc-1242	165	20	the	the	DET
dpc-1242	165	21	study	study	NOUN
dpc-1242	165	22	population	population	NOUN
dpc-1242	165	23	.	.	PUNCT
dpc-1242	166	1	in	in	ADP
dpc-1242	166	2	a	a	DET
dpc-1242	166	3	study	study	NOUN
dpc-1242	166	4	conducted	conduct	VERB
dpc-1242	166	5	by	by	ADP
dpc-1242	166	6	doss	doss	PROPN
dpc-1242	166	7	et	et	PROPN
dpc-1242	166	8	al	al	PROPN
dpc-1242	166	9	[	[	X
dpc-1242	166	10	20	20	NUM
dpc-1242	166	11	]	]	PUNCT
dpc-1242	166	12	on	on	ADP
dpc-1242	166	13	479	479	NUM
dpc-1242	166	14	children	child	NOUN
dpc-1242	166	15	with	with	ADP
dpc-1242	166	16	ad	ad	NOUN
dpc-1242	166	17	who	who	PRON
dpc-1242	166	18	had	have	AUX
dpc-1242	166	19	responded	respond	VERB
dpc-1242	166	20	insufficiently	insufficiently	ADV
dpc-1242	166	21	to	to	ADP
dpc-1242	166	22	conventional	conventional	ADJ
dpc-1242	166	23	tcs	tcs	NOUN
dpc-1242	166	24	treatment	treatment	NOUN
dpc-1242	166	25	,	,	PUNCT
dpc-1242	166	26	fluticasone	fluticasone	NOUN
dpc-1242	166	27	0.005	0.005	NUM
dpc-1242	166	28	%	%	NOUN
dpc-1242	166	29	ointment	ointment	NOUN
dpc-1242	166	30	and	and	CCONJ
dpc-1242	166	31	tacrolimus	tacrolimus	NOUN
dpc-1242	166	32	0.03	0.03	NUM
dpc-1242	166	33	%	%	NOUN
dpc-1242	166	34	ointment	ointment	NOUN
dpc-1242	166	35	were	be	AUX
dpc-1242	166	36	used	use	VERB
dpc-1242	166	37	as	as	ADP
dpc-1242	166	38	second	second	ADJ
dpc-1242	166	39	-	-	PUNCT
dpc-1242	166	40	line	line	NOUN
dpc-1242	166	41	treatment	treatment	NOUN
dpc-1242	166	42	.	.	PUNCT
dpc-1242	167	1	the	the	DET
dpc-1242	167	2	response	response	NOUN
dpc-1242	167	3	rate	rate	NOUN
dpc-1242	167	4	was	be	AUX
dpc-1242	167	5	86.3	86.3	NUM
dpc-1242	167	6	%	%	NOUN
dpc-1242	167	7	in	in	ADP
dpc-1242	167	8	the	the	DET
dpc-1242	167	9	tacrolimus	tacrolimus	NOUN
dpc-1242	167	10	group	group	NOUN
dpc-1242	167	11	and	and	CCONJ
dpc-1242	167	12	91.5	91.5	NUM
dpc-1242	167	13	%	%	NOUN
dpc-1242	167	14	in	in	ADP
dpc-1242	167	15	the	the	DET
dpc-1242	167	16	fluticasone	fluticasone	NOUN
dpc-1242	167	17	group	group	NOUN
dpc-1242	167	18	at	at	ADP
dpc-1242	167	19	day	day	NOUN
dpc-1242	167	20	21	21	NUM
dpc-1242	167	21	.	.	PUNCT
dpc-1242	168	1	this	this	DET
dpc-1242	168	2	result	result	NOUN
dpc-1242	168	3	was	be	AUX
dpc-1242	168	4	comparable	comparable	ADJ
dpc-1242	168	5	to	to	ADP
dpc-1242	168	6	our	our	PRON
dpc-1242	168	7	study	study	NOUN
dpc-1242	168	8	,	,	PUNCT
dpc-1242	168	9	as	as	SCONJ
dpc-1242	168	10	we	we	PRON
dpc-1242	168	11	had	have	VERB
dpc-1242	168	12	an	an	DET
dpc-1242	168	13	approximately	approximately	ADV
dpc-1242	168	14	equal	equal	ADJ
dpc-1242	168	15	reduction	reduction	NOUN
dpc-1242	168	16	in	in	ADP
dpc-1242	168	17	severity	severity	NOUN
dpc-1242	168	18	between	between	ADP
dpc-1242	168	19	both	both	DET
dpc-1242	168	20	treatment	treatment	NOUN
dpc-1242	168	21	groups	group	NOUN
dpc-1242	168	22	.	.	PUNCT
dpc-1242	169	1	ad	ad	NOUN
dpc-1242	169	2	is	be	AUX
dpc-1242	169	3	known	know	VERB
dpc-1242	169	4	to	to	PART
dpc-1242	169	5	affect	affect	VERB
dpc-1242	169	6	the	the	DET
dpc-1242	169	7	qol	qol	NOUN
dpc-1242	169	8	of	of	ADP
dpc-1242	169	9	patients	patient	NOUN
dpc-1242	169	10	and	and	CCONJ
dpc-1242	169	11	their	their	PRON
dpc-1242	169	12	family	family	NOUN
dpc-1242	169	13	members	member	NOUN
dpc-1242	169	14	.	.	PUNCT
dpc-1242	170	1	a	a	DET
dpc-1242	170	2	majority	majority	NOUN
dpc-1242	170	3	of	of	ADP
dpc-1242	170	4	studies	study	NOUN
dpc-1242	170	5	use	use	VERB
dpc-1242	170	6	scorad	scorad	NOUN
dpc-1242	170	7	,	,	PUNCT
dpc-1242	170	8	but	but	CCONJ
dpc-1242	170	9	there	there	PRON
dpc-1242	170	10	are	be	VERB
dpc-1242	170	11	limited	limited	ADJ
dpc-1242	170	12	studies	study	NOUN
dpc-1242	170	13	that	that	PRON
dpc-1242	170	14	try	try	VERB
dpc-1242	170	15	to	to	PART
dpc-1242	170	16	find	find	VERB
dpc-1242	170	17	the	the	DET
dpc-1242	170	18	association	association	NOUN
dpc-1242	170	19	between	between	ADP
dpc-1242	170	20	severity	severity	NOUN
dpc-1242	170	21	of	of	ADP
dpc-1242	170	22	disease	disease	NOUN
dpc-1242	170	23	and	and	CCONJ
dpc-1242	170	24	qol	qol	NOUN
dpc-1242	170	25	.	.	PUNCT
dpc-1242	171	1	the	the	DET
dpc-1242	171	2	present	present	ADJ
dpc-1242	171	3	study	study	NOUN
dpc-1242	171	4	tried	try	VERB
dpc-1242	171	5	to	to	PART
dpc-1242	171	6	assess	assess	VERB
dpc-1242	171	7	the	the	DET
dpc-1242	171	8	qol	qol	NOUN
dpc-1242	171	9	of	of	ADP
dpc-1242	171	10	children	child	NOUN
dpc-1242	171	11	and	and	CCONJ
dpc-1242	171	12	analyze	analyze	VERB
dpc-1242	171	13	the	the	DET
dpc-1242	171	14	association	association	NOUN
dpc-1242	171	15	between	between	ADP
dpc-1242	171	16	the	the	DET
dpc-1242	171	17	severity	severity	NOUN
dpc-1242	171	18	of	of	ADP
dpc-1242	171	19	the	the	DET
dpc-1242	171	20	disease	disease	NOUN
dpc-1242	171	21	and	and	CCONJ
dpc-1242	171	22	children	child	NOUN
dpc-1242	171	23	’s	’s	PART
dpc-1242	171	24	qol	qol	NOUN
dpc-1242	171	25	.	.	PUNCT
dpc-1242	172	1	the	the	DET
dpc-1242	172	2	association	association	NOUN
dpc-1242	172	3	between	between	ADP
dpc-1242	172	4	the	the	DET
dpc-1242	172	5	scorad	scorad	NOUN
dpc-1242	172	6	and	and	CCONJ
dpc-1242	172	7	cdlqi	cdlqi	NOUN
dpc-1242	172	8	indices	index	NOUN
dpc-1242	172	9	showed	show	VERB
dpc-1242	172	10	reasonable	reasonable	ADJ
dpc-1242	172	11	positive	positive	ADJ
dpc-1242	172	12	moderate	moderate	ADJ
dpc-1242	172	13	correlation	correlation	NOUN
dpc-1242	172	14	(	(	PUNCT
dpc-1242	172	15	r	r	NOUN
dpc-1242	172	16	=	=	SYM
dpc-1242	172	17	0.4668	0.4668	NUM
dpc-1242	172	18	)	)	PUNCT
dpc-1242	172	19	with	with	ADP
dpc-1242	172	20	p	p	NOUN
dpc-1242	172	21	=	=	NOUN
dpc-1242	172	22	0.004	0.004	NUM
dpc-1242	172	23	.	.	PUNCT
dpc-1242	173	1	a	a	DET
dpc-1242	173	2	similar	similar	ADJ
dpc-1242	173	3	study	study	NOUN
dpc-1242	173	4	done	do	VERB
dpc-1242	173	5	by	by	ADP
dpc-1242	173	6	kim	kim	PROPN
dpc-1242	173	7	et	et	PROPN
dpc-1242	173	8	al	al	PROPN
dpc-1242	174	1	[	[	X
dpc-1242	174	2	21	21	NUM
dpc-1242	174	3	]	]	PUNCT
dpc-1242	174	4	showed	show	VERB
dpc-1242	174	5	positive	positive	ADJ
dpc-1242	174	6	correlation	correlation	NOUN
dpc-1242	174	7	between	between	ADP
dpc-1242	174	8	the	the	DET
dpc-1242	174	9	scorad	scorad	ADJ
dpc-1242	174	10	index	index	NOUN
dpc-1242	174	11	and	and	CCONJ
dpc-1242	174	12	cdlqi	cdlqi	NOUN
dpc-1242	174	13	(	(	PUNCT
dpc-1242	174	14	r	r	NOUN
dpc-1242	174	15	=	=	SYM
dpc-1242	174	16	0.312	0.312	NUM
dpc-1242	174	17	,	,	PUNCT
dpc-1242	174	18	p	p	X
dpc-1242	174	19	=	=	NOUN
dpc-1242	174	20	0.039	0.039	NUM
dpc-1242	174	21	)	)	PUNCT
dpc-1242	174	22	.	.	PUNCT
dpc-1242	175	1	another	another	DET
dpc-1242	175	2	study	study	NOUN
dpc-1242	175	3	by	by	ADP
dpc-1242	175	4	bezerra	bezerra	PROPN
dpc-1242	175	5	campos	campos	PROPN
dpc-1242	175	6	et	et	PROPN
dpc-1242	175	7	al	al	PROPN
dpc-1242	176	1	[	[	X
dpc-1242	176	2	22	22	NUM
dpc-1242	176	3	]	]	PUNCT
dpc-1242	176	4	found	find	VERB
dpc-1242	176	5	significant	significant	ADJ
dpc-1242	176	6	positive	positive	ADJ
dpc-1242	176	7	correlation	correlation	NOUN
dpc-1242	176	8	(	(	PUNCT
dpc-1242	176	9	r	r	NOUN
dpc-1242	176	10	=	=	SYM
dpc-1242	176	11	0.68	0.68	NUM
dpc-1242	176	12	,	,	PUNCT
dpc-1242	176	13	p	p	X
dpc-1242	176	14	<	<	X
dpc-1242	176	15	0.001	0.001	NUM
dpc-1242	176	16	)	)	PUNCT
dpc-1242	176	17	between	between	ADP
dpc-1242	176	18	severity	severity	NOUN
dpc-1242	176	19	of	of	ADP
dpc-1242	176	20	disease	disease	NOUN
dpc-1242	176	21	and	and	CCONJ
dpc-1242	176	22	qol	qol	NOUN
dpc-1242	176	23	of	of	ADP
dpc-1242	176	24	pediatric	pediatric	ADJ
dpc-1242	176	25	patients	patient	NOUN
dpc-1242	176	26	with	with	ADP
dpc-1242	176	27	ad	ad	NOUN
dpc-1242	176	28	.	.	PUNCT
dpc-1242	177	1	our	our	PRON
dpc-1242	177	2	study	study	NOUN
dpc-1242	177	3	had	have	VERB
dpc-1242	177	4	similar	similar	ADJ
dpc-1242	177	5	comparable	comparable	ADJ
dpc-1242	177	6	results	result	NOUN
dpc-1242	177	7	and	and	CCONJ
dpc-1242	177	8	indicates	indicate	VERB
dpc-1242	177	9	the	the	DET
dpc-1242	177	10	importance	importance	NOUN
dpc-1242	177	11	of	of	ADP
dpc-1242	177	12	including	include	VERB
dpc-1242	177	13	the	the	DET
dpc-1242	177	14	assessment	assessment	NOUN
dpc-1242	177	15	of	of	ADP
dpc-1242	177	16	qol	qol	PROPN
dpc-1242	177	17	as	as	ADP
dpc-1242	177	18	an	an	DET
dpc-1242	177	19	objective	objective	NOUN
dpc-1242	177	20	to	to	ADP
dpc-1242	177	21	the	the	DET
dpc-1242	177	22	clinical	clinical	ADJ
dpc-1242	177	23	analysis	analysis	NOUN
dpc-1242	177	24	.	.	PUNCT
dpc-1242	178	1	the	the	DET
dpc-1242	178	2	result	result	NOUN
dpc-1242	178	3	of	of	ADP
dpc-1242	178	4	the	the	DET
dpc-1242	178	5	present	present	ADJ
dpc-1242	178	6	study	study	NOUN
dpc-1242	178	7	demonstrates	demonstrate	VERB
dpc-1242	178	8	that	that	SCONJ
dpc-1242	178	9	the	the	DET
dpc-1242	178	10	qol	qol	NOUN
dpc-1242	178	11	is	be	AUX
dpc-1242	178	12	related	relate	VERB
dpc-1242	178	13	to	to	ADP
dpc-1242	178	14	the	the	DET
dpc-1242	178	15	severity	severity	NOUN
dpc-1242	178	16	of	of	ADP
dpc-1242	178	17	ad	ad	NOUN
dpc-1242	178	18	.	.	PUNCT
dpc-1242	179	1	the	the	PRON
dpc-1242	179	2	higher	high	ADJ
dpc-1242	179	3	the	the	DET
dpc-1242	179	4	scorad	scorad	NOUN
dpc-1242	179	5	,	,	PUNCT
dpc-1242	179	6	the	the	PRON
dpc-1242	179	7	poorer	poor	ADJ
dpc-1242	179	8	the	the	DET
dpc-1242	179	9	qol	qol	NOUN
dpc-1242	179	10	;	;	PUNCT
dpc-1242	179	11	therefore	therefore	ADV
dpc-1242	179	12	,	,	PUNCT
dpc-1242	179	13	early	early	ADJ
dpc-1242	179	14	management	management	NOUN
dpc-1242	179	15	of	of	ADP
dpc-1242	179	16	ad	ad	NOUN
dpc-1242	179	17	may	may	AUX
dpc-1242	179	18	help	help	VERB
dpc-1242	179	19	improve	improve	VERB
dpc-1242	179	20	the	the	DET
dpc-1242	179	21	qol	qol	NOUN
dpc-1242	179	22	of	of	ADP
dpc-1242	179	23	ad	ad	NOUN
dpc-1242	179	24	patients	patient	NOUN
dpc-1242	179	25	.	.	PUNCT
dpc-1242	180	1	in	in	ADP
dpc-1242	180	2	addition	addition	NOUN
dpc-1242	180	3	to	to	ADP
dpc-1242	180	4	medical	medical	ADJ
dpc-1242	180	5	management	management	NOUN
dpc-1242	180	6	,	,	PUNCT
dpc-1242	180	7	psychological	psychological	ADJ
dpc-1242	180	8	support	support	NOUN
dpc-1242	180	9	may	may	AUX
dpc-1242	180	10	improve	improve	VERB
dpc-1242	180	11	the	the	DET
dpc-1242	180	12	longterm	longterm	ADJ
dpc-1242	180	13	physical	physical	ADJ
dpc-1242	180	14	and	and	CCONJ
dpc-1242	180	15	emotional	emotional	ADJ
dpc-1242	180	16	outcomes	outcome	NOUN
dpc-1242	180	17	of	of	ADP
dpc-1242	180	18	all	all	DET
dpc-1242	180	19	ad	ad	NOUN
dpc-1242	180	20	sufferers	sufferer	NOUN
dpc-1242	180	21	.	.	PUNCT
dpc-1242	181	1	the	the	DET
dpc-1242	181	2	qol	qol	NOUN
dpc-1242	181	3	of	of	ADP
dpc-1242	181	4	children	child	NOUN
dpc-1242	181	5	improved	improve	VERB
dpc-1242	181	6	dramatically	dramatically	ADV
dpc-1242	181	7	in	in	ADP
dpc-1242	181	8	both	both	CCONJ
dpc-1242	181	9	the	the	DET
dpc-1242	181	10	treatment	treatment	NOUN
dpc-1242	181	11	groups	group	NOUN
dpc-1242	181	12	and	and	CCONJ
dpc-1242	181	13	continued	continue	VERB
dpc-1242	181	14	to	to	PART
dpc-1242	181	15	improve	improve	VERB
dpc-1242	181	16	even	even	ADV
dpc-1242	181	17	through	through	ADP
dpc-1242	181	18	the	the	DET
dpc-1242	181	19	maintenance	maintenance	NOUN
dpc-1242	181	20	phase	phase	NOUN
dpc-1242	181	21	.	.	PUNCT
dpc-1242	182	1	in	in	ADP
dpc-1242	182	2	our	our	PRON
dpc-1242	182	3	study	study	NOUN
dpc-1242	182	4	,	,	PUNCT
dpc-1242	182	5	of	of	ADP
dpc-1242	182	6	all	all	DET
dpc-1242	182	7	children	child	NOUN
dpc-1242	182	8	with	with	ADP
dpc-1242	182	9	ad	ad	NOUN
dpc-1242	182	10	,	,	PUNCT
dpc-1242	182	11	3	3	NUM
dpc-1242	182	12	(	(	PUNCT
dpc-1242	182	13	8	8	NUM
dpc-1242	182	14	%	%	NOUN
dpc-1242	182	15	)	)	PUNCT
dpc-1242	182	16	of	of	ADP
dpc-1242	182	17	those	those	PRON
dpc-1242	182	18	receiving	receive	VERB
dpc-1242	182	19	tacrolimus	tacrolimus	NOUN
dpc-1242	182	20	treatment	treatment	NOUN
dpc-1242	182	21	developed	develop	VERB
dpc-1242	182	22	adr	adr	PROPN
dpc-1242	182	23	.	.	PUNCT
dpc-1242	183	1	the	the	DET
dpc-1242	183	2	adr	adr	PROPN
dpc-1242	183	3	observed	observe	VERB
dpc-1242	183	4	was	be	AUX
dpc-1242	183	5	a	a	DET
dpc-1242	183	6	mild	mild	ADJ
dpc-1242	183	7	and	and	CCONJ
dpc-1242	183	8	transient	transient	ADJ
dpc-1242	183	9	application	application	NOUN
dpc-1242	183	10	site	site	NOUN
dpc-1242	183	11	reaction	reaction	NOUN
dpc-1242	183	12	.	.	PUNCT
dpc-1242	184	1	in	in	ADP
dpc-1242	184	2	a	a	DET
dpc-1242	184	3	12	12	NUM
dpc-1242	184	4	-	-	PUNCT
dpc-1242	184	5	week	week	NOUN
dpc-1242	184	6	study	study	NOUN
dpc-1242	184	7	of	of	ADP
dpc-1242	184	8	both	both	PRON
dpc-1242	184	9	0.03	0.03	NUM
dpc-1242	184	10	%	%	NOUN
dpc-1242	184	11	and	and	CCONJ
dpc-1242	184	12	0.1	0.1	NUM
dpc-1242	184	13	%	%	NOUN
dpc-1242	184	14	tacrolimus	tacrolimus	NOUN
dpc-1242	184	15	by	by	ADP
dpc-1242	184	16	paller	paller	NOUN
dpc-1242	184	17	et	et	PROPN
dpc-1242	184	18	al	al	PROPN
dpc-1242	185	1	[	[	X
dpc-1242	185	2	23	23	NUM
dpc-1242	185	3	]	]	PUNCT
dpc-1242	185	4	,	,	PUNCT
dpc-1242	185	5	the	the	DET
dpc-1242	185	6	most	most	ADV
dpc-1242	185	7	common	common	ADJ
dpc-1242	185	8	adrs	adr	NOUN
dpc-1242	185	9	observed	observe	VERB
dpc-1242	185	10	were	be	AUX
dpc-1242	185	11	application	application	NOUN
dpc-1242	185	12	site	site	NOUN
dpc-1242	185	13	reactions	reaction	NOUN
dpc-1242	185	14	,	,	PUNCT
dpc-1242	185	15	particularly	particularly	ADV
dpc-1242	185	16	skin	skin	NOUN
dpc-1242	185	17	burning	burning	NOUN
dpc-1242	185	18	and	and	CCONJ
dpc-1242	185	19	pruritus	pruritus	PROPN
dpc-1242	185	20	.	.	PUNCT
dpc-1242	186	1	they	they	PRON
dpc-1242	186	2	appeared	appear	VERB
dpc-1242	186	3	during	during	ADP
dpc-1242	186	4	the	the	DET
dpc-1242	186	5	first	first	ADJ
dpc-1242	186	6	few	few	ADJ
dpc-1242	186	7	days	day	NOUN
dpc-1242	186	8	and	and	CCONJ
dpc-1242	186	9	then	then	ADV
dpc-1242	186	10	declined	decline	VERB
dpc-1242	186	11	.	.	PUNCT
dpc-1242	187	1	8	8	NUM
dpc-1242	187	2	research	research	NOUN
dpc-1242	187	3	|	|	ADV
dpc-1242	187	4	dermatol	dermatol	NOUN
dpc-1242	187	5	pract	pract	NOUN
dpc-1242	187	6	concept	concept	NOUN
dpc-1242	187	7	2020;10(4):e2020094	2020;10(4):e2020094	NUM
dpc-1242	187	8	15	15	NUM
dpc-1242	187	9	.	.	PUNCT
dpc-1242	188	1	lewis	lewis	PROPN
dpc-1242	188	2	-	-	PUNCT
dpc-1242	188	3	jones	jones	PROPN
dpc-1242	188	4	ms	ms	PROPN
dpc-1242	188	5	,	,	PUNCT
dpc-1242	188	6	finlay	finlay	VERB
dpc-1242	188	7	ay	ay	NOUN
dpc-1242	188	8	.	.	PUNCT
dpc-1242	189	1	the	the	DET
dpc-1242	189	2	children	child	NOUN
dpc-1242	189	3	’s	’s	PART
dpc-1242	189	4	dermatology	dermatology	NOUN
dpc-1242	189	5	life	life	NOUN
dpc-1242	189	6	quality	quality	NOUN
dpc-1242	189	7	index	index	NOUN
dpc-1242	189	8	(	(	PUNCT
dpc-1242	189	9	cdlqi	cdlqi	PROPN
dpc-1242	189	10	):	):	PUNCT
dpc-1242	189	11	initial	initial	ADJ
dpc-1242	189	12	validation	validation	NOUN
dpc-1242	189	13	and	and	CCONJ
dpc-1242	189	14	practical	practical	ADJ
dpc-1242	189	15	use	use	NOUN
dpc-1242	189	16	.	.	PUNCT
dpc-1242	190	1	br	br	PROPN
dpc-1242	190	2	j	j	PROPN
dpc-1242	190	3	dermatol	dermatol	NOUN
dpc-1242	190	4	.	.	PUNCT
dpc-1242	191	1	1995;132(6):942	1995;132(6):942	NUM
dpc-1242	191	2	-	-	SYM
dpc-1242	191	3	949	949	NUM
dpc-1242	191	4	.	.	PUNCT
dpc-1242	191	5	doi	doi	NOUN
dpc-1242	191	6	:	:	PUNCT
dpc-1242	191	7	10.1111	10.1111	NUM
dpc-1242	191	8	/	/	SYM
dpc-1242	191	9	j.13652133.1995.tb16953.x	j.13652133.1995.tb16953.x	PROPN
dpc-1242	191	10	.	.	PROPN
dpc-1242	191	11	16	16	NUM
dpc-1242	191	12	.	.	PUNCT
dpc-1242	192	1	sarkar	sarkar	PROPN
dpc-1242	192	2	r	r	PROPN
dpc-1242	192	3	,	,	PUNCT
dpc-1242	192	4	kanwar	kanwar	PROPN
dpc-1242	192	5	aj	aj	PROPN
dpc-1242	192	6	.	.	PUNCT
dpc-1242	193	1	clinico	clinico	NOUN
dpc-1242	193	2	-	-	PUNCT
dpc-1242	193	3	epidemiological	epidemiological	ADJ
dpc-1242	193	4	profile	profile	NOUN
dpc-1242	193	5	and	and	CCONJ
dpc-1242	193	6	factors	factor	NOUN
dpc-1242	193	7	affecting	affect	VERB
dpc-1242	193	8	severity	severity	NOUN
dpc-1242	193	9	of	of	ADP
dpc-1242	193	10	atopic	atopic	NOUN
dpc-1242	193	11	dermatitis	dermatitis	NOUN
dpc-1242	193	12	in	in	ADP
dpc-1242	193	13	north	north	NOUN
dpc-1242	193	14	indian	indian	ADJ
dpc-1242	193	15	children	child	NOUN
dpc-1242	193	16	.	.	PUNCT
dpc-1242	194	1	indian	indian	PROPN
dpc-1242	194	2	j	j	PROPN
dpc-1242	194	3	dermatol	dermatol	NOUN
dpc-1242	194	4	.	.	PUNCT
dpc-1242	195	1	2004;49(3):117	2004;49(3):117	NUM
dpc-1242	195	2	-	-	SYM
dpc-1242	195	3	122	122	NUM
dpc-1242	195	4	.	.	PUNCT
dpc-1242	195	5	17	17	NUM
dpc-1242	195	6	.	.	PUNCT
dpc-1242	196	1	sampson	sampson	PROPN
dpc-1242	196	2	ha	ha	PROPN
dpc-1242	196	3	.	.	PUNCT
dpc-1242	196	4	atopic	atopic	PROPN
dpc-1242	196	5	dermatitis	dermatitis	PROPN
dpc-1242	196	6	.	.	PUNCT
dpc-1242	197	1	in	in	ADP
dpc-1242	197	2	:	:	PUNCT
dpc-1242	197	3	feigin	feigin	PROPN
dpc-1242	197	4	rd	rd	PROPN
dpc-1242	197	5	,	,	PUNCT
dpc-1242	197	6	oski	oski	PROPN
dpc-1242	197	7	fa	fa	PROPN
dpc-1242	197	8	,	,	PUNCT
dpc-1242	197	9	deangelis	deangelis	PROPN
dpc-1242	197	10	c	c	PROPN
dpc-1242	197	11	,	,	PUNCT
dpc-1242	197	12	eds	eds	PROPN
dpc-1242	197	13	.	.	PUNCT
dpc-1242	197	14	oski	oski	PROPN
dpc-1242	197	15	’s	’s	PART
dpc-1242	197	16	pediatrics	pediatric	NOUN
dpc-1242	197	17	principles	principle	NOUN
dpc-1242	197	18	&	&	CCONJ
dpc-1242	197	19	practice	practice	NOUN
dpc-1242	197	20	.	.	PUNCT
dpc-1242	198	1	4th	4th	ADJ
dpc-1242	198	2	ed	ed	NOUN
dpc-1242	198	3	.	.	PUNCT
dpc-1242	199	1	lippincott	lippincott	PROPN
dpc-1242	199	2	williams	williams	PROPN
dpc-1242	199	3	&	&	CCONJ
dpc-1242	199	4	wilkins	wilkins	PROPN
dpc-1242	199	5	;	;	PUNCT
dpc-1242	199	6	2006:2423	2006:2423	NUM
dpc-1242	199	7	-	-	SYM
dpc-1242	199	8	2424	2424	NUM
dpc-1242	199	9	.	.	PUNCT
dpc-1242	200	1	18	18	NUM
dpc-1242	200	2	.	.	X
dpc-1242	201	1	takeuchi	takeuchi	PROPN
dpc-1242	201	2	s	s	PROPN
dpc-1242	201	3	,	,	PUNCT
dpc-1242	201	4	saeki	saeki	PROPN
dpc-1242	201	5	h	h	NOUN
dpc-1242	201	6	,	,	PUNCT
dpc-1242	201	7	tokunaga	tokunaga	NOUN
dpc-1242	201	8	s	s	PROPN
dpc-1242	201	9	,	,	PUNCT
dpc-1242	201	10	et	et	PROPN
dpc-1242	201	11	al	al	PROPN
dpc-1242	201	12	.	.	PUNCT
dpc-1242	202	1	a	a	DET
dpc-1242	202	2	randomized	randomized	ADJ
dpc-1242	202	3	,	,	PUNCT
dpc-1242	202	4	open	open	ADJ
dpc-1242	202	5	-	-	PUNCT
dpc-1242	202	6	label	label	NOUN
dpc-1242	202	7	,	,	PUNCT
dpc-1242	202	8	multicenter	multicenter	ADJ
dpc-1242	202	9	trial	trial	NOUN
dpc-1242	202	10	of	of	ADP
dpc-1242	202	11	topical	topical	ADJ
dpc-1242	202	12	tacrolimus	tacrolimus	NOUN
dpc-1242	202	13	for	for	ADP
dpc-1242	202	14	the	the	DET
dpc-1242	202	15	treatment	treatment	NOUN
dpc-1242	202	16	of	of	ADP
dpc-1242	202	17	pruritus	pruritus	PROPN
dpc-1242	202	18	in	in	ADP
dpc-1242	202	19	patients	patient	NOUN
dpc-1242	202	20	with	with	ADP
dpc-1242	202	21	atopic	atopic	NOUN
dpc-1242	202	22	dermatitis	dermatitis	NOUN
dpc-1242	202	23	.	.	PUNCT
dpc-1242	203	1	ann	ann	PROPN
dpc-1242	203	2	dermatol	dermatol	NOUN
dpc-1242	203	3	.	.	PUNCT
dpc-1242	204	1	2012;24(2):144	2012;24(2):144	NUM
dpc-1242	204	2	-	-	SYM
dpc-1242	204	3	150	150	NUM
dpc-1242	204	4	.	.	PUNCT
dpc-1242	205	1	doi	doi	NOUN
dpc-1242	205	2	:	:	PUNCT
dpc-1242	205	3	10.5021	10.5021	NUM
dpc-1242	205	4	/	/	SYM
dpc-1242	205	5	ad.2012.24.2.144	ad.2012.24.2.144	PROPN
dpc-1242	205	6	19	19	NUM
dpc-1242	205	7	.	.	PUNCT
dpc-1242	206	1	pacor	pacor	PROPN
dpc-1242	206	2	ml	ml	PROPN
dpc-1242	206	3	,	,	PUNCT
dpc-1242	206	4	di	di	PROPN
dpc-1242	206	5	lorenzo	lorenzo	PROPN
dpc-1242	206	6	g	g	PROPN
dpc-1242	206	7	,	,	PUNCT
dpc-1242	206	8	martinelli	martinelli	PROPN
dpc-1242	206	9	n	n	AUX
dpc-1242	206	10	,	,	PUNCT
dpc-1242	206	11	mansueto	mansueto	VERB
dpc-1242	206	12	p	p	NOUN
dpc-1242	206	13	,	,	PUNCT
dpc-1242	206	14	rini	rini	PROPN
dpc-1242	206	15	gb	gb	PROPN
dpc-1242	206	16	,	,	PUNCT
dpc-1242	206	17	corrocher	corrocher	PROPN
dpc-1242	206	18	r.	r.	PROPN
dpc-1242	206	19	comparing	compare	VERB
dpc-1242	206	20	tacrolimus	tacrolimus	NOUN
dpc-1242	206	21	ointment	ointment	NOUN
dpc-1242	206	22	and	and	CCONJ
dpc-1242	206	23	oral	oral	ADJ
dpc-1242	206	24	cyclosporine	cyclosporine	NOUN
dpc-1242	206	25	in	in	ADP
dpc-1242	206	26	adult	adult	NOUN
dpc-1242	206	27	patients	patient	NOUN
dpc-1242	206	28	affected	affect	VERB
dpc-1242	206	29	by	by	ADP
dpc-1242	206	30	atopic	atopic	NOUN
dpc-1242	206	31	dermatitis	dermatitis	NOUN
dpc-1242	206	32	:	:	PUNCT
dpc-1242	206	33	a	a	DET
dpc-1242	206	34	randomized	randomized	ADJ
dpc-1242	206	35	study	study	NOUN
dpc-1242	206	36	.	.	PUNCT
dpc-1242	207	1	clin	clin	PROPN
dpc-1242	207	2	exp	exp	NOUN
dpc-1242	207	3	allergy	allergy	PROPN
dpc-1242	207	4	.	.	PUNCT
dpc-1242	208	1	2004;34(4):639	2004;34(4):639	NUM
dpc-1242	208	2	-	-	PUNCT
dpc-1242	208	3	645	645	NUM
dpc-1242	208	4	.	.	PUNCT
dpc-1242	209	1	doi	doi	NOUN
dpc-1242	209	2	:	:	PUNCT
dpc-1242	209	3	10.1111	10.1111	NUM
dpc-1242	209	4	/	/	SYM
dpc-1242	209	5	j.1365	j.1365	NOUN
dpc-1242	209	6	-	-	PUNCT
dpc-1242	209	7	2222.2004.1907.x	2222.2004.1907.x	NUM
dpc-1242	209	8	20	20	NUM
dpc-1242	209	9	.	.	PUNCT
dpc-1242	210	1	doss	doss	PROPN
dpc-1242	210	2	n	n	SYM
dpc-1242	210	3	,	,	PUNCT
dpc-1242	210	4	kamoun	kamoun	PROPN
dpc-1242	210	5	mr	mr	PROPN
dpc-1242	210	6	,	,	PUNCT
dpc-1242	210	7	dubertret	dubertret	NOUN
dpc-1242	210	8	l	l	NOUN
dpc-1242	210	9	,	,	PUNCT
dpc-1242	210	10	et	et	PROPN
dpc-1242	210	11	al	al	PROPN
dpc-1242	210	12	.	.	PROPN
dpc-1242	210	13	efficacy	efficacy	NOUN
dpc-1242	210	14	of	of	ADP
dpc-1242	210	15	tacrolimus	tacrolimus	NOUN
dpc-1242	210	16	0.03	0.03	NUM
dpc-1242	210	17	%	%	NOUN
dpc-1242	210	18	ointment	ointment	NOUN
dpc-1242	210	19	as	as	ADP
dpc-1242	210	20	second	second	ADJ
dpc-1242	210	21	-	-	PUNCT
dpc-1242	210	22	line	line	NOUN
dpc-1242	210	23	treatment	treatment	NOUN
dpc-1242	210	24	for	for	ADP
dpc-1242	210	25	children	child	NOUN
dpc-1242	210	26	with	with	ADP
dpc-1242	210	27	moderate	moderate	ADJ
dpc-1242	210	28	-	-	PUNCT
dpc-1242	210	29	to	to	ADP
dpc-1242	210	30	-	-	PUNCT
dpc-1242	210	31	severe	severe	ADJ
dpc-1242	210	32	atopic	atopic	NOUN
dpc-1242	210	33	dermatitis	dermatitis	NOUN
dpc-1242	210	34	:	:	PUNCT
dpc-1242	210	35	evidence	evidence	NOUN
dpc-1242	210	36	from	from	ADP
dpc-1242	210	37	a	a	DET
dpc-1242	210	38	randomized	randomized	ADJ
dpc-1242	210	39	double	double	ADJ
dpc-1242	210	40	-	-	PUNCT
dpc-1242	210	41	blind	blind	ADJ
dpc-1242	210	42	,	,	PUNCT
dpc-1242	210	43	non	non	ADJ
dpc-1242	210	44	-	-	ADJ
dpc-1242	210	45	inferiority	inferiority	ADJ
dpc-1242	210	46	trial	trial	NOUN
dpc-1242	210	47	vs.	vs.	ADP
dpc-1242	210	48	fluticasone	fluticasone	NOUN
dpc-1242	210	49	0.005	0.005	NUM
dpc-1242	210	50	%	%	NOUN
dpc-1242	210	51	ointment	ointment	NOUN
dpc-1242	210	52	.	.	PUNCT
dpc-1242	211	1	pediatr	pediatr	ADJ
dpc-1242	211	2	allergy	allergy	PROPN
dpc-1242	211	3	immunol	immunol	NOUN
dpc-1242	211	4	.	.	PUNCT
dpc-1242	212	1	2010;21(2	2010;21(2	NUM
dpc-1242	212	2	pt	pt	NOUN
dpc-1242	212	3	1):321	1):321	NOUN
dpc-1242	212	4	-	-	PUNCT
dpc-1242	212	5	329	329	NUM
dpc-1242	212	6	.	.	PUNCT
dpc-1242	213	1	doi	doi	NOUN
dpc-1242	213	2	:	:	PUNCT
dpc-1242	213	3	10.1111	10.1111	NUM
dpc-1242	213	4	/	/	SYM
dpc-1242	213	5	j.1399	j.1399	NOUN
dpc-1242	213	6	-	-	PUNCT
dpc-1242	213	7	3038.2009.00895.x	3038.2009.00895.x	NUM
dpc-1242	213	8	.	.	PUNCT
dpc-1242	214	1	21	21	NUM
dpc-1242	214	2	.	.	PUNCT
dpc-1242	215	1	kim	kim	PROPN
dpc-1242	215	2	dh	dh	PROPN
dpc-1242	215	3	,	,	PUNCT
dpc-1242	215	4	li	li	PROPN
dpc-1242	215	5	k	k	PROPN
dpc-1242	215	6	,	,	PUNCT
dpc-1242	215	7	seo	seo	NOUN
dpc-1242	215	8	sj	sj	PROPN
dpc-1242	215	9	,	,	PUNCT
dpc-1242	215	10	et	et	PROPN
dpc-1242	215	11	al	al	PROPN
dpc-1242	215	12	.	.	PUNCT
dpc-1242	215	13	quality	quality	NOUN
dpc-1242	215	14	of	of	ADP
dpc-1242	215	15	life	life	NOUN
dpc-1242	215	16	and	and	CCONJ
dpc-1242	215	17	disease	disease	NOUN
dpc-1242	215	18	severity	severity	NOUN
dpc-1242	215	19	are	be	AUX
dpc-1242	215	20	correlated	correlate	VERB
dpc-1242	215	21	in	in	ADP
dpc-1242	215	22	patients	patient	NOUN
dpc-1242	215	23	with	with	ADP
dpc-1242	215	24	atopic	atopic	NOUN
dpc-1242	215	25	dermatitis	dermatitis	NOUN
dpc-1242	215	26	.	.	PUNCT
dpc-1242	216	1	j	j	PROPN
dpc-1242	216	2	korean	korean	PROPN
dpc-1242	216	3	med	med	PROPN
dpc-1242	216	4	sci	sci	PROPN
dpc-1242	216	5	.	.	PUNCT
dpc-1242	217	1	2012;27(11):1327	2012;27(11):1327	PROPN
dpc-1242	217	2	-	-	SYM
dpc-1242	217	3	1332	1332	NUM
dpc-1242	217	4	.	.	PUNCT
dpc-1242	218	1	doi	doi	NOUN
dpc-1242	218	2	:	:	PUNCT
dpc-1242	218	3	10.3346/	10.3346/	NUM
dpc-1242	218	4	jkms.2012.27.11.1327	jkms.2012.27.11.1327	NOUN
dpc-1242	218	5	22	22	NUM
dpc-1242	218	6	.	.	PUNCT
dpc-1242	219	1	bezerra	bezerra	PROPN
dpc-1242	219	2	campos	campos	PROPN
dpc-1242	219	3	al	al	PROPN
dpc-1242	219	4	,	,	PUNCT
dpc-1242	219	5	moreira	moreira	PROPN
dpc-1242	219	6	de	de	PROPN
dpc-1242	219	7	araujo	araujo	PROPN
dpc-1242	219	8	f	f	PROPN
dpc-1242	219	9	,	,	PUNCT
dpc-1242	219	10	lopes	lopes	PROPN
dpc-1242	219	11	dos	do	VERB
dpc-1242	219	12	santos	santos	PROPN
dpc-1242	219	13	ma	ma	PROPN
dpc-1242	219	14	,	,	PUNCT
dpc-1242	219	15	de	de	X
dpc-1242	219	16	assis	assis	PROPN
dpc-1242	219	17	santos	santos	PROPN
dpc-1242	219	18	dos	do	VERB
dpc-1242	219	19	santos	santos	PROPN
dpc-1242	219	20	a	a	PRON
dpc-1242	219	21	,	,	PUNCT
dpc-1242	219	22	avelar	avelar	PROPN
dpc-1242	219	23	pires	pire	VERB
dpc-1242	219	24	ca	can	AUX
dpc-1242	219	25	.	.	PUNCT
dpc-1242	220	1	impact	impact	NOUN
dpc-1242	220	2	of	of	ADP
dpc-1242	220	3	atopic	atopic	NOUN
dpc-1242	220	4	dermatitis	dermatitis	NOUN
dpc-1242	220	5	on	on	ADP
dpc-1242	220	6	the	the	DET
dpc-1242	220	7	quality	quality	NOUN
dpc-1242	220	8	of	of	ADP
dpc-1242	220	9	life	life	NOUN
dpc-1242	220	10	of	of	ADP
dpc-1242	220	11	pediatric	pediatric	ADJ
dpc-1242	220	12	patients	patient	NOUN
dpc-1242	220	13	and	and	CCONJ
dpc-1242	220	14	their	their	PRON
dpc-1242	220	15	guardians	guardian	NOUN
dpc-1242	220	16	.	.	PUNCT
dpc-1242	221	1	rev	rev	VERB
dpc-1242	221	2	paul	paul	PROPN
dpc-1242	221	3	pediatr	pediatr	PROPN
dpc-1242	221	4	.	.	PUNCT
dpc-1242	222	1	2017;35(1):5	2017;35(1):5	NUM
dpc-1242	222	2	-	-	SYM
dpc-1242	222	3	10	10	NUM
dpc-1242	222	4	.	.	PUNCT
dpc-1242	223	1	doi	doi	NOUN
dpc-1242	223	2	:	:	PUNCT
dpc-1242	223	3	10.1590/1984	10.1590/1984	NUM
dpc-1242	223	4	-	-	NOUN
dpc-1242	223	5	0462/;2017;35;1;00006	0462/;2017;35;1;00006	NOUN
dpc-1242	223	6	.	.	PUNCT
dpc-1242	224	1	23	23	NUM
dpc-1242	224	2	.	.	PUNCT
dpc-1242	224	3	paller	paller	PROPN
dpc-1242	224	4	a	a	PROPN
dpc-1242	224	5	,	,	PUNCT
dpc-1242	224	6	eichenfield	eichenfield	PROPN
dpc-1242	224	7	lf	lf	PROPN
dpc-1242	224	8	,	,	PUNCT
dpc-1242	224	9	leung	leung	PROPN
dpc-1242	224	10	dy	dy	PROPN
dpc-1242	224	11	,	,	PUNCT
dpc-1242	224	12	stewart	stewart	PROPN
dpc-1242	224	13	d	d	PROPN
dpc-1242	224	14	,	,	PUNCT
dpc-1242	224	15	appell	appell	PROPN
dpc-1242	224	16	m.	m.	NOUN
dpc-1242	224	17	a	a	DET
dpc-1242	224	18	12	12	NUM
dpc-1242	224	19	-	-	PUNCT
dpc-1242	224	20	week	week	NOUN
dpc-1242	224	21	study	study	NOUN
dpc-1242	224	22	of	of	ADP
dpc-1242	224	23	tacrolimus	tacrolimus	PROPN
dpc-1242	224	24	ointment	ointment	NOUN
dpc-1242	224	25	for	for	ADP
dpc-1242	224	26	the	the	DET
dpc-1242	224	27	treatment	treatment	NOUN
dpc-1242	224	28	of	of	ADP
dpc-1242	224	29	atopic	atopic	NOUN
dpc-1242	224	30	dermatitis	dermatitis	NOUN
dpc-1242	224	31	in	in	ADP
dpc-1242	224	32	pediatric	pediatric	ADJ
dpc-1242	224	33	patients	patient	NOUN
dpc-1242	224	34	.	.	PUNCT
dpc-1242	225	1	j	j	PROPN
dpc-1242	225	2	am	be	AUX
dpc-1242	225	3	acad	acad	ADJ
dpc-1242	225	4	dermatol	dermatol	NOUN
dpc-1242	225	5	.	.	PUNCT
dpc-1242	226	1	2001;44(1	2001;44(1	NUM
dpc-1242	226	2	suppl):s47	suppl):s47	PROPN
dpc-1242	226	3	-	-	PUNCT
dpc-1242	226	4	s57	s57	NOUN
dpc-1242	226	5	.	.	PUNCT
dpc-1242	227	1	doi	doi	NOUN
dpc-1242	227	2	:	:	PUNCT
dpc-1242	227	3	10.1067	10.1067	NUM
dpc-1242	227	4	/	/	SYM
dpc-1242	227	5	mjd.2001.109813	mjd.2001.109813	NUM
dpc-1242	227	6	.	.	PUNCT
dpc-1242	227	7	nisms	nism	NOUN
dpc-1242	227	8	of	of	ADP
dpc-1242	227	9	action	action	NOUN
dpc-1242	227	10	:	:	PUNCT
dpc-1242	227	11	an	an	DET
dpc-1242	227	12	update	update	NOUN
dpc-1242	227	13	.	.	PUNCT
dpc-1242	228	1	mediators	mediator	NOUN
dpc-1242	228	2	inflamm	inflamm	NOUN
dpc-1242	228	3	.	.	PUNCT
dpc-1242	229	1	1998;7(3):183193	1998;7(3):183193	X
dpc-1242	229	2	.	.	PUNCT
dpc-1242	230	1	doi	doi	NOUN
dpc-1242	230	2	:	:	PUNCT
dpc-1242	230	3	10.1080/09629359891126	10.1080/09629359891126	NUM
dpc-1242	230	4	.	.	NOUN
dpc-1242	231	1	6	6	NUM
dpc-1242	231	2	.	.	X
dpc-1242	231	3	altura	altura	PROPN
dpc-1242	231	4	bm	bm	PROPN
dpc-1242	231	5	.	.	PUNCT
dpc-1242	231	6	role	role	NOUN
dpc-1242	231	7	of	of	ADP
dpc-1242	231	8	glucocorticoids	glucocorticoid	NOUN
dpc-1242	231	9	in	in	ADP
dpc-1242	231	10	local	local	ADJ
dpc-1242	231	11	regulation	regulation	NOUN
dpc-1242	231	12	of	of	ADP
dpc-1242	231	13	blood	blood	NOUN
dpc-1242	231	14	flow	flow	NOUN
dpc-1242	231	15	.	.	PUNCT
dpc-1242	232	1	am	be	AUX
dpc-1242	232	2	j	j	PROPN
dpc-1242	232	3	physiol	physiol	PROPN
dpc-1242	232	4	.	.	PUNCT
dpc-1242	233	1	1966;211(6):1393	1966;211(6):1393	NUM
dpc-1242	233	2	-	-	SYM
dpc-1242	233	3	1397	1397	NUM
dpc-1242	233	4	.	.	PUNCT
dpc-1242	234	1	doi	doi	NOUN
dpc-1242	234	2	:	:	PUNCT
dpc-1242	234	3	10.1152	10.1152	NUM
dpc-1242	234	4	/	/	SYM
dpc-1242	234	5	ajplegacy.1966.211.6.1393	ajplegacy.1966.211.6.1393	PROPN
dpc-1242	234	6	.	.	PUNCT
dpc-1242	235	1	7	7	X
dpc-1242	235	2	.	.	X
dpc-1242	235	3	eichenfield	eichenfield	PROPN
dpc-1242	235	4	lf	lf	PROPN
dpc-1242	235	5	,	,	PUNCT
dpc-1242	235	6	tom	tom	PROPN
dpc-1242	235	7	wl	wl	PROPN
dpc-1242	235	8	,	,	PUNCT
dpc-1242	235	9	berger	berger	PROPN
dpc-1242	235	10	tg	tg	PROPN
dpc-1242	235	11	,	,	PUNCT
dpc-1242	235	12	et	et	PROPN
dpc-1242	235	13	al	al	PROPN
dpc-1242	235	14	.	.	PUNCT
dpc-1242	235	15	guidelines	guideline	NOUN
dpc-1242	235	16	of	of	ADP
dpc-1242	235	17	care	care	NOUN
dpc-1242	235	18	for	for	ADP
dpc-1242	235	19	the	the	DET
dpc-1242	235	20	management	management	NOUN
dpc-1242	235	21	of	of	ADP
dpc-1242	235	22	atopic	atopic	NOUN
dpc-1242	235	23	dermatitis	dermatitis	NOUN
dpc-1242	235	24	:	:	PUNCT
dpc-1242	235	25	section	section	NOUN
dpc-1242	235	26	2	2	NUM
dpc-1242	235	27	.	.	PUNCT
dpc-1242	235	28	management	management	NOUN
dpc-1242	235	29	and	and	CCONJ
dpc-1242	235	30	treatment	treatment	NOUN
dpc-1242	235	31	of	of	ADP
dpc-1242	235	32	atopic	atopic	NOUN
dpc-1242	235	33	dermatitis	dermatitis	NOUN
dpc-1242	235	34	with	with	ADP
dpc-1242	235	35	topical	topical	ADJ
dpc-1242	235	36	therapies	therapy	NOUN
dpc-1242	235	37	.	.	PUNCT
dpc-1242	236	1	j	j	PROPN
dpc-1242	236	2	am	be	AUX
dpc-1242	236	3	acad	acad	ADJ
dpc-1242	236	4	dermatol	dermatol	NOUN
dpc-1242	236	5	.	.	PUNCT
dpc-1242	237	1	2014;71(1):116	2014;71(1):116	NUM
dpc-1242	237	2	-	-	SYM
dpc-1242	237	3	132	132	NUM
dpc-1242	237	4	.	.	PUNCT
dpc-1242	238	1	doi	doi	NOUN
dpc-1242	238	2	:	:	PUNCT
dpc-1242	238	3	10.1016	10.1016	NUM
dpc-1242	238	4	/	/	SYM
dpc-1242	238	5	j.	j.	PROPN
dpc-1242	238	6	jaad.2014.03.023	jaad.2014.03.023	PROPN
dpc-1242	238	7	.	.	PROPN
dpc-1242	238	8	8	8	NUM
dpc-1242	238	9	.	.	X
dpc-1242	239	1	rico	rico	PROPN
dpc-1242	239	2	mj	mj	PROPN
dpc-1242	239	3	,	,	PUNCT
dpc-1242	239	4	lawrence	lawrence	PROPN
dpc-1242	239	5	i.	i.	PROPN
dpc-1242	239	6	tacrolimus	tacrolimus	PROPN
dpc-1242	239	7	ointment	ointment	NOUN
dpc-1242	239	8	for	for	ADP
dpc-1242	239	9	the	the	DET
dpc-1242	239	10	treatment	treatment	NOUN
dpc-1242	239	11	of	of	ADP
dpc-1242	239	12	atopic	atopic	NOUN
dpc-1242	239	13	dermatitis	dermatitis	NOUN
dpc-1242	239	14	:	:	PUNCT
dpc-1242	239	15	clinical	clinical	ADJ
dpc-1242	239	16	and	and	CCONJ
dpc-1242	239	17	pharmacological	pharmacological	ADJ
dpc-1242	239	18	effects	effect	NOUN
dpc-1242	239	19	.	.	PUNCT
dpc-1242	240	1	allergy	allergy	PROPN
dpc-1242	240	2	asthma	asthma	PROPN
dpc-1242	240	3	proc	proc	PROPN
dpc-1242	240	4	.	.	PUNCT
dpc-1242	241	1	2002;23(3):191	2002;23(3):191	NUM
dpc-1242	241	2	-	-	SYM
dpc-1242	241	3	197	197	NUM
dpc-1242	241	4	.	.	PUNCT
dpc-1242	242	1	pmid	pmid	NOUN
dpc-1242	242	2	:	:	PUNCT
dpc-1242	242	3	12125507	12125507	NUM
dpc-1242	242	4	.	.	PUNCT
dpc-1242	243	1	9	9	X
dpc-1242	243	2	.	.	X
dpc-1242	243	3	billiach	billiach	VERB
dpc-1242	243	4	a	a	PRON
dpc-1242	243	5	,	,	PUNCT
dpc-1242	243	6	aschauer	aschauer	NOUN
dpc-1242	243	7	h	h	PROPN
dpc-1242	243	8	,	,	PUNCT
dpc-1242	243	9	aszodi	aszodi	PROPN
dpc-1242	243	10	a	a	PRON
dpc-1242	243	11	,	,	PUNCT
dpc-1242	243	12	steutz	steutz	ADJ
dpc-1242	243	13	a.	a.	NOUN
dpc-1242	243	14	percutaneous	percutaneous	ADJ
dpc-1242	243	15	absorption	absorption	NOUN
dpc-1242	243	16	of	of	ADP
dpc-1242	243	17	drugs	drug	NOUN
dpc-1242	243	18	used	use	VERB
dpc-1242	243	19	in	in	ADP
dpc-1242	243	20	atopic	atopic	ADJ
dpc-1242	243	21	eczema	eczema	NOUN
dpc-1242	243	22	:	:	PUNCT
dpc-1242	243	23	pimecrolimus	pimecrolimus	NOUN
dpc-1242	243	24	permeates	permeate	VERB
dpc-1242	243	25	less	less	ADV
dpc-1242	243	26	through	through	ADP
dpc-1242	243	27	skin	skin	NOUN
dpc-1242	243	28	than	than	ADP
dpc-1242	243	29	corticosteroids	corticosteroid	NOUN
dpc-1242	243	30	and	and	CCONJ
dpc-1242	243	31	tacrolimus	tacrolimus	NOUN
dpc-1242	243	32	.	.	PUNCT
dpc-1242	244	1	int	int	PROPN
dpc-1242	244	2	j	j	PROPN
dpc-1242	244	3	pharm	pharm	PROPN
dpc-1242	244	4	.	.	PUNCT
dpc-1242	245	1	2004;269(1):29	2004;269(1):29	NUM
dpc-1242	245	2	-	-	SYM
dpc-1242	245	3	35	35	NUM
dpc-1242	245	4	.	.	PUNCT
dpc-1242	246	1	doi	doi	NOUN
dpc-1242	246	2	:	:	PUNCT
dpc-1242	246	3	10.1016	10.1016	NUM
dpc-1242	246	4	/	/	SYM
dpc-1242	246	5	j.ijpharm.2003.07.013	j.ijpharm.2003.07.013	PROPN
dpc-1242	246	6	.	.	PROPN
dpc-1242	246	7	10	10	NUM
dpc-1242	246	8	.	.	X
dpc-1242	247	1	berth	berth	NOUN
dpc-1242	247	2	-	-	PUNCT
dpc-1242	247	3	jones	jones	PROPN
dpc-1242	247	4	j	j	PROPN
dpc-1242	247	5	,	,	PUNCT
dpc-1242	247	6	damstra	damstra	PROPN
dpc-1242	247	7	rj	rj	PROPN
dpc-1242	247	8	,	,	PUNCT
dpc-1242	247	9	golsch	golsch	NOUN
dpc-1242	247	10	s	s	PROPN
dpc-1242	247	11	,	,	PUNCT
dpc-1242	247	12	et	et	PROPN
dpc-1242	247	13	al	al	PROPN
dpc-1242	247	14	.	.	PROPN
dpc-1242	248	1	twice	twice	ADJ
dpc-1242	248	2	weekly	weekly	ADJ
dpc-1242	248	3	fluticasone	fluticasone	NOUN
dpc-1242	248	4	propionate	propionate	NOUN
dpc-1242	248	5	added	add	VERB
dpc-1242	248	6	to	to	ADP
dpc-1242	248	7	emollient	emollient	NOUN
dpc-1242	248	8	maintenance	maintenance	NOUN
dpc-1242	248	9	treatment	treatment	NOUN
dpc-1242	248	10	to	to	PART
dpc-1242	248	11	reduce	reduce	VERB
dpc-1242	248	12	risk	risk	NOUN
dpc-1242	248	13	of	of	ADP
dpc-1242	248	14	relapse	relapse	NOUN
dpc-1242	248	15	in	in	ADP
dpc-1242	248	16	atopic	atopic	NOUN
dpc-1242	248	17	dermatitis	dermatitis	NOUN
dpc-1242	248	18	:	:	PUNCT
dpc-1242	248	19	randomised	randomise	VERB
dpc-1242	248	20	,	,	PUNCT
dpc-1242	248	21	double	double	ADV
dpc-1242	248	22	blind	blind	ADJ
dpc-1242	248	23	,	,	PUNCT
dpc-1242	248	24	parallel	parallel	ADJ
dpc-1242	248	25	group	group	NOUN
dpc-1242	248	26	study	study	NOUN
dpc-1242	248	27	.	.	PUNCT
dpc-1242	249	1	bmj	bmj	PROPN
dpc-1242	249	2	.	.	PUNCT
dpc-1242	250	1	2003;326(7403):1367	2003;326(7403):1367	NUM
dpc-1242	250	2	.	.	PUNCT
dpc-1242	251	1	doi	doi	NOUN
dpc-1242	251	2	:	:	PUNCT
dpc-1242	252	1	10.1136/	10.1136/	NUM
dpc-1242	252	2	bmj.326.7403.1367	bmj.326.7403.1367	PROPN
dpc-1242	252	3	.	.	PUNCT
dpc-1242	252	4	doi	doi	NOUN
dpc-1242	252	5	:	:	PUNCT
dpc-1242	252	6	10.1136	10.1136	NUM
dpc-1242	252	7	/	/	SYM
dpc-1242	252	8	bmj.326.7403.1367	bmj.326.7403.1367	PROPN
dpc-1242	252	9	.	.	PUNCT
dpc-1242	252	10	11	11	NUM
dpc-1242	252	11	.	.	PUNCT
dpc-1242	253	1	breneman	breneman	PROPN
dpc-1242	253	2	d	d	PROPN
dpc-1242	253	3	,	,	PUNCT
dpc-1242	253	4	fleischer	fleischer	PROPN
dpc-1242	253	5	ab	ab	PROPN
dpc-1242	253	6	,	,	PUNCT
dpc-1242	253	7	abramovits	abramovits	PROPN
dpc-1242	253	8	w	w	PROPN
dpc-1242	253	9	,	,	PUNCT
dpc-1242	253	10	et	et	PROPN
dpc-1242	253	11	al	al	PROPN
dpc-1242	253	12	.	.	PUNCT
dpc-1242	254	1	intermittent	intermittent	PROPN
dpc-1242	254	2	therapy	therapy	NOUN
dpc-1242	254	3	for	for	ADP
dpc-1242	254	4	flare	flare	NOUN
dpc-1242	254	5	prevention	prevention	NOUN
dpc-1242	254	6	and	and	CCONJ
dpc-1242	254	7	long	long	ADJ
dpc-1242	254	8	-	-	PUNCT
dpc-1242	254	9	term	term	NOUN
dpc-1242	254	10	disease	disease	NOUN
dpc-1242	254	11	controlled	control	VERB
dpc-1242	254	12	in	in	ADP
dpc-1242	254	13	stabilized	stabilize	VERB
dpc-1242	254	14	atopic	atopic	NOUN
dpc-1242	254	15	dermatitis	dermatitis	NOUN
dpc-1242	254	16	:	:	PUNCT
dpc-1242	254	17	a	a	DET
dpc-1242	254	18	randomized	randomized	ADJ
dpc-1242	254	19	comparison	comparison	NOUN
dpc-1242	254	20	of	of	ADP
dpc-1242	254	21	3	3	NUM
dpc-1242	254	22	-	-	PUNCT
dpc-1242	254	23	times	time	NOUN
dpc-1242	254	24	-	-	PUNCT
dpc-1242	254	25	weekly	weekly	ADJ
dpc-1242	254	26	applications	application	NOUN
dpc-1242	254	27	of	of	ADP
dpc-1242	254	28	tacrolimus	tacrolimus	PROPN
dpc-1242	254	29	ointment	ointment	NOUN
dpc-1242	254	30	versus	versus	ADP
dpc-1242	254	31	vehicle	vehicle	NOUN
dpc-1242	254	32	.	.	PUNCT
dpc-1242	255	1	j	j	PROPN
dpc-1242	255	2	am	be	AUX
dpc-1242	255	3	acad	acad	ADJ
dpc-1242	255	4	dermatol	dermatol	NOUN
dpc-1242	255	5	.	.	PUNCT
dpc-1242	256	1	2008;58(6):990	2008;58(6):990	NUM
dpc-1242	256	2	-	-	SYM
dpc-1242	256	3	999	999	NUM
dpc-1242	256	4	.	.	PUNCT
dpc-1242	257	1	doi	doi	NOUN
dpc-1242	257	2	:	:	PUNCT
dpc-1242	257	3	10.1016	10.1016	NUM
dpc-1242	257	4	/	/	SYM
dpc-1242	257	5	j.jaad.2008.02.008	j.jaad.2008.02.008	NOUN
dpc-1242	257	6	.	.	PUNCT
dpc-1242	258	1	12	12	NUM
dpc-1242	258	2	.	.	PUNCT
dpc-1242	259	1	hanifin	hanifin	PROPN
dpc-1242	259	2	jm	jm	PROPN
dpc-1242	259	3	,	,	PUNCT
dpc-1242	259	4	rajka	rajka	PROPN
dpc-1242	259	5	g.	g.	PROPN
dpc-1242	259	6	diagnostic	diagnostic	PROPN
dpc-1242	259	7	features	feature	NOUN
dpc-1242	259	8	of	of	ADP
dpc-1242	259	9	atopic	atopic	NOUN
dpc-1242	259	10	dermatitis	dermatitis	NOUN
dpc-1242	259	11	.	.	PUNCT
dpc-1242	260	1	acta	acta	PROPN
dpc-1242	260	2	dermatovener	dermatovener	PROPN
dpc-1242	260	3	(	(	PUNCT
dpc-1242	260	4	stockholm	stockholm	PROPN
dpc-1242	260	5	)	)	PUNCT
dpc-1242	260	6	.	.	PUNCT
dpc-1242	261	1	1980;92:44	1980;92:44	NUM
dpc-1242	261	2	-	-	SYM
dpc-1242	261	3	47	47	NUM
dpc-1242	261	4	.	.	PUNCT
dpc-1242	262	1	13	13	NUM
dpc-1242	262	2	.	.	X
dpc-1242	263	1	finlay	finlay	VERB
dpc-1242	263	2	ay	ay	PROPN
dpc-1242	263	3	,	,	PUNCT
dpc-1242	263	4	williams	williams	PROPN
dpc-1242	263	5	ay	ay	PROPN
dpc-1242	263	6	,	,	PUNCT
dpc-1242	263	7	harding	harding	PROPN
dpc-1242	263	8	kg	kg	PROPN
dpc-1242	263	9	.	.	PUNCT
dpc-1242	264	1	“	"	PUNCT
dpc-1242	264	2	fingertip	fingertip	NOUN
dpc-1242	264	3	unit	unit	NOUN
dpc-1242	264	4	”	"	PUNCT
dpc-1242	264	5	in	in	ADP
dpc-1242	264	6	dermatology	dermatology	NOUN
dpc-1242	264	7	.	.	PUNCT
dpc-1242	265	1	lancet	lancet	PROPN
dpc-1242	265	2	.	.	PUNCT
dpc-1242	266	1	1989;2:155	1989;2:155	X
dpc-1242	266	2	.	.	PUNCT
dpc-1242	267	1	doi	doi	NOUN
dpc-1242	267	2	:	:	PUNCT
dpc-1242	267	3	10.1016	10.1016	NUM
dpc-1242	267	4	/	/	SYM
dpc-1242	267	5	s01406736(89)90204	s01406736(89)90204	NOUN
dpc-1242	267	6	-	-	PUNCT
dpc-1242	267	7	3	3	NUM
dpc-1242	267	8	.	.	NOUN
dpc-1242	267	9	14	14	NUM
dpc-1242	267	10	.	.	PUNCT
dpc-1242	268	1	kunz	kunz	PROPN
dpc-1242	268	2	b	b	PROPN
dpc-1242	268	3	,	,	PUNCT
dpc-1242	268	4	oranje	oranje	PROPN
dpc-1242	268	5	ap	ap	PROPN
dpc-1242	268	6	,	,	PUNCT
dpc-1242	268	7	labreze	labreze	PROPN
dpc-1242	268	8	l	l	PROPN
dpc-1242	268	9	,	,	PUNCT
dpc-1242	268	10	stalder	stalder	PROPN
dpc-1242	268	11	jf	jf	PROPN
dpc-1242	268	12	,	,	PUNCT
dpc-1242	268	13	ring	ring	PROPN
dpc-1242	268	14	j	j	PROPN
dpc-1242	268	15	,	,	PUNCT
dpc-1242	268	16	taieb	taieb	PROPN
dpc-1242	268	17	a.	a.	PROPN
dpc-1242	268	18	clinical	clinical	PROPN
dpc-1242	268	19	validation	validation	NOUN
dpc-1242	268	20	and	and	CCONJ
dpc-1242	268	21	guidelines	guideline	NOUN
dpc-1242	268	22	for	for	ADP
dpc-1242	268	23	the	the	DET
dpc-1242	268	24	scorad	scorad	PROPN
dpc-1242	268	25	index	index	NOUN
dpc-1242	268	26	:	:	PUNCT
dpc-1242	268	27	consensus	consensus	NOUN
dpc-1242	268	28	report	report	NOUN
dpc-1242	268	29	of	of	ADP
dpc-1242	268	30	the	the	DET
dpc-1242	268	31	european	european	PROPN
dpc-1242	268	32	task	task	PROPN
dpc-1242	268	33	force	force	NOUN
dpc-1242	268	34	on	on	ADP
dpc-1242	268	35	atopic	atopic	NOUN
dpc-1242	268	36	dermatitis	dermatitis	NOUN
dpc-1242	268	37	.	.	PUNCT
dpc-1242	269	1	dermatology	dermatology	NOUN
dpc-1242	269	2	.	.	PUNCT
dpc-1242	270	1	1997;195(1):10	1997;195(1):10	NUM
dpc-1242	270	2	-	-	SYM
dpc-1242	270	3	19	19	NUM
dpc-1242	270	4	.	.	PUNCT
dpc-1242	270	5	doi	doi	NOUN
dpc-1242	270	6	:	:	PUNCT
dpc-1242	270	7	10.1159/000245677	10.1159/000245677	NUM
dpc-1242	270	8	.	.	PUNCT